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Telemedicine has skyrocketed to national attention with the COVID-19 crisis, raising 
questions about how to best use virtual tools to support public health. One emerging sector of 
telemedicine is the rise of telecontraception platforms, such as Nurx, Pill Club, and Planned 
Parenthood Direct. Known as “the Uber for birth control”, these platforms represent a growing 
market and innovative approach that aim to address barriers to obtaining birth control such as 
geography, cost, time, and gatekeeping by providing contraception and other sexual and 
reproductive healthcare services directly to consumers (Sundstrom et al. 2019; Grindlay and 
Grossman 2016; Chuck 2017; Stormo et al. 2011). Contraception historically was and currently 
is riddled with red tape for women trying to access critical care they need to make decisions 
about their own bodies and lives. Telecontraception represents an important potential solution to 
these long-standing issues, yet its impact on women and health care has not yet been studied in 
depth. What are telecontraception platforms adding to the current landscape of reproductive 
health care? What problems are they solving and where are they falling short? Using mixed 
methods, this research aims to address this gap by exploring the accessibility, affordability, and 
equitability of these growing platforms.  
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Findings illustrate telecontraception alleviates many existing access barriers. Yet there 
are mixed findings regarding affordability and equitability. Cost, insurance, and state availability 
limit the scope of telecontraception and mirror existing systemic challenges women face on the 
ground. This carries important implications because this research also found that the majority of 
women across the United States expressed strong pregnancy avoidance attitudes regardless of 
subgroup. Having a large presence of women legislators alongside other state conditions was 
linked to telecontraception availability in Republican and Democrat politically controlled states, 
suggesting that gender and having women in positions of power, in combination with other 
political, social, and economic state-level factors, is another growing and important factor to 
consider in advocating for issues related to women such as reproductive rights and policy.  
Overall, this project identifies areas of progress and opportunities for improvement not only for 
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Telemedicine is a rapidly growing area of healthcare with the potential to cut costs and 
increase access, particularly for underserved and rural populations (Centers for Disease Control 
and Prevention 2020). The current COVID-19 crisis has brought telemedicine into the national 
spotlight. Rates of telehealth visits have increased during the pandemic, expanding access to 
services and improving reimbursement policies (Koonin et al. 2020; Campos-Castillo and 
Anthony 2021). One emerging sector of telemedicine is telecontraception platforms, such as 
Nurx, Pill Club, and Planned Parenthood Direct. Known as “the Uber for birth control”, these 
platforms provide birth control and sexual and reproductive healthcare services directly to 
consumers and aim to address barriers to obtaining contraception, particularly in the United 
States (Chuck 2017). The United States is unique in requiring a doctor’s prescription for birth 
control, compared to other countries where it is often free or sold over the counter without a 
prescription (Drum 2012; Khosla 2015). Furthermore, legislation and orders can also vary across 
different states, adding another layer of complexity to access (Nash et al. 2020).  
Nearly one-third of women report difficulties obtaining prescription contraception, with 
the most common barriers related to access and affordability (Grindlay and Grossman 2016). 
Moreover, the COVID-19 pandemic has impacted in-person access to contraception due to 
economic and logistic barriers (Lindberg et al. 2020). Requests for contraception from Nurx have 
increased by fifty percent since the beginning of the COVID-19 pandemic (St-Esprit 2021). 
Telecontraception serves as a potential avenue to help increase access to contraception and 
sexual and reproductive healthcare services by alleviating obstacles related to geography, cost, 
and time (Sundstrom et al. 2019; Weigel et al. 2019; Grindlay and Grossman 2016; Rodler et al. 
2020; Jain and Mehrotra 2020). Research has demonstrated both family planning provider and 
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patient support for telecontraception services (Stifani, Avila, and Levi 2021; Sundstrom et al. 
2019). However, currently it is unknown whether telecontraception increases access for those 
who face barriers or whether they provide convenience for those who already have access 
(Dorland, Fowler, and Morain 2019; Zuniga et al. 2020).  
Despite recent media coverage of telecontraception platforms (Rinker 2021; Shieber 
2020; Landi 2020; Chuck 2017), research has not yet examined their impact on women in depth 
or how women experience and evaluate these platforms. By examining how existing inequalities 
shape contraception access and user evaluations of telecontraception platforms, this research can 
inform both virtual and in-person healthcare systems. Telemedicine can save time, money, and is 
linked with high patient and provider satisfaction (Hanson et al. 2019), yet it not known whether 
these same findings carry over to telecontraception. Users may have positive or negative 
evaluations of telecontraception, and uptake of these platforms may be patterned by existing 
systemic disparities such as socioeconomic status. Highlighting user perspectives and 
evaluations of telecontraception platforms can uncover reasons for using the platform, delineate 
the pros and cons of using the platforms, and illuminate needs gaps in the traditional in-person 
healthcare system.   
Informed by the ecosocial model of health (Krieger 1994; Krieger 2001), this dissertation 
examines the multiple, overlapping processes at work in reproductive healthcare and 
telecontraception ranging from individual attitudes to state-level conditions. The research design 
uses mixed methods to investigate both micro and macro factors shaping reproductive healthcare 
access, affordability, and equity with an emphasis on priority populations such as racial and 
ethnic minority and uninsured women. Using national population analyses, state-level data, and 
user reviews, I map the state of reproductive health care for a national aggregate sample of 
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women as well as subsets of women such as priority populations and telecontraception platform 
users. Together, these findings provide a more comprehensive view of the current landscape and 
highlight opportunities for improved service delivery in both virtual and in-person healthcare 
spaces. This dissertation has three aims and is structured sequentially according to these aims.  
Aim #1: The Current Landscape of Reproductive Healthcare 
The goal of the first aim is to better understand sources of reproductive healthcare access, 
affordability, and equitability issues. This section of the dissertation aims to provide a picture of 
the current landscape of reproductive healthcare services, paying particular attention to 
subgroups of women such as racial and ethnic minority women, uninsured women, low-income 
women, and women living in metro versus nonmetro areas. Over ten percent of women in the 
United States are uninsured, and there are still significant racial and ethnic disparities in 
insurance coverage despite passage of the Affordable Care Act (Kaiser Family Foundation 2021; 
Shane and Ayyagari 2014; Breslau et al. 2018; Smith and Medalia 2014; O’Hara and Brault 
2013). This analysis builds on previous research by simultaneously examining multiple aspects 
of reproductive health such as individual attitudes, interpersonal influences, and institutional 
policy factors post-Affordable Care Act for key subgroups using a national survey of women. 
Doing so allows for a more in-depth look into the factors behind reproductive healthcare 
disparities and whether different levels (individual, interpersonal, institutional) matter more than 
others to identify areas and opportunities for improvement.  
Aim #2: Understanding State-Level Variation in Telecontraception Access 
 The second aim investigates the state-level conditions that pattern accessibility and 
availability of telecontraception platforms across the United States. Although telecontraception 
platforms claim to provide contraception and sexual and reproductive healthcare services directly 
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to patients, policy and legislation can affect the reach of telecontraception across states by 
dictating a platform’s ability to prescribe and/or dispense medications. Therefore, patients may 
not be able to access these services if their state has not granted telecontraception platforms the 
prescribing and dispensing authority. Recent research mapping out telecontraception platform 
characteristics has identified differences in cost, age requirements, and state availability across 
platforms (Zuniga et al. 2020; Dorland, Fowler, and Morain 2019). However, it is unknown what 
affects these different factors. The political, economic, or social conditions within a state can all 
interact to impact telecontraception platform availability. Using an original dataset constructed 
from public-use websites, these analyses identify specific combinations of state-level conditions 
that pattern access and availability of telecontraception platforms across the United States and 
illustrate the social shaping of technological innovations. 
Aim #3: Understanding the Experiences of Telecontraception Users  
 The goal of Aim #3 is to illuminate user evaluations of telecontraception platforms to 
gain access to contraception and sexual and reproductive healthcare services. Doing so allows for 
an on-the-ground perspective of what women experience accessing contraception and 
reproductive healthcare services both in the virtual and in-person healthcare spheres. Research 
examining user motivations, experiences, and evaluations of telecontraception platforms is 
lacking. While there has been research on health and wellness app users as well as informational 
reproductive health app users (Carroll et al. 2017; Whitfield, Welti, and Manlove 2019; Gressel 
et al. 2014; Akinola et al. 2019), little research exists on telecontraception platform users and 
research on their experiences using these platforms. Knowing more about how women 
experience and evaluate these platforms is important to delineating what telecontraception is 
adding to the landscape of reproductive healthcare services, specifically whether and how it is 
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addressing existing barriers to obtain contraception and other sexual and reproductive health 
services. This is important because it can identify areas where telecontraception may be helping 
women as well as areas for improvement, and this knowledge can be used to improve both 
virtual and traditional in-person healthcare spaces. This section of the dissertation aims to 
address this knowledge gap by analyzing publicly available user reviews for two major 
telecontraception platforms, Nurx and Planned Parenthood Direct, which represent opposites in 
terms of size, development stage, and user orientation. Findings from this qualitative analysis 
illustrate that telecontraception addresses many barriers present in the traditional healthcare 
system by providing timely access to contraception and connecting patients with on-demand 
access to supportive, knowledgeable providers and information about birth control options. 
Support and gratitude for the idea of telecontraception and its services uncover a long-standing 
need for these types of services for women. Findings also demonstrate that while users share 
similar motivations for accessing telecontraception platforms, their experiences can differ 
depending on existing systemic issues such as cost and insurance.  
Dissertation Significance and Impact 
More informed understandings of reproductive healthcare accessibility, affordability, and 
equitability on the individual, state, and national levels will allow for more nuanced, targeted 
refinement of reproductive healthcare service delivery and policy. This can provide more 
openings for intervention and improvement of reproductive health care for all women across the 
United States. Providing a current snapshot of telecontraception, an emerging area of 
telemedicine, and the specific factors patterning its availability and impacting user experiences 
can also inform and improve broader telehealth measures, interventions, and policy. 
Telecontraception platforms are a rapidly growing area of telemedicine that have the potential to 
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improve access, affordability, and equitability of reproductive healthcare. While research is 
beginning to examine these platforms (Zuniga et al. 2020; Dorland, Fowler, and Morain 2019), 
this study is the first to assess the accessibility, affordability, and equity of these innovative 
platforms and their impact on women and healthcare in depth.   
Findings from this dissertation demonstrate multiple, overlapping influences on 
contraception access and how these influences are patterned by existing social, economic, and 
political conditions. Health apps and telemedicine are growing in numbers and demand (Lupton 
2018; Carroll et al. 2017; Payne et al. 2015). As these new platforms enter our world, new 
research will be needed to analyze how they shape and are shaped by current institutions. This 
dissertation answers this call by examining the specific case of telecontraception. Technological 
innovations operate within specific contexts, so research is needed to illuminate how emerging 
technologies such as telecontraception impact, and are impacted by, society. Using a sociological 
lens to examine these technological innovations allows for a more holistic way of investigating 
their accessibility and delivery because it encompasses the broader social, economic, and 
political conditions and context from which these platforms are born and in which they operate. 
This dissertation analyzes the promises and pitfalls of telecontraception platforms, illuminating 
areas for improvement in both the virtual and traditional in-person healthcare systems. Findings 
can help inform legislators, policymakers, stakeholders, researchers, and health practitioners 
involved with reproductive healthcare and telemedicine, as well as those focused on 
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AIM #1: Individual, Interpersonal, or Institutional Influences? Using Ecosocial Theory to 
Examine Disparities in Women’s Healthcare Visits 
 
Just over one in ten, or 11.1 million women, in the United States did not have insurance 
in 2019 (Kaiser Family Foundation 2021). Although the Affordable Care Act (ACA) has 
increased insurance coverage rates, disparities persist by race and ethnicity (Shane and Ayyagari 
2014; Breslau et al. 2018; Smith and Medalia 2014; O’Hara and Brault 2013). Insurance 
coverage carries implications for health outcomes and disparities, especially for women’s access 
to reproductive healthcare visits. Previous research indicates that healthcare visits are a critical 
element contributing to health (Antonisse et al. 2018; Collins et al. 2016; Baicker et al. 2013), 
and quality of women’s health care visits can vary by insurance type (Ranji, Gomez, and 
Salganicoff 2019). Despite the vast amount of literature demonstrating racial/ethnic and 
socioeconomic disparities in unintended pregnancy (Kim et al. 2016; Finer and Zolna 2016), less 
is known about the specific factors which contribute towards broader disparities in women’s 
reproductive health, specifically their access to office visits.  
Moreover, influences at multiple levels, from attitudes to policy, can affect women’s 
access and experiences of reproductive healthcare. Recent research using the social ecological 
model (SEM) to investigate factors associated with unintended pregnancy found that 
intrapersonal, interpersonal, institutional, and policy factors all contributed to racial and ethnic 
disparities in unintended pregnancy (Kim et al. 2016). In addition to cost and access issues, 
research on rural reproductive health disparities point to other barriers such as generational 
habits and attitudes toward health (Smith, Sundstrom, and DeMaria 2019), illustrating that 
interpersonal influences and individual attitudes may also play a role in health disparities.  
Higher numbers of low-income women, immigrant women, and women of color are 
uninsured compared to white women (Kaiser Family Foundation 2021; Eliason 2019). What 
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implications does this have for reproductive health disparities? While previous research has 
examined reproductive healthcare access and affordability before and after ACA (Finer, 
Sonfield, and Jones 2014; Sonfield et al. 2015), less is known about reproductive healthcare 
services post-ACA for key population subgroups, such as race/ethnicity, income, and insurance 
status, and the specific factors which influence women’s reproductive healthcare experiences and 
visits. Recent studies have begun to look into this: Eliason (2019) compared the use of sexual 
and reproductive health services before and after ACA, and Hammond (2019) examined 
contraception access by subgroup post-ACA. In addition to access and affordability, women’s 
feelings and attitudes toward contraception and pregnancy are an integral part of reproductive 
healthcare, since they can drive behavior (Jones 2017). More research is needed on which factors 
drive reproductive healthcare visits and whether different levels (individual, interpersonal, 
institutional) matter more than others so that healthcare providers, professionals, and 
policymakers can better serve the reproductive healthcare needs of all women.  
This study builds on previous research by simultaneously examining multiple factors of 
reproductive health, such as individual attitudes, interpersonal variables, and institutional policy 
factors, post-ACA for key population subgroups using a national survey of women. Moreover, 
data for this study allows us to go beyond insurance coverage to investigate multiple 
reproductive healthcare factors, from individual to policy, and how they are patterned across 
women. Examining the state of in-person reproductive healthcare services for different 
populations of women can illuminate the accessibility and equitability of reproductive healthcare 
services as well as individual attitudes and feelings toward pregnancy and contraception, 
providing a more in-depth look into the factors behind reproductive healthcare disparities. Doing 
so can help inform researchers, policymakers, and stakeholders about the factors driving 
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women’s reproductive healthcare visits, allowing for more nuanced, targeted refinement of 
public messaging and education, medical protocols, and reproductive healthcare policy. 
LITERATURE REVIEW 
Women’s Healthcare Visits: An Overview 
The Affordable Care Act expanded coverage of preventative healthcare services for 
women, such as cancer and mental health screenings, prenatal care, and contraceptive method 
counseling (Health Resources & Services Administration 2019). However, research focused on 
access to sexual and reproductive health service visits shows that increased access under ACA 
only tells part of the story. Eliason (2019) looked at racial and ethnic differences in making a 
sexual or reproductive healthcare visit before and after the dependent care provision of the ACA 
was passed, which allowed young people to stay on a parent’s health insurance plan until their 
26th birthday. The young adult population under the age of 26 is disproportionately non-white in 
the United States (Schaeffer 2019), meaning that this provision of the ACA has the potential to 
address racial disparities. Although lacking health insurance coverage decreased during this time 
period, utilization of sexual and reproductive health services did not change for non-Hispanic 
black women and non-Hispanic white women (Eliason 2019). However, there was an increase in 
receiving birth control methods or prescriptions for Hispanic women before and after this 
provision (Eliason 2019). Another study found that although rates of uninsured women declined 
post-ACA, they did not change for Latinas, either U.S.-born or foreign-born (Jones and Sonfield 
2016).  
Taken together, the above research illustrates how making a women’s healthcare visit can 
vary depending on many factors ranging from attitudes to access. Research shows that 
preventative healthcare visits are a critical point of contact that influences healthcare disparities 
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(Antonisse et al. 2018; Collins et al. 2016; Baicker et al. 2013; Benard et al. 2014). More 
research is needed to untangle what drives making a visit and whether certain factors matter 
more than others. Moreover, the type of visit may also matter if there are different influences at 
play depending on the type of healthcare visit, such as whether it is a preventative visit or a 
sexual health visit.    
Ecosocial Model of Health Theory 
Nancy Krieger’s (1994) ecosocial framework posits a theory of health that recognizes the 
dynamic, intertwined nature of individuals and societal structures (Krieger 2014). This theory 
seeks to explain patterns of health disparities by illustrating particular time-period and context-
specific combinations of norms, social structures, policies, institutions, and individual agency as 
well as the dynamic interrelationships among them. It seeks to move beyond biological causes of 
health by incorporating social explanations to provide a fuller picture of “‘who and what drives 
current and changing patterns of social inequalities in health’” (Krieger 2001, p. 672). Central to 
Krieger’s theory is the image of a “web” of pathways linking together at multiple levels, and the 
individual as the embodiment of both their biological and social world; their lived experience 
(Krieger 2014; Krieger 1994). Both biology and society structure the pathways of embodiment; it 
is not one or the other because they are interlinked. This framework recognizes the dynamic, 
multilevel, overlapping processes at work in health outcomes, challenging the separation 
between an “exogenous” environment and a biological “organism” (Krieger 1994, p. 899). The 
following review of the literature examines aspects of reproductive healthcare on multiple levels 




Individual. One important component of the reproductive healthcare “web” of pathways 
concerns individual attitudes, feelings, and knowledge about contraceptive use and pregnancy. 
Pregnancy attitudes are often divided into two distinct dimensions: cognitive (intentions) and 
affective (feelings) (Jones 2017). Cognitive attitudes towards pregnancy consist of an 
individual’s intention to avoid pregnancy, while affective attitudes consist of an individual’s 
feelings towards possible pregnancy (Jones 2017). Research has found that these are two 
different concepts, and that cognitive attitudes are associated with consistent contraceptive use 
more than affective attitudes (Jones 2017). Having a strong pregnancy avoidance attitude was 
associated with ten times higher odds of using contraceptives consistently compared to those 
who had a weak pregnancy avoidance attitude (Jones et al. 2015). Measures of pregnancy 
attitudes can change over time, illustrating the need for longitudinal data (Vaisanen and Jones 
2015). Knowledge of birth control is another factor in contraceptive use and behavior. Research 
has found that misinformation and misperceptions about birth control, such as needing to take a 
break from it or not getting pregnant after stopping a shot, affected contraception use (Kendall et 
al. 2005; Reed et al. 2014). This misinformation can be particularly risky because it can result in 
unintended pregnancy. Qualitative research has found that women using contraception 
inconsistently or not at all had false beliefs about their likelihood of pregnancy, viewing 
themselves as “safe” from pregnancy since they did not get pregnant after unprotected sex (Reed 
et al. 2014).  
Pregnancy attitudes and feelings can also differ by race/ethnicity, education, and age. 
One study found that although cognitive attitudes toward pregnancy avoidance were not 
associated with race/ethnicity, affective attitudes (feelings about experiencing an unplanned 
pregnancy) were associated with race/ethnicity (Hayford and Guzzo 2013). Another study found 
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that Hispanic women and white women were more likely to start trying to get pregnant than 
other racial and ethnic groups, and higher-educated women had a higher likelihood of weaker 
pregnancy avoidance attitudes (Vaisanen and Jones 2015). These findings illustrate how social 
structures may impact individual attitudes, such as having more resources to support a 
pregnancy. Age is also associated with differences in pregnancy avoidance attitudes. One study 
found that attitudes changed more among older than younger (18 to 24 years) women (Vaisanen 
and Jones 2015). Research has shown that teens prefer to go to family planning clinics for sexual 
and reproductive health services (Oglesby 2014; Sugerman et al. 2000), regardless of insurance 
status: approximately half of teens visiting a Planned Parenthood clinic had health insurance 
(Sugerman et al. 2000). While cost and confidentiality were cited as important preferences in that 
study, another study found that patients rated Planned Parenthood highly on additional 
dimensions of care, such as ease of getting care and medical staff treatment (Oglesby 2014). On 
the other hand, another study found that Latinas and black women preferred receiving 
reproductive healthcare at a general health care site (Becker and Tsui 2008). Women’s 
preferences for where to go may be based on the specific context of the facility in which they 
receive their services. These findings indicate that preferences and attitudes at the individual 
level do not exist in isolation but rather are shaped by interpersonal and community factors, such 
as staff interaction with patients and facility type characteristics.  
Interpersonal. Interactions between an individual and the people around them, and how 
they exert a reciprocal influence upon one another, illustrate the interpersonal level of the 
ecosocial theory (Rimer and Glanz 2005). Patient-provider communication is one example of 
this reciprocal interaction, and there is an extensive literature devoted to this topic. Doctors and 
patients influence one another through their interactions, and these interactions can influence 
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health behavior and outcomes. Research on patient-provider communication during reproductive 
and sexual health visits illustrate how these interactions can result in different outcomes based on 
patient characteristics such as sexual orientation (Agénor et al. 2015; Everett et al. 2019) or 
gender (Emmers-Sommer et al. 2009). Ashton et al. (2003) argue that racial/ethnic health 
disparities occur as a result of doctor-patient interactions rather than obtaining access to a doctor. 
Poor communication is posited as the main driver behind racial/ethnic health disparities, more so 
than provider racial bias or patient preferences, and the authors provide suggestions for how this 
can be remedied (Ashton et al. 2003).   
Research on racial and ethnic disparities in reproductive healthcare specifically has 
uncovered differences in service delivery preferences and service quality perceptions among 
black, Latina, and white women (Becker and Tsui 2008). Preferences and perceptions do not 
exist in a vacuum but are shaped by individual, interpersonal, and institutional factors. Historical 
abuses and systemic control, surveillance, and sterilization of women of color (Roberts 1999; 
Salas 2019) may impact their trust and experiences of reproductive healthcare interactions. 
Research has found that blacks were more likely than whites to report pressure to use 
contraceptives by a provider (Becker and Tsui 2008), pressure that can be implicit such as 
through provider tone of voice or imbalanced information favoring certain methods (Gomez and 
Wapman 2017). Other research did not find differences in contraceptive counseling by 
race/ethnicity and socioeconomic status of the patient but found that providers largely did not 
assess patient pregnancy intention, birth control preferences, or allow patients an opportunity to 
ask questions (Dehlendorf et al. 2017). Educational, interactive decision tools for patients to 
choose birth control and a printout given to the provider about their preferences prior to a 
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healthcare visit have been effective in patient-provider communication by allowing patient 
concerns and preferences to enter the discussion (Holt et al. 2020).  
Patient-provider interactions can influence patient behavior such as contraceptive use and 
pregnancy planning. One study found that contraceptive use was associated with the quality of 
care from a family planning service provider, with higher predicted probabilities of contraceptive 
use increasing as the quality of care increased from low, to medium, to high (RamaRao et al. 
2003). Having a women’s health care visit is linked with consistent contraceptive use (Jones et 
al. 2015). Another study found that women were less uncertain about their current plan to have a 
(another) baby if they discussed it with a healthcare provider in the last six months (Jones 2017). 
Taken together, the research on patient-provider interaction illustrates an important aspect of the 
ecosocial theory: interactions between women and their doctors can influence feelings and 
behaviors, and thus health outcomes. 
Other interactions and relationships in a woman’s life can also influence contraceptive 
use. Research on African American mother-daughter relationships illustrated that mother-
daughter closeness and communication influenced reproductive health care and behavior, with 
more open communication between mothers and daughters facilitating better communication 
between daughters and their health care providers (Warren-Jeanpiere 2006). Relationship status 
and satisfaction has also been linked with sexual health behavior. Relationship status and past 
use of contraception was significantly associated with contraception use intention (Campo et al. 
2012). Choice of method also differed depending on relationship status, with condoms associated 
with short-term relationships and hormonal methods used during longer-term relationships (Reed 
et al. 2014). Interestingly, while communication with a sexual partner was positively associated 
with contraceptive use intention, talking with friends was negatively associated with intention to 
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use birth control (Campo et al. 2012). Many different relationships and interactions can thus 
influence women’s health behavior and outcomes, ranging from mothers, to friends, to sexual 
partners. 
Institutional and Policy. Larger systematic and policy changes can also affect health 
behavior and outcomes. Insurance coverage and type of health insurance (for example, public or 
private) is a key factor associated with health outcomes. Women who are uninsured or have 
Medicaid insurance have more advanced breast cancer when diagnosed compared to privately 
insured women and also had higher risk of death and worse survival outcomes (Ayanian et al. 
1993), particularly for black and Hispanic women (Halpern et al. 2007). Lacking health 
insurance or having fee-for-service insurance was associated with lack of breast, colorectal, and 
cervical cancer screening (Hsia et al. 2000; Garfield, Orgera, Damico 2019). One explanation is 
that uninsured individuals do not have a regular place to go to for medical care (Garfield, Orgera, 
Damico 2019; Hsia et al. 2000). A recent Kaiser Family Foundation report found that 50 percent 
of uninsured individuals did not have a usual source of care, compared to just 11 percent of 
employer or privately insured individuals (Garfield, Orgera, Damico 2019). Expanding coverage 
to the uninsured can result in improved healthcare access and outcomes. An enormous body of 
research on Medicaid expansion under ACA (see Antonisse et al. 2018) illustrates how gaining 
coverage is associated with a myriad of improved outcomes, such as receipt of preventive care 
services (Baicker et al. 2013), contraceptive prescriptions (Ghosh, Simon, and Sommers 2017), 
improved access to doctor visits and prescriptions (Collins et al. 2016), decreased probability of 
positive depression screening (Baicker et al. 2013), and better physical and mental self-reported 
health compared to a control group which did not receive the expanded Medicaid access 
(Finkelstein et al. 2011).  
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Insurance status carries important consequences for reproductive healthcare costs. While 
preventive screenings and care are now covered under the ACA, racial and ethnic disparities 
persist in insurance coverage rates (Shane and Ayyagari 2014; Breslau et al. 2018; O’Hara and 
Brault 2013) as well as sexual and reproductive health services uptake (Hall, Moreau, and 
Trussell 2012; Eliason 2019). Higher numbers of low-income women, immigrant women, and 
women of color are uninsured compared to white women (KFF 2021; Eliason 2019). Another 
study found that Medicaid expansion and subsidized marketplace coverage under the ACA 
starting in 2014 decreased the percentage of uninsured women in states that expanded Medicaid, 
but not for women in states that opted out nor for U.S. and foreign-born Latinas (Jones and 
Sonfield 2016). Taken together, this research illustrates that policy matters both for health 
outcomes and disparities. Breslau et al. (2018) argues that these findings illustrate how 
researchers need to look at both current and historical causes for these disparities and that health 
equity cannot simply be achieved through policy, such as ACA. This illustrates the importance of 
looking at multiple levels, such as individual attitudes, patient-provider interactions, and 
institutional policy factors, because this may illuminate whether some levels impact healthcare 
disparities more than others.  
Significance 
 As this literature review shows, research on health outcomes and disparities occurs on the 
individual, interpersonal, and institutional levels. Do all levels matter equally for all types of 
women, or are some levels more important than others?  This study builds on previous work by 
simultaneously examining reproductive healthcare access, affordability, and attitudes post-ACA 
for important population subgroups using a national survey of women to better understand the 
relative importance of these different factors (see Figure 1). Specifically, this study looks at 
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individual, interpersonal, and institutional influences on making a birth control visit and a 
preventative reproductive healthcare visit using the 2012-2014 Continuity and Change in 
Contraceptive Use Study (CCCU), a national survey of 4,634 women between the ages of 18 and  
39 containing questions surrounding reproductive health attitudes, access, and affordability 
(Jones 2018). 
 
Figure 1.  Ecosocial Model of Health: Individual, Interpersonal, and Institutional Influences 
 
Previous research has used the CCCU to examine out-of-pocket contraceptive costs for 
privately insured women before and after the ACA (Finer, Sonfield, and Jones 2014; Sonfield et 
al. 2015), reproductive health access by demographic subgroups at Wave 2 in spring 2013 
(Hammond 2019), as well as contraceptive use, methods, and attitudes (Jones et al. 2015; 
Vaisanen and Jones 2015; Jones 2017; Jones 2017; Jones 2018; Jones, Lindberg, and Higgins 
2014; Lindberg, Jones, and Higgins 2014). Using the most recent wave of the CCCU (Wave 4, 
conducted in spring 2014) provides a national picture of reproductive healthcare across groups, 
allowing for a glimpse into both individual and policy factors that affect reproductive healthcare 
access and affordability. Moreover, previous research conducted by Jones and Sonfield (2016) 
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using the CCCU examined whether insurance coverage expanded for women living in states that 
expanded Medicaid under ACA. This study builds on this research by looking in greater detail at 
the breakdown of subgroups living in these states and whether women living in these states made 
a visit for reproductive healthcare due to this expansion. This study also addresses a gap in the 
literature raised by Hammond (2019) by looking at access and attitudes for women with 
Medicaid insurance and uninsured women.  
METHODS 
Sample 
Data for this project comes from the 2012-2014 Continuity and Change in Contraceptive 
Use Study (CCCU), a national survey of 4,634 women between the ages of 18 and 39 containing 
questions surrounding reproductive health attitudes, access, and affordability (Jones 2018). The 
CCCU administered four waves of online surveys to the sample every six months. Wave 1 of the 
study had a response rate of 59% (N=4,634). Retention rates for Waves 2 through 4 were 69% 
(N=3,207), 75% (N=2,398), and 77% (N=1,842), respectively. The survey contains measures 
about reproductive access, affordability, and attitudes on a national level and allows for analyses 
by key subgroup, such as race/ethnicity, socioeconomic status, and insurance status. Moreover, 
this study uses data from 2014 (Wave 4), a year in which additional policy changes led to some 
states expanding Medicaid under ACA as well as the creation of the health insurance 
marketplace. This study builds on previous literature by examining attitudes, interpersonal 
variables, and access simultaneously in the same national sample of women to provide a 
comprehensive understanding of reproductive healthcare access and experiences that can inform 
health education and policy in this area. Informed by the ecosocial model of health theory 
(Krieger 1994; Krieger 2001; Krieger 2014), the framework for this study recognizes the 
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multilevel processes at work in reproductive healthcare access, affordability, and equity, from 
individual attitudes to state and federal-level policies. 
 Analytic Sample. Data for this study comes from Wave 1 and Wave 4 of the CCCU 
(N=1,842). Women were asked if they made a women’s health care visit for any of the following 
three reasons in the last six months: visit for birth control or contraception, annual gyn visit or 
pap smear, or other women’s health care (pregnancy-related care, STDs, breast or other exams). 
A filter variable was created to assess whether a woman made a women’s health care (WHC) 
visit for any of the three reasons in the last six months, or did not make any women’s health care 
visit in the last six months. Out of the total 1,842 Wave 4 women, 1,020 (55.4%) made a WHC 
visit while 797 (43.3%) did not. I exclude women who did not have a visit (N = 797) as well as 
cases with missing data on any included variables (N = 63), resulting in a final analytic sample of 
982 women.  
 Analyses of the 797 women who did not make any WHC visit in the last six months 
illustrated that they were very similar in their demographic characteristics (race/ethnicity, 
education, employment, marital status, living in a Medicaid expansion state) to those in the final 
analytic sample, but had higher percentages of using a long-acting reversible contraceptive at the 
last wave, not dating anyone, and were older. The main differences were that they had higher 
percentages of not being insured (16.73%, compared to 6.31%) and not having a regular place to 
go for medical care (29.54%, compared to 12.73%). While these are important differences, the 
aim of this study is to look at individual, interpersonal, and institutional influences on making a 
WHC visit, specifically the predictors of making a birth control visit and the predictors of 
making an annual gynecological or pap smear visit. Since the 797 sample of women did not 
make any WHC visit in the last six months, we cannot look at visit-specific variables, such as 
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patient-provider communication or payment type, which may have influenced making a visit. 
Therefore, we exclude these women because the goal is to uncover information about which 
factors influence making a birth control visit as well as a preventative reproductive healthcare 
visit.   
 Missing Data. Missing data accounted for 6.03 percent (N = 63) of the eligible sample. 
Robustness checks were conducted to analyze findings with and without the missing data. 
Although there is no formal rule for when to impute data, low rates of missing data ranging from 
one to five percent generally do not require imputation models (Little et al. 2014; Social Science 
Computing Cooperative 2013). Data analyses of the 63 cases with missing data did not indicate 
concentration of missingness on one variable. The variable with the largest amount of missing 
data was the birth control visit dependent variable, with 12 cases missing data on that variable. 
However, since the amount of missing data was over five percent, multiple imputation was 
conducted in Stata as a robustness check to compare results with listwise deletion results. While 
there has been a long history of debate regarding imputing values on the dependent variable, 
research has demonstrated that the values of the dependent variable can be used to give 
information about the independent variables and the associations among all variables (not just 
those associated with missing data) and therefore should be included in analyses (Young and 
Johnson 2010; Allison 2000; Social Science Computing Cooperative 2015). Using imputed data 
can result in less biased data than dropping all cases with missing data (Horton and Kleinman 
2007). Findings using imputed data were similar to those using listwise deletion, so listwise 
deletion results are presented. Additionally, findings comparing results excluding pregnant 
women were compared to results including pregnant women since being pregnant could 
influence whether a woman has made a visit for birth control in the last six months. Results are 
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similar, so pregnant women are retained in all analyses. Supplementary analyses comparing 
estimation samples are available in Appendix A.    
Statistical Analyses  
Quantitative data analyses are two-fold. First, cross-tabulations, chi-square tests, and one-
way analysis of variance (ANOVA) tests were conducted to test for statistically significant 
relationships between reproductive health variables and key subgroups of women (race and 
ethnicity, socioeconomic status, and insurance status) in order to investigate which factors may 
be influencing disparities in healthcare visits. Second, logistic regression models predicting two 
different types of visits (birth control visit and women’s preventative reproductive healthcare 
visit) were conducted to better understand which level(s) may be driving reproductive health 
disparities. All statistical analyses were conducted in SPSS 25.0 (IBM Corp. 2017) and Stata IC 
15.1 (StataCorp. 2017). This study was approved by the University of Wisconsin-Milwaukee 
Institutional Review Board (IRB #20.339).    
Measures 
Dependent Variables. Reproductive healthcare visit type was measured using two 
variables, one for a birth control or contraception visit and one for preventive services (annual 
gynecological visit or pap smear). Despite the expansion of women’s healthcare services under 
ACA, disparities in making a visit persist by race/ethnicity, age, and geographic location (Benard 
et al. 2014; Shomo 2019; Nardi, Sandhu, and Selix 2016; Eliason 2019). To assess healthcare 
utilization of preventive and sexual health services, respondents were asked “Did you make a 
visit for any of the following medical services in the last 6 months?” with the option of 
responding “yes” or “no” (Jones 2018). The two dependent variables of interest in this study are 
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whether a respondent made a visit for “an annual gyn visit or pap smear” or “a visit for birth 
control or contraception” in the last six months (Jones 2018).  
Individual Attitudes, Knowledge, and Contraception Use. Cognitive attitude toward 
pregnancy was used as a measure for pregnancy avoidance attitude, following previous research 
(Jones et al. 2015; Jones 2017). Women were asked “How important is it to you to AVOID 
becoming pregnant now?” and could respond on a six-point scale ranging from 1 “not at all 
important” to 6 “very important” (Jones 2018). Birth control methods knowledge was asked 
about at Wave 1 (“How much do you know about birth control methods?” (Jones 2018)) and 
respondents could answer on a scale from 1 “I know nothing” to 6 “I know everything”. 
Knowledge of birth control methods was treated as a continuous rather than categorical variable 
in all analyses due to problems with small cell sizes when used in the logit analyses. Hormonal 
contraception use utilized a recoded variable from GfK, the company that administered the 
survey, indicating whether the respondent used the birth control pill at any of the previous survey 
waves, as well as whether they used an implant or IUD at Wave 3 (six months prior to Wave 4).  
Interpersonal Variables. Patient-provider communication was assessed using two 
variables. Discussions with a healthcare provider about pregnancy intention was measured using 
the question “At your last visit for women's health care, did a doctor or nurse spend time talking 
with you about your future plans for having or not having children (or more children)?” 
Contraceptive counseling was measured by using the question “At your last visit for women's 
health care, did you get information about birth control and pregnancy prevention?” (Jones 
2018). Although these questions cannot assess whether the respondent wanted to talk about these 
subjects during their last women’s health care visit, they still provide valuable information on 
whether providers actually discussed these topics with their patients and whether this differed by 
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subgroup. Previous research did not find differences in contraceptive counseling by 
race/ethnicity and socioeconomic status of the patient but found that providers largely did not 
assess patient pregnancy intention or birth control preferences (Dehlendorf et al. 2017). The last 
interpersonal variable is relationship status, since previous research demonstrated its link with 
contraceptive method and use (Reed et al. 2014; Campo et al. 2012). Respondents were asked 
whether they have been with their current partner for six months or longer, and response options 
consisted of: “yes”, “no”, and “yes, though we have broken up and gotten back together during 
that time” (Jones 2018). A fourth category was coded as “N/A, not in a relationship” if the 
respondent was not currently dating someone on a regular basis. 
Institutional Policy Factors. Having a regular place to go for medical care, living in a 
state that expanded Medicaid as of December 2013, facility type, and payment method all 
measure structural, systemic access to reproductive healthcare. Regular place for medical care 
was measured using the question “Do you have a regular place you go to for medical care?” (yes 
or no) (Jones 2018). Living in a state that expanded Medicaid was measured as a dichotomous 
variables (yes or no), and was constructed using a list of states that expanded Medicaid as of 
December 2013, the time period before Wave 4 of the CCCU was conducted in 2014. Facility 
type was measured using responses to the question “Thinking about your last visit where you 
received women’s health care, what type of place did you go to?” (Jones 2018). Responses 
options consisted of: private doctor’s office or group practice; Planned Parenthood or other 
family planning clinic; public health department or community health clinic; student health 
clinic; or some other type of health care facility (Jones 2018). Responses for student health clinic 
and some other type of health care facility were combined into one category due to low cell 
count sizes. Payment method was measured by the question “How did you pay for your last 
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women’s healthcare visit?” with possible responses of: paying some or all of the costs including 
co-pays myself, insurance paying some or all of the costs, reduced fee, or free services (Jones 
2018). Reduced fee and free services were combined into one category due to low cell count 
sizes. 
 Key Subgroups. Important population subgroups of the national sample of women were 
measured using three categorical variables: race and ethnicity, socioeconomic status, and 
insurance status. Race and ethnicity consisted of five mutually exclusive response options: non-
Hispanic white women, non-Hispanic black women, non-Hispanic other women, non-Hispanic 
multiracial (2 or more races) women, and Hispanic women. Socioeconomic status utilized a 
recoded variable from GfK, the company that administered the survey, which calculated poverty 
status based on household income and size. Household income and size were only asked about at 
Wave 1 in 2012. Insurance status consisted of the following categories: private insurance, 
Medicaid, marketplace, and uninsured.  
Control Variables. Control variables include age, education (less than high school, high 
school, some college no degree, associate’s degree, bachelor’s degree, master’s degree, or 
professional or doctorate degree; master’s and professional and doctorate degree were combined 
into one category due to low cell count sizes), employment status (full-time, part-time, or 
unemployed), marital status (never married, living with partner, married, divorced, or separated; 
divorced and separated were combined into one category due to low cell count sizes), and 
nativity status (born in the U.S. or not). Nativity status is an important factor to include in health 
disparities research because lumping together these two groups can obscure the findings (Krieger 
2012). Analyses were run with age as both a continuous and categorical variable, and results 
were statistically significant with either coding decision. In order to illuminate possible policy 
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effects of the dependent care coverage provision and based on the histogram cutoffs, the 
categorical coding of age was retained in analyses (18 to 26, 27 to 30, 31 to 36, and 37 to 39). 
RESULTS 
Overall Sample Characteristics 
Table 1 illustrates descriptive statistics for all study variables. Approximately half of 
women made a visit for birth control while over 75% of women made a visit for an annual 
gynecological visit. Just over 45 percent of women indicated that it is very important to avoid 
becoming pregnant now, and most of the sample indicated moderately high knowledge of birth 
control methods. Past use of the pill was the most popular method, with smaller percentages for 
long-acting reversible contraceptives. For those who made a WHC visit in the last six months, 
just under half (49%) said their doctor talked to them about their plans for children and 41% got 
information about birth control and pregnancy prevention. Nearly 82% had been with a partner 
for six months or longer, and just over 10% were not currently dating anyone. The majority of 
the sample (83%) went to a private doctor’s office or group practice for their last WHC visit, and 
nearly 75% used insurance to pay for some or all of the costs of the visit. Just over 87% had a 
regular place for medical care and 65% lived in a state that expanded Medicaid under ACA. 
Regarding the key subgroups, over two-thirds of the sample (69%) was non-Hispanic 
white and 65% were at 200% or above the federal poverty level. Just over 15% of the sample 
was below the federal poverty level. Approximately 72% had private health insurance, 16% had 
Medicaid insurance, 6% had marketplace insurance, and just over 6% were uninsured. Almost 
half (49%) were married, 35% had a bachelor’s degree, and 55% were employed full-time. 
Almost a third (32%) were unemployed. Approximately 10% were foreign-born and 40% were 
in the age group of 18 to 26 years old, with an overall mean age of 29 years.  
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Comparing the sample characteristics to 2014-2018 U.S. Census Data on females 16 
years and older, black or African American respondents are underrepresented in our sample (9% 
of our sample, versus national estimate of 13%) as well as white respondents, who represent 69% 
of our sample versus a national estimate of 76% (United States Census Bureau N.d.). The sample 
also has slightly higher levels of education, with 35 percent of the sample having a bachelor’s 
degree compared to 32% of women age 25 years and older (U.S. Census Bureau N.d.). Foreign-
born women represent nearly 10 percent of our sample compared to national estimates of 14% 
(U.S. Census Bureau N.d.).  
Individual, Interpersonal, and Institutional Reproductive Health Variables by Key Subgroup 
Individual Attitudes, Knowledge, and Contraception Use. Table 2 shows individual 
attitudes, knowledge, and contraception use by key subgroup. The majority of women both 
within and across all key subgroups reported a strong pregnancy avoidance attitude, with no 
statistically significant difference among the subgroups. Knowledge of birth control methods 
differed significantly only among socioeconomic status, although when looking at pairwise 
comparisons of these means none of the comparisons were statistically significant. The average 
score for birth control methods knowledge was 4.30 for those at 200% or above the federal 
poverty level, compared to 4.16 for those below the federal poverty level.   
 Hormonal contraception use also differed significantly by key subgroup. There were 
significant racial and ethnic differences in past use of the pill and long-acting reversible 
contraceptive (LARC; either an implant or IUD). Over half of non-Hispanic white women had 
used the pill, compared to 36 percent of Hispanic women. Use of a LARC method was highest 
among Hispanic and multiracial women, and lowest among black and other race women. There 
were also significant differences in past use of the pill (but not LARC) by socioeconomic status 
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and insurance type. Higher proportions of high-SES women had used the pill compared to lower 
SES women. Women with Medicaid insurance had the lowest proportions of past pill use 
compared to all other insurance types, and privately insured women had the highest proportion of 
past pill use. Hispanic women reported the highest percentages of past LARC use (17%). 
Approximately 10% of women in all socioeconomic groups had used a LARC method in the 
past. Past LARC use was highest for women with private insurance (11%), and lowest for those 
without insurance (6%).  
Interpersonal Variables. Discussions between a patient and provider about future plans 
for children did not differ significantly by race/ethnicity, socioeconomic status, or insurance 
status (see Table 3). Approximately half of women reported that their doctor or nurse spent time 
talking with them about their future plans for having or not having children (or more children) 
during their last women’s health care visit, with other race, low-income, and uninsured women 
reporting lower rates. On the other hand, contraceptive counseling differed significantly by 
socioeconomic status and insurance status. As socioeconomic status increased, the percentage of 
women responding that they got information about birth control and pregnancy prevention 
decreased. Higher percentages of uninsured women and women with marketplace insurance 
reported receiving birth control and pregnancy prevention information compared to women with 
Medicaid or private insurance. The majority of women had been with the same partner for six 
months or longer, although relationship status differed significantly by subgroup. Over 80 
percent of white, Hispanic, and other race/ethnicity women reported being with the same partner 
for six months or longer uninterrupted. Non-Hispanic black and multiracial women reported the 
largest percentages of not dating anyone or breaking up and getting back together with their 
partner in the last six months. The percentage of women reporting being with a partner for six 
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months or longer was higher for higher-SES women compared to low-SES women. Women with 
private insurance and uninsured women reported the highest proportions of being with a partner 
for six months or longer.  
Institutional Policy Factors. There were significant differences by subgroup for nearly all 
the systemic access variables (see Table 4). Hispanic women had the highest rates of being 
uninsured (18%), compared to all other racial groups which had single-digit rates of no 
insurance. Rates of private insurance increased as socioeconomic status increased. Low-SES 
women reported higher proportions of not having a regular place to go for medical care 
compared to high-SES women. Uninsured women had three to four times the rate of not having a 
regular place to go for medical care compared to all other insurance types. For those women who 
did make a women’s health care visit in the last six months, there were significant differences in 
facility type by race, socioeconomic status, and insurance type. While most women went to a 
private doctor’s office or group practice (with the exception of uninsured women), these 
proportions were highest for white, high-SES, and privately insured women. Just over one in ten 
black women and one in ten Hispanic women went to Planned Parenthood for their last women’s 
health care visit. The proportion of women going to Planned Parenthood or a public health 
department or community health clinic were highest among low-SES women. Nearly one in four 
women with marketplace insurance went to Planned Parenthood or another family planning 
clinic, compared to 2% of privately insured women.  
Most women made a women’s healthcare visit, with higher percentages of an annual 
gynecological visit compared to a visit for birth control or contraception, although none of the 
differences were statistically significant by subgroup. Women’s healthcare visit payment differed 
significantly by race, socioeconomic status, and insurance type. Approximately one in five non-
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Hispanic black, non-Hispanic other, and Hispanic women received free or reduced fee services, 
compared to 8% of non-Hispanic white and multiracial women. One in four low-income women, 
and nearly half of uninsured women received free or reduced fee services. Most women (with the 
exception of uninsured women1) paid for their women’s health care visit with insurance. Just 
over 35 percent of uninsured women paid for the visit themselves, compared to approximately 14 
percent of privately insured and marketplace-insured women. The majority of women lived in a 
state that expanded Medicaid under ACA, with the exception of non-Hispanic black women. 
Uninsured women reported the lowest proportions of living in a state that expanded Medicaid 
under ACA compared to all other insurance types. 
Predictors of Making a Visit for Birth Control or Contraception 
 Overall Model Fit. Table 5 contains the results of four nested logistic regression models 
examining individual, interpersonal, and institutional policy factors influencing making a visit 
for birth control or contraception in the last six months. Likelihood ratio tests comparing model 
fit indicated that each subsequent model was better fitting than the previous model in which it 
was nested (Model 2 was a better fit than Model 1, Model 3 was a better fit than Model 2), 
except when comparing Model 3 and Model 4. The likelihood ratio test favored Model 3 over 
Model 4, which indicates that adding additional variables did not significantly improve the 
model fit. This could be due to statistically significant correlations between insurance status and 
three out of the four institutional policy variables (facility type, visit payment, and regular place 
for medical care). However, the pairwise correlation coefficients between insurance status and 
each institutional policy variable ranged from 0.03 to 0.27, indicating that these correlations were 
                                                           
1
 Another survey question asked whether a respondent had insurance during any of the last six months, and 15 
uninsured women responded “yes”. So the 10 uninsured women in Table 4 who used insurance to pay for their last 
women’s healthcare visit most likely had insurance at the time of the visit (within the last six months). 
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small. Overall, summary goodness-of-fit statistics give an overall picture of model fit but cannot 
provide information about model components (Hosmer and Lemeshow 2000). While results of 
the likelihood ratio tests indicate that Model 4 does not provide a significantly improved fit 
compared to Model 3, the reason for this finding is most likely not due to collinearity issues 
between insurance status and institutional policy variables.  
 Birth Control Visit: Model 1. Results shown in Model 1 (health disparities model) 
indicate that insurance status had a significant influence on making a visit for birth control or 
contraception. Women with Medicaid insurance had lower odds of making a birth control visit 
compared to women with private insurance (OR=.55; p<.05). Compared to privately insured 
women, the odds of making a birth control visit are reduced by 45% for women with Medicaid 
insurance.  
Birth Control Visit: Model 2. Model 2 adds individual pregnancy attitudes, knowledge, 
and contraception use to the base model. Results show that stronger pregnancy avoidance 
attitudes were significantly associated with greater odds of making a visit for birth control 
compared to those with weaker pregnancy avoidance attitudes. Women who indicated that it is 
very important for them to avoid pregnancy right now had 6.22 higher odds of making a birth 
control visit compared to women who responded that it was not at all important for them to avoid 
pregnancy right now (p<.001). Knowledge of birth control methods did not have a statistically 
significant influence on making a birth control visit. Past use of the pill was significantly 
associated with higher odds (OR=5.71; p<.001) of making a visit for birth control compared to 
those who did not use the pill in the past, controlling for other variables. Using a LARC method 




 Birth Control Visit: Model 3. Adding in the interpersonal variables, the odds of making a 
visit for birth control were over three times larger (OR=3.87) for women who got information 
about birth control and pregnancy prevention during their last visit, compared to those who did 
not get this information during their last visit (p<.001). Women who were not dating anyone on a 
regular basis had lower odds of making a visit for birth control compared to women who had 
been with their partner for six months or longer (OR=.41; p<.01). Compared to women who had 
been with a partner for six months or longer, the odds of making a birth control visit were 
reduced by 59% for women who were not dating anyone.  
Birth Control Visit: Model 4. Adding in the institutional policy factors, women who went 
to Planned Parenthood or another family planning clinic for a women’s health care visit in the 
last six months had 2.71 higher odds of making a visit for birth control compared to those who 
went to a private doctor for a women’s health care visit (p<.05). Visit payment method, having a 
regular place to go for medical care, and living in a state that expanded Medicaid under ACA did 
not have a significant effect on making a birth control visit, controlling for other variables. 
Uninsured women had lower odds of making a visit for birth control compared to privately 
insured women (OR=.32; p<.01). Compared to privately insured women, the odds of making a 
birth control visit were reduced by 68% for uninsured women. Age had a significant impact on 
making a birth control visit in all four models, with higher odds for younger women compared to 
older women.  
Predictors of Making an Annual Gynecological or Pap Smear Visit 
 Overall Model Fit. Table 6 contains the results of four nested logistic regression models 
examining individual, interpersonal, and institutional policy factors influencing making an 
annual gynecological or pap smear visit in the last six months. Likelihood ratio tests yielded 
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mixed findings regarding model fit. Overall, the likelihood ratio tests favored the fuller models 
with one exception. Results of likelihood ratio tests indicated that adding individual attitudes, 
knowledge, and contraception use variables (Model 2) significantly improved model fit 
compared to the base model (Model 1). However, adding interpersonal variables (Model 3) did 
not significantly improve the model fit compared to Model 2. Adding in institutional policy 
factors in Model 4 significantly improved model fit compared to Model 3.  
 Annual Gynecological Visit: Model 1. In Model 1 on Table 6, the base health disparities 
model, there were significant subgroup differences by race. Non-Hispanic black women had two 
times higher odds of making an annual gynecological visit compared to white women, 
controlling for other variables (OR=2.01; p<.05). There were no statistically significant 
differences in making an annual gynecological visit by socioeconomic status or insurance status. 
 Annual Gynecological Visit: Model 2. Adding in individual pregnancy attitudes, 
knowledge, and contraception use in Model 2, women with strong pregnancy avoidance attitudes 
had lower odds of making an annual gynecological visit compared to those with weaker 
pregnancy avoidance attitudes. Compared to women with weaker pregnancy avoidance attitudes, 
the odds of making an annual gynecological visit were reduced by 54% for women with strong 
pregnancy avoidance attitudes (OR=.46; p<.05). Knowledge of birth control methods and past 
use of the pill did not have a significant influence on making an annual gynecological visit, 
controlling for other variables. The odds of making an annual gynecological visit were nearly 
twice as high for women who had used a LARC method at the last wave, compared to women 
who did not (OR=1.86; p<.05). Model 2 also illustrates that race remains significant.  
 Annual Gynecological Visit: Model 3. Model 3 on Table 6 adds in interpersonal variables 
and demonstrates that women whose doctor or nurse talked about future plans for children at 
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their last women’s health care visit had 1.50 higher odds of making an annual gynecological visit 
compared to women whose doctors did not discuss this with them (p<.05). Contraceptive 
counseling and relationship status did not have a significant effect on making an annual 
gynecological visit.  
Annual Gynecological Visit: Model 4. Looking at the full model (Model 4), the patterns 
are similar to Model 3 but facility type has a statistically significant effect on the odds of making 
an annual gynecological visit. Women who went to Planned Parenthood or another family 
planning clinic, or a student health clinic/some other type of health care facility in the last six 
months for a women’s health care visit had lower odds of making an annual gynecological visit 
compared to those who went to a private doctor’s office. Compared to women who went to a 
private doctor’s office for their last women’s healthcare visit, the odds of making an annual 
gynecological visit were reduced by 71% for women who went to Planned Parenthood or another 
family planning clinic for their last women’s healthcare visit (OR=.29; p<.001). The odds of 
making an annual gynecological visit were reduced by 56% for women who went to a student 
health clinic or some other type of healthcare facility for their last WHC visit, compared to those 
who went to a private doctor’s office (OR=.44; p<.05).  
Visit payment method, having a regular place to go for medical care, and living in a 
Medicaid expansion state did not have a significant effect on the odds of making an annual 
gynecological visit, controlling for other variables. However, race and insurance status did have 
a significant effect on making an annual gynecological visit in Model 4. Non-Hispanic black 
women had 2.44 higher odds of making an annual gynecological visit compared to non-Hispanic 
white women (p<.05). Women with marketplace insurance had 2.43 higher odds of making an 
annual gynecological visit compared to women with private insurance (p<.05). Age also had a 
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significant effect on making an annual gynecological visit in all four models, with younger 
women having significantly lower odds of making a visit compared to older women.   
DISCUSSION  
This study utilized a nationwide survey of women to examine reproductive healthcare by 
incorporating information about individual attitudes, interpersonal variables, and institutional 
policy structures to provide a more holistic view on which elements are most or least influential 
in making a women’s reproductive healthcare visit. Previous research has investigated these 
issues separately, but this study looks at all these factors together and for key subgroups. Results 
indicate that while some aspects are shared by all women, such as the majority of women having 
strong pregnancy avoidance attitudes regardless of subgroup, there are other significant 
differences patterned by systemic access factors such as race and ethnicity, insurance, and 
socioeconomic status. These findings illustrate the importance of examining reproductive 
healthcare both on an aggregate and subgroup level, because they may yield opposite findings. It 
also demonstrates how focusing solely on individual attitudes or institutional factors can tell 
different stories, so examining all three levels is important. As the literature review 
demonstrated, law and policy may not play out the same for all groups of women (Ross et al. 
2016; Shane and Ayyagari 2014; Breslau et al. 2018; Smith and Medalia 2014; O’Hara and 
Brault 2013). This is important because despite shared pregnancy avoidance attitudes, the ability 
of women to access reproductive healthcare is patterned by existing systemic access inequalities. 
Overall, findings from this study indicate that context matters when it comes to 
reproductive healthcare visits. Many of the patterns which operated in the birth control visit 
context were the opposite for the annual gynecological visit context. Individual attitudes, 
interpersonal variables, and institutional policy factors were all important and significant 
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influences on making a birth control visit, but institutional factors were the main factors driving 
making an annual gynecological visit. This illustrates that the drivers of sexual/reproductive 
healthcare visits are different from those of preventative reproductive healthcare visits. 
Moreover, interpersonal variables were particularly significant in the birth control visit context 
but not in the annual gynecological visit context. This aligns with previous research which links 
contraceptive use with relationship status (Campo et al. 2012; Reed et al. 2014). In addition, race 
was a significant predictor of making an annual gynecological visit but not a birth control visit. 
Black women had nearly two and a half times the odds of making an annual gynecological visit 
compared to white women. This could reflect the influence of interpersonal relationships, such as 
Warren-Jeanpiere’s (2006) research on African American mother-daughter relationships and 
how mothers can strongly influence their daughters to get an annual gynecological visit. It could 
also reflect more pressure on African American women to get annual checkups or pap smears 
due to higher incidence and death rates of cervical cancer among minority women compared to 
white women (Benard et al. 2014; Shomo 2019). More research is needed to illuminate the 
reasons behind this racial difference in making an annual gynecological visit or pap smear.  
Facility type played an important role in both types of women’s reproductive healthcare 
visits. Women who went to Planned Parenthood or another family planning clinic for their last 
women’s healthcare visit had nearly three times higher odds of making a birth control visit than 
women who went to a private doctor’s office, while the opposite was true for preventative 
reproductive healthcare visits. Moreover, younger women (ages 18 to 26) had three times higher 
odds of making a visit for birth control or contraception compared to older women, but again the 
opposite was true for annual gynecological preventative healthcare visits. These findings mirror 
that of previous research which has shown teens prefer to go to family planning clinics for sexual 
40 
 
and reproductive health services (Oglesby 2014; Sugerman et al. 2000). This may explain why 
previous research did not find an increase in sexual and reproductive health service utilization 
due to the dependent coverage of the ACA (Eliason 2019). Teens or other groups of women may 
prefer to utilize Planned Parenthood for cost and confidentiality (Sugerman et al. 2000), or for 
additional dimensions of care, such as ease of getting care and medical staff treatment (Oglesby 
2014). These findings may also explain why Eliason (2019) did not find an increase in utilization 
of sexual and reproductive health services after the dependent coverage provision of the ACA 
passed. Young women may prefer to go to facilities such as Planned Parenthood for birth control 
to protect their confidentiality, such as if they are still on a parent’s health insurance plan and are 
worried about privacy. This carries important implications for policy, as women who are insured 
may still utilize public family planning centers for their birth control needs.  
Socioeconomic status alone was not a significant predictor of the likelihood of making 
either a birth control visit or annual gynecological visit. However, insurance status was a key 
difference and driver of making visits. Uninsured women had lower odds of making a birth 
control visit compared to privately insured women, despite having the highest pregnancy 
avoidance attitudes. More research is needed to uncover the reasons behind this finding. It could 
be due to the cross-tabulation analyses finding that uninsured women had three to four times 
higher percentages of reporting that they did not have a regular place to go for medical care, 
compared to other insurance types. Or it could be that uninsured women fall into a “coverage 
gap”, where they make too much to qualify for Medicaid insurance but cannot afford 
marketplace or private insurance. On the other hand, women with marketplace insurance had 
over twice the odds of making an annual gynecological visit compared to privately insured 
women. Marketplace insurance was significantly associated with preventative healthcare visits, 
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but not birth control visits. Taken together, these findings carry important implications for 
research on women’s health disparities and reproductive healthcare policy. Rather than 
socioeconomic status, insurance type and status may be a stand-in and important driver of 
reproductive healthcare disparities.  
One final important finding to note is that pregnancy avoidance attitudes were largely the 
same among all subgroups. There were no statistically significant differences in pregnancy 
avoidance attitudes by race/ethnicity, socioeconomic status, or insurance status. Most women in 
each subgroup expressed a strong pregnancy avoidance attitude, with percentages ranging from 
53 percent to 63 percent. These findings illustrate that pregnancy avoidance is largely a shared 
attitude among the majority of women, even by subgroup, and the importance of creating equal 
reproductive healthcare access for all women. However, hormonal contraception use differed by 
subgroup, with use varying by race/ethnicity, socioeconomic status, and insurance status. 
Whether this reflects individual preferences or larger access issues is unknown. Previous 
research has demonstrated a gap between women’s use and preference for certain contraceptive 
methods, particularly for groups such as the uninsured (Potter et al. 2017).  
Limitations 
One limitation is that the survey question about obtaining information about birth control 
and pregnancy prevention during the last women’s healthcare visit did not ask if the information 
was requested or not, so it is unclear whether information was provided to the patient upon their 
request or not. Previous research has shown racial differences in pressure to use contraceptives 
by a clinician (Becker and Tsui 2008), raising questions about whether this information was 
given by patient request or not. However, including these visit questions can yield valuable 
information as to whether different levels matter equally or if some are more important than 
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others in healthcare visits, so it is imperative that they are included in the analyses. Another 
limitation to note is that the patterns and findings noted in this study may change drastically 
given the current COVID-19 pandemic, with many out of work and either losing employer-
sponsored health coverage or not being able to afford insurance, as well as the Trump 
administration’s attempts to abolish the Affordable Care Act. Both factors raise questions about 
insurance coverage and the future of healthcare, and could shift the findings and patterns found 
in this study in a major way.  
CONCLUSION 
As Krieger (2012) has written in her discussion of ecosocial theory, there are many 
different pathways of embodiment. In the words of Nancy Krieger, “no one is an individual one 
day and a member of a population another. Each person is both, simultaneously” (Krieger 
2012:939). This study examined individual attitudes, interpersonal variables, and institutional 
policy factors to further untangle the web of reproductive health disparities, while recognizing 
that these influences are dynamic, overlapping, and co-constitutive. Findings illustrate that the 
relative importance of each level can depend on the context of the healthcare visit, such as 
whether a woman is seeking preventative reproductive healthcare or birth control. The factors 
that influence making a reproductive healthcare visit are different for birth control visits versus 
preventative visits. Individual attitudes and interpersonal interactions played a larger role in 
making a birth control visit than a preventative health care visit. Institutional variables such as 
insurance status and facility type mattered in both cases. These findings demonstrate the 
importance of looking at multiple levels, such as individual attitudes, doctor-patient interactions, 
and institutional policy factors, because the importance of each factor depends on the type of 
medical care involved. Considering the context in which services are received and the factors 
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influencing making a particular type of healthcare visit is essential because this can influence 








Agénor, Madina, Zinzi Bailey, Nancy Krieger, S. Bryn Austin, and Barbara R. Gottlieb. 2015. "Exploring the 
Cervical Cancer Screening Experiences of Black Lesbian, Bisexual, And Queer Women: The Role of 
Patient-Provider Communication." Women & Health 55(6):717-736. 
Allison, Paul D. 2000. "Multiple Imputation for Missing Data: A Cautionary Tale." Sociological Methods & 
Research 28(3):301-309. 
Antonisse, Larisa, Rachel Garfield, Robin Rudowitz, and Samantha Artiga. 2018. The Effects of Medicaid 
Expansion Under the ACA: Updated Findings from a Literature Review (Washington, D.C.: Kaiser Family 
Foundation, March 2018). 
Ashton, Carol M., Paul Haidet, Debora A. Paterniti, Tracie C. Collins, Howard S. Gordon, Kimberly O’Malley, 
Laura A. Petersen et al. 2003. "Racial and Ethnic Disparities in the Use of Health Services." Journal of 
General Internal Medicine 18(2):146-152. 
Baicker, Katherine, Sarah L. Taubman, Heidi L. Allen, Mira Bernstein, Jonathan H. Gruber, Joseph P. Newhouse, 
Eric C. Schneider, Bill J. Wright, Alan M. Zaslavsky, and Amy N. Finkelstein. 2013. "The Oregon 
Experiment—Effects of Medicaid on Clinical Outcomes." New England Journal of Medicine 
368(18):1713-1722. 
Becker, Davida, and Amy O. Tsui. 2008. "Reproductive Health Service Preferences and Perceptions of Quality 
Among Low‐Income Women: Racial, Ethnic and Language Group Differences." Perspectives on Sexual 
and Reproductive Health 40(4):202-211. 
Benard, Vicki B., Cheryll C. Thomas, Jessica King, Greta M. Massetti, V. Paul Doria-Rose, and Mona Saraiya. 
2014. "Vital Signs: Cervical Cancer Incidence, Mortality, And Screening—United States, 2007–2012." 
Morbidity and Mortality Weekly Report 63(44):1004-1009. 
Breslau, Joshua, Bing Han, Bradley D. Stein, Rachel M. Burns, and Hao Yu. 2018. "Did The Affordable Care Act's 
Dependent Coverage Expansion Affect Race/Ethnic Disparities In Health Insurance Coverage?" Health 
Services Research 53(2):1286-1298. 
45 
 
Campo, Shelly, Natoshia M. Askelson, Erica L. Spies, and Mary Losch. 2012. "Ambivalence, Communication and 
Past Use: Understanding What Influences Women's Intentions to Use Contraceptives." Psychology, Health 
& Medicine 17(3):356-365. 
Collins, Sara R., Munira Gunja, Michelle M. Doty, and Sophie Beutel. 2016. "Americans' Experiences with ACA 
Marketplace and Medicaid Coverage: Access to Care and Satisfaction: Findings from the Commonwealth 
Fund Affordable Care Act Tracking Survey, February–April 2016." Issue Brief (Commonwealth Fund) 
14:1-18. http://www.commonwealthfund.org/publications/issue-briefs/2016/may/aca-tracking-survey-
access-to-care-and-satisfaction  
Dehlendorf, Christine, Nora Anderson, Eric Vittinghoff, Kevin Grumbach, Kira Levy, and Jody Steinauer. 2017. 
"Quality and Content of Patient–Provider Communication About Contraception: Differences By 
Race/Ethnicity and Socioeconomic Status." Women's Health Issues 27(5):530-538. 
Eliason, Erica. 2019. “The Effects of the Dependent Coverage Provision on Young Women's Utilization of Sexual 
and Reproductive Health Services.” Preventive Medicine 129:1-6.  
Emmers-Sommer, Tara M., Sarah Nebel, Mae-Li Allison, Michele L. Cannella, Desiree Cartmill, Sarah Ewing, 
Daniel Horvath, Jonathan K. Osborne, and Brittney Wojtaszek. 2009. "Patient–Provider Communication 
About Sexual Health: The Relationship with Gender, Age, Gender-Stereotypical Beliefs, and Perceptions 
of Communication Inappropriateness." Sex Roles 60(9-10):669-681. 
Everett, Bethany G., Jenny A. Higgins, Sadia Haider, and Emma Carpenter. 2019. "Do Sexual Minorities Receive 
Appropriate Sexual And Reproductive Health Care And Counseling?" Journal of Women's Health 
28(1):53-62. 
Finer, Lawrence B., Adam Sonfield, and Rachel K. Jones. 2014. "Changes in Out-of-Pocket Payments for 
Contraception by Privately Insured Women During Implementation of the Federal Contraceptive Coverage 
Requirement." Contraception 89(2):97-102.  
Finer, Lawrence B., and Mia R. Zolna. 2016. "Declines in Unintended Pregnancy in the United States, 2008–2011." 
New England Journal of Medicine 374(9):843-852. 
Finkelstein, Amy, Sarah Taubman, Bill Wright, Mira Bernstein, Jonathan Gruber, Joseph P. Newhouse, Heidi Allen, 
Katherine Baicker, The Oregon Health Study Group. 2011. “The Oregon Health Insurance Experiment: 
46 
 
Evidence from the First Year” (National Bureau of Economic Research, July 2011, Working Paper 17190). 
Retrieved from http://www.nber.org/papers/w17190 
Garfield, Rachel, Kendal Orgera, and Anthony Damico. 2019. “The Uninsured and the ACA: A Primer – Key Facts 




Ghosh, Ausmita, Kosali Simon, and Benjamin D. Sommers. 2017. The Effect of State Medicaid Expansions on 
Prescription Drug Use: Evidence From The Affordable Care Act. (Working Paper No. 23044. National 
Bureau of Economic Research, January 2017). Retrieved from 
http://www.nber.org/papers/w23044?utm_campaign=ntw&utm_medium=email&utm_source=ntw 
Gomez, Anu Manchikanti, and Mikaela Wapman. 2017. "Under (Implicit) Pressure: Young Black and Latina 
Women's Perceptions of Contraceptive Care." Contraception 96(4):221-226. 
Hammond, Alexandra. 2019. "Disparities in Access to Contraception in the United States: An Intersectional 
Analysis." Senior Thesis, Scripps College. 
Hayford, Sarah R., And Karen Benjamin Guzzo. 2013. "Racial and Ethnic Variation in Unmarried Young Adults’ 
Motivation to Avoid Pregnancy." Perspectives on Sexual And Reproductive Health 45(1):41-51. 
Health Resources & Services Administration. 2019. “Women’s Preventive Services Guidelines.” Retrieved from 
https://www.hrsa.gov/womens-guidelines/index.html 
Holt, Kelsey, Katrina Kimport, Miriam Kuppermann, Judith Fitzpatrick, Jody Steinauer, and Christine Dehlendorf. 
2020. "Patient-Provider Communication Before and After Implementation of the Contraceptive Decision 
Support Tool My Birth Control." Patient Education and Counseling 103(2):315-320. 
Horton, Nicholas J., and Ken P. Kleinman. 2007. "Much Ado About Nothing: A Comparison of Missing Data 
Methods and Software to Fit Incomplete Data Regression Models." The American Statistician 61(1):79-90. 
Hosmer, David W. and Lemeshow, Stanley. 2000. Applied Logistic Regression, 2nd Edition. John Wiley & Sons, 
Inc. 
IBM Corp. Released 2017. IBM SPSS Statistics for Windows, Version 25.0. Armonk, NY: IBM Corp. 
47 
 
Jones, Rachel K., Laura D. Lindberg, and Jenny A. Higgins. 2014. "Pull and Pray or Extra Protection? 
Contraceptive Strategies Involving Withdrawal Among US Adult Women." Contraception 90(4):416-421. 
Jones, Rachel K., Athena Tapales, Laura D. Lindberg, and Jennifer Frost. 2015. "Using Longitudinal Data to 
Understand Changes in Consistent Contraceptive Use." Perspectives on Sexual and Reproductive Health 
47(3):131-139. 
Jones, Rachel K., and Adam Sonfield. 2016. "Health Insurance Coverage Among Women of Reproductive Age 
Before And After Implementation Of The Affordable Care Act." Contraception 93(5):386-391. 
Jones, Rachel K. 2017. "Are Uncertain Fertility Intentions A Temporary or Long-Term Outlook? Findings from a 
Panel Study." Women's Health Issues 27(1):21-28. 
Jones, Rachel K. 2017. "Change and Consistency in US Women's Pregnancy Attitudes and Associations with 
Contraceptive Use." Contraception 95(5):485-490. 
Jones, Rachel K. 2018. "Is Pregnancy Fatalism Normal? An Attitudinal Assessment Among Women Trying to Get 
Pregnant and Those Not Using Contraception." Contraception 98(4):255-259. 
Jones, Rachel. 2018. Continuity and Change in Contraceptive Use, United States, 2012-2014. Ann Arbor, MI: Inter-
university Consortium for Political and Social Research [distributor], 2018-05-09. 
https://doi.org/10.3886/ICPSR37067.v1 
Kaiser Family Foundation. 2021. “Women’s Health Insurance Coverage.” Retrieved 
from https://www.kff.org/womens-health-policy/fact-sheet/womens-health-insurance-coverage/ 
Kendall, Carl, Aimee Afable-Munsuz, Ilene Speizer, Alexis Avery, Norine Schmidt, and John Santelli. 2005. 
"Understanding Pregnancy in a Population of Inner-City Women in New Orleans—Results of Qualitative 
Research." Social Science & Medicine 60(2):297-311. 
Kim, Theresa Y., Rada K. Dagher, and Jie Chen. 2016. "Racial/Ethnic Differences In Unintended Pregnancy: 
Evidence From A National Sample Of U.S. Women." American Journal Of Preventive Medicine 
50(4):427-435. 
Krieger, Nancy. 1994. "Epidemiology and the Web of Causation: Has Anyone Seen the Spider?." Social Science & 
Medicine 39(7):887-903. 
Krieger, Nancy. 2001. "Theories for Social Epidemiology in the 21st Century: An Ecosocial Perspective." 
International Journal of Epidemiology 30(4):668-677. 
48 
 
Krieger, Nancy. 2012. "Methods For The Scientific Study Of Discrimination And Health: An Ecosocial Approach." 
American Journal Of Public Health 102(5):936-944. 
Krieger, Nancy. 2014. "Got Theory? On the 21st c. CE Rise of Explicit Use of Epidemiologic Theories of Disease 
Distribution: A Review and Ecosocial Analysis." Current Epidemiology Reports 1(1):45-56. 
Lindberg, Laura, Rachel Jones, and Jenny Higgins. 2014. "Use of Withdrawal Among Young Adults in the US: 
Pulling Out All the Stops?" Journal of Adolescent Health 54(2):S61. 
Little, Todd D., Terrence D. Jorgensen, Kyle M. Lang, and E. Whitney G. Moore. 2014. "On The Joys Of Missing 
Data." Journal Of Pediatric Psychology 39(2):151-162. 
Nardi, Christina, Prabjot Sandhu, and Nancy Selix. 2016. "Cervical Cancer Screening Among Minorities in the 
United States." The Journal for Nurse Practitioners 12(10):675-682. 
Oglesby, Willie H. 2014. "Perceptions Of And Preferences For Federally-Funded Family Planning Clinics." 
Reproductive Health 11(1):50. 
O'Hara, Brett, and Matthew W. Brault. 2013. "The Disparate Impact Of The ACA‐Dependent Expansion Across 
Population Subgroups." Health Services Research 48(5):1581-1592. 
Potter, Joseph E., Kate Coleman-Minahan, Kari White, Daniel A. Powers, Chloe Dillaway, Amanda J. Stevenson, 
Kristine Hopkins, and Daniel Grossman. 2017. "Contraception after Delivery among Publicly Insured 
Women in Texas: Use Compared With Preference." Obstetrics and Gynecology 130(2):393.  
RamaRao, Saumya, Marlina Lacuesta, Marilou Costello, Blesilda Pangolibay, and Heidi Jones. 2003. "The Link 
Between Quality Of Care And Contraceptive Use." International Family Planning Perspectives 29(2):76-
83. 
Ranji, Usha, Ivette Gomez, and Alina Salganicoff. 2019. In Their Own Voices: Low-Income Women and Their 
Health Providers in Three Communities Talk About Access to Care, Reproductive Health, and 
Immigration. San Francisco, CA: Henry J. Kaiser Family Foundation. Retrieved from 
https://www.kff.org/report-section/in-their-own-voices-low-income-women-and-their-health-providers-
talk-about-access-to-care-reproductive-health-and-immigration-report/ 
Reed, Joanna, Paula England, Krystale Littlejohn, Brooke Conroy Bass, and Mónica L. Caudillo. 2014. "Consistent 




Rimer, Barbara K., and Karen Glanz. 2005. Theory at a Glance: A Guide For Health Promotion Practice. U.S. 
Department of Health and Human Services, National Institutes of Health, National Cancer Institute. 
Roberts, Dorothy E. 1999. Killing The Black Body: Race, Reproduction, And The Meaning Of Liberty. New York: 
Vintage Books. 
Ross, Loretta, Elena Gutiérrez, Marlene Gerber, and Jael Silliman. 2016. Undivided Rights: Women of Color 
Organizing for Reproductive Justice. Haymarket Books.  
Schaeffer, Katherine. 2019. “The Most Common Age Among Whites in U.S. is 58 – More than Double That of 
Racial and Ethnic Minorities.” Retrieved from https://www.pewresearch.org/fact-tank/2019/07/30/most-
common-age-among-us-racial-ethnic-groups/ 
Shane, Dan M. and Padmaja Ayyagari. 2014. “Will Health Care Reform Reduce Disparities in Insurance Coverage? 
Evidence from the Dependent Coverage Mandate.” Medical Care 52(6):528-534. 
Shomo, Anisa. 2019. “Black Women in America and Cervical Cancer Prevention.” Retrieved from 
https://www.theatlantavoice.com/articles/black-women-in-america-and-cervical-cancer-prevention/ 
Smith, Jessica C., and Carla Medalia. 2014. Health Insurance Coverage in the United States: 2013. Washington, 
DC: US Department of Commerce, Economics and Statistics Administration, Bureau of the Census. 
Smith, Ellie, Beth Sundstrom, and Andrea L. DeMaria. 2019. "“Nobody Ever Asks Me:” A Reproductive Justice 
Approach to Rural Health Disparities." Analyses of Social Issues and Public Policy 19(1):78-103. 
Social Science Computing Cooperative. 2013. “Multiple Imputation in Stata: Deciding to Impute.” University of 
Wisconsin-Madison. Retrieved from https://www.ssc.wisc.edu/sscc/pubs/stata_mi_decide.htm 
Social Science Computing Cooperative. 2015. “Multiple Imputation in Stata: Creating Imputation Models.” 
University of Wisconsin-Madison. Retrieved from 
https://www.ssc.wisc.edu/sscc/pubs/stata_mi_models.htm#ChoosingVariables 
Sonfield, Adam, Athena Tapales, Rachel K. Jones, and Lawrence B. Finer. 2015. "Impact of the Federal 
Contraceptive Coverage Guarantee on Out-of-Pocket Payments for Contraceptives: 2014 Update." 
Contraception 91(1):44-48. 
StataCorp. 2017. Stata Statistical Software: Release 15. College Station, TX: StataCorp LLC.  
50 
 
Sugerman, Susan, Neal Halfon, Arleen Fink, Martin Anderson, Laurie Valle, and Robert H. Brook. 2000. "Family 
Planning Clinic Patients: Their Usual Health Care Providers, Insurance Status, and Implications for 
Managed Care." Journal of Adolescent Health 27(1):25-33. 
United States Census Bureau. N.d. “QuickFacts United States. In Civilian Labor Force, Female, Percent of 
Population Age 16 Years+, 2014-2018.” Retrieved from 
https://www.census.gov/quickfacts/fact/table/US/LFE046218#qf-headnote-a 
Väisänen, Heini, and Rachel K. Jones. 2015. "Using Panel Data to Examine Pregnancy Attitudes over Time." 
International Journal of Population Studies 1(1):1-17. 
Warren-Jeanpiere, Lari., 2006. From Mothers to Daughters: A Qualitative Examination of The Reproductive Health 
Seeking Behaviour of African American Women. Women’s Health and Urban Life 5(2):42-61. 
Young, Rebekah, and David R. Johnson. 2010. "Imputing the Missing Y’s: Implications for Survey Producers and 











Table 1. Aggregate Sample Characteristics (N=982) 
 N % or Mean 
(S.D.) 
Dependent Variables   
Made a visit for birth control or contraception in the last six months 982 100.00 
Yes 497 50.61 
No 485 49.39 
Made a visit for an annual gynecological visit or pap smear in the last six months 982 100.00 
Yes 748 76.17 
No 234 23.83 
Individual Attitudes, Knowledge, & Contraception Use   
Pregnancy avoidance attitude 982 100.00 
1 Not at all important to avoid pregnancy 128 13.03 
2 36 3.67 
3 71 7.23 
4 109 11.10 
5 98 9.98 
6 Very important to avoid pregnancy 447 45.52 
N/A (currently pregnant) 93 9.47 
Knowledge of birth control methods (scale of 1 to 6, from 1 “I know nothing” to 6 “I 
know everything) 
982 4.24 (1.02) 
Used the pill at T1, T2, or T3 982 100.00 
Yes 463 47.15 
No 519 52.85 
Used LARC method (IUD or implant) at T3 982 100.00 
Yes 98 9.98 
No 884 90.02 
Interpersonal Variables   
Last WHC Visit: Doctor or nurse talked about plans for children 982 100.00 
Yes 480 48.88 
No 502 51.12 
Last WHC Visit: Got information about birth control and pregnancy prevention   
Yes 403 41.04 
No 579 58.96 
Relationship status 982 100.00 
Been together for 6 months or longer 801 81.57 
Broken up but back together 27 2.75 
Not together for 6 months or longer 53 5.40 
N/A, not dating anyone 101 10.29 
Institutional Policy Factors   
Last WHC visit – Facility 982 100.00 
Private doctor’s office or group practice 819 83.40 
Planned Parenthood or other family planning clinic 62 6.31 
Public health department or community health clinic 67 6.82 
Student health clinic or some other type of health care facility 34 3.46 
Last WHC visit - Payment 982 100.00 
I paid some or all of the costs myself (including any insurance co-pays) 136 13.85 
My insurance paid some or all of the costs 733 74.64 
I received services at a reduced fee or the services were free 113 11.51 
Regular place to go for medical care 982 100.00 
Yes 857 87.27 
No 125 12.73 
Lives in a state that expanded Medicaid under ACA (as of December 2013) 982 100.00 
Yes 639 65.07 
No 343 34.93 
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Key Subgroups   
Race and ethnicity 982 100.00 
White, Non-Hispanic 679 69.14 
Black, Non-Hispanic 84 8.55 
Other, Non-Hispanic 42 4.28 
Hispanic 139 14.15 
2+ Races, Non-Hispanic 38 3.87 
Socioeconomic status 982 100.00 
Less than 100% 149 15.17 
100-199% 195 19.86 
200%+ 638 64.97 
Insurance status 982 100.00 
Private health insurance that I get through my job, school, a family member or 
that I pay for myself 
705 71.79 
Medicaid or some other government-sponsored health insurance 158 16.09 
I don’t have health insurance 62 6.31 
Insurance obtained through a health insurance marketplace or exchange, such 
as www.healthcare.gov 
57 5.80 
Control Variables   
Marital Status 982 100.00 
Married 478 48.68 
Never married 303 30.86 
Living with partner 162 16.50 
Divorced or separated 39 3.97 
Education 982 100.00 
Less than high school 38 3.87 
High school 107 10.90 
Some college, no degree 226 23.01 
Associate’s degree 96 9.78 
Bachelor’s degree 348 35.44 
Master’s degree or professional or doctorate degree 167 17.01 
Employment 982 100.00 
Full-time 544 55.40 
Part-time 121 12.32 
Unemployed  317 32.28 
Foreign-born 982 100.00 
Yes 98 9.98 
No 884 90.02 
Age 982 100.00 
18-26 389 39.61 
27-30 254 25.87 
31-36 258 26.27 
37-39 81 8.25 






Table 2. Individual Pregnancy Attitudes, Knowledge, and Contraception Use, by Key Subgroup 
 Race and Ethnicity Socioeconomic Status Insurance  
White Black Other Multiracial Hispanic Less than 
100% 
100-199% 200%+ Private Medicaid Marketplace Uninsured 
Pregnancy avoidance 
attitude 
            
1 Not at all important 
to avoid pregnancy 
13.11 17.86 14.29 7.89 10.79 13.42 12.82 13.01 12.34 16.46 12.28 12.90 
2 4.12 1.19 4.76 2.63 2.88 2.01 4.10 3.92 4.40 1.27 1.75 3.23 
3 7.22 4.76 4.76 13.16 7.91 10.07 7.18 6.58 7.09 6.96 10.53 6.45 
4 11.63 10.71 9.52 7.89 10.07 7.38 11.79 11.76 11.91 8.86 7.02 11.29 
5 11.05 8.33 9.52 7.89 6.47 6.04 10.26 10.82 10.64 9.49 10.53 3.23 
6 Very important to 
avoid pregnancy 
42.71 50.00 45.24 52.63 54.68 51.68 43.08 44.83 44.68 43.04 47.37 59.68 
Currently pregnant 10.16 7.14 11.90 7.89 7.19 9.40 10.77 9.09 8.94 13.92 10.53 3.23 
Chi-square test of 
independence 
Χ2 (24, N=982)=18.26, p=.790 Χ2 (12, N=982)=10.35, p=.585 Χ2 (18, N=982)=21.19, p=.270 
             
Birth control methods 
knowledge 
            
Mean 4.24  4.42  4.31  4.39  4.06  4.16 4.11 4.30 4.24 4.12 4.42 4.32 
Standard Deviation (.97) (1.16) (1.07) (1.08) (1.14) (1.16) (1.13) (.95) (.97) (1.16) (1.24) (1.02) 
N 679 84 42 38 139 149 195 638 705 158 57 62 
One-way ANOVA F(4,977)=2.01, p=.091 F(2,979)=3.11, p=.045 F(3,978)=1.46, p=.224 
             
Used pill at T1, T2, or T3             
Yes 50.96 41.67 38.10 42.11 35.97 40.94 37.95 51.41 50.92 31.65 45.61 45.16 
No 49.04 58.33 61.90 57.89 64.03 59.06 62.05 48.59 49.08 68.35 54.39 54.84 
Chi-square test of 
independence 
Χ2 (4, N=982)=13.70, p=.008 Χ2 (2, N=982)=13.58, p=.001 Χ2 (3, N=982)=19.42, p=.000 
      
Used implant or IUD at 
T3 
            
Yes 9.28 5.95 2.38 13.16 17.27 10.07 9.23 10.19 10.92 8.23 7.02 6.45 
No 90.72 94.05 97.62 86.84 82.73 89.93 90.77 89.81 89.08 91.77 92.98 93.55 
Chi-square test of 
independence 









Table 3. Interpersonal Variables, by Key Subgroup 
 Race and Ethnicity Socioeconomic Status Insurance 
Doctor or nurse spent time talking 
with you about your future plans 
for having or not having children 
(or more children) at last women's 
health care visit 





200%+ Private Medicaid Marketplace Uninsured 
Yes 49.48 44.05 42.86 60.53 47.48 46.98 46.15 50.16 48.94 50.00 52.63 41.94 
No 50.52 55.95 57.14 39.47 52.52 53.02 53.85 49.84 51.06 50.00 47.37 58.06 
Chi-square test of independence Χ2 (4, N=982)=3.67, p=.453 Χ2 (2, N=982)=1.21, 
p=.546 
Χ2 (3, N=982)=1.60, p=.660 
Got information about birth 
control and pregnancy prevention 
at last women's health care visit 
            
Yes 39.03 47.62 50.00 50.00 41.73 53.02 36.92 39.50 37.87 45.57 54.39 53.23 
No 60.97 52.38 50.00 50.00 58.27 46.98 63.08 60.50 62.13 54.43 45.61 46.77 
Chi-square test of independence Χ2 (4, N=982)=5.32, p=.256 Χ2 (2, N=982)=10.83, 
p=.004 
Χ2 (3, N=982)=12.26, p=.007 
Been together with partner for six 
months or longer 
     
Yes 83.65 58.33 88.10 73.68 85.61 71.81 83.59 83.23 84.68 72.78 68.42 80.65 
Yes, though we have broken up 
and gotten back together during 
that time 
1.77 10.71 0.00 5.26 2.88 4.70 3.08 2.19 1.70 6.33 5.26 3.23 
No 4.57 8.33 4.76 13.16 5.76 10.07 4.10 4.70 3.83 9.49 10.53 8.06 
N/A, not dating anyone 10.01 22.62 7.14 7.89 5.76 13.42 9.23 9.87 9.79 11.39 15.79 8.06 
Chi-square test of independence Χ2 (12, N=982)=52.89, p=.000 Χ2 (6, N=982)=13.84, 
p=.031 














Table 4. Reproductive Healthcare Institutional Policy Factors, by Key Subgroup 
 Race or Ethnicity Socioeconomic Status Insurance 





200%+ Private Medicaid Marketplace Uninsured 
Current insurance             
Private 77.32 52.38 71.43 76.32 55.40 24.16 57.95 87.15 - - - - 
Medicaid 13.25 29.76 19.05 18.42 20.14 51.68 25.13 5.02 - - - - 
Marketplace 5.30 9.52 7.14 2.63 6.47 10.07 6.15 4.70 - - - - 
I don’t have health insurance 4.12 8.33 2.38 2.63 17.99 14.09 10.77 3.13 - - - - 
Chi-square test of 
independence 
Χ2 (12, N=982)=68.27, p=.000 Χ2 (6, N=982)=285.73, 
p=.000 
    
Regular place to go for medical 
care 
            
Yes 88.07 84.52 88.10 86.84 84.89 82.55 82.56 89.81 90.92 84.18 84.21 56.45 
No 11.93 15.48 11.90 13.16 15.11 17.45 17.44 10.19 9.08 15.82 15.79 43.55 
Chi-square test of 
independence 
Χ2 (4, N=982)=1.70, p=.790 Χ2 (2, N=982)=10.59, 
p=.005 
Χ2 (3, N=982)=63.31, p=.000 
Place where you last received 
women’s health care 
            
Private doctor’s office or 
group practice 
88.37 67.86 80.95 73.68 71.94 65.77 74.36 90.28 92.20 67.72 66.67 38.71 
Planned Parenthood or other 
family planning clinic 
4.42 10.71 7.14 13.16 10.79 16.11 7.69 3.61 2.41 11.39 24.56 20.97 
Public health dept. or 
community health clinic 
4.27 17.86 7.14 7.89 12.23 12.75 12.31 3.76 2.27 18.35 7.02 29.03 
Student health clinic or some 
other type of health care 
facility 
2.95 3.57 4.76 5.26 5.04 5.37 5.64 2.35 3.12 2.53 1.75 11.29 
Chi-square test of 
independence 
Χ2 (12, N=982)=50.39, p=.000 Χ2 (6, N=982)=73.27, 
p=.000 
Χ2 (9, N=982)=211.70, p=.000 
Made a visit in the last 6 months             
Annual gyn visit or pap 
smear 
            
Yes 74.96 85.71 83.33 68.42 76.26 73.83 73.33 77.59 77.16 74.05 82.46 64.52 
No 25.04 14.29 16.67 31.58 23.74 26.17 26.67 22.41 22.84 25.95 17.54 35.48 
Chi-square test of 
independence 
Χ2 (4, N=982)=7.21, p=.125 Χ2 (2, N=982)=2.02, 
p=.364 
Χ2 (3, N=982)=6.65, p=.084 
Visit for birth control or 
contraception 
            
Yes 50.66 52.38 42.86 44.74 53.24 57.72 50.26 49.06 50.78 46.20 57.89 53.23 






Chi-square test of 
independence 
Χ2 (4, N=982)=2.02, p=.731 Χ2 (2, N=982)=3.64, 
p=.162 
Χ2 (3, N=982)=2.62, p=.455 
Women’s health care visit 
payment 
            
Respondent paid 13.11 13.10 14.29 10.53 18.71 11.41 13.33 14.58 14.04 4.43 14.04 35.48 
Insurance paid 78.50 65.48 66.67 81.58 61.87 63.09 68.21 79.31 81.84 69.62 63.16 16.13 
Free or reduced fee 8.39 21.43 19.05 7.89 19.42 25.50 18.46 6.11 4.11 25.95 22.81 48.39 
Chi-square test of 
independence 
Χ2 (8, N=982)=31.90, p=.000 Χ2 (4, N=982)=56.23, 
p=.000 
Χ2 (6, N=982)=207.71, p=.000 
Lives in a state that expanded 
Medicaid 
     
Yes 65.83 47.62 78.57 73.68 65.47 65.77 69.23 63.64 63.12 77.22 68.42 53.23 
No 34.17 52.38 21.43 26.32 34.53 34.23 30.77 36.36 36.88 22.78 31.58 46.77 
Chi-square test of 
independence 
Χ2 (4, N=982)=16.05, p=.003 Χ2 (2, N=982)=2.09, 
p=.351 





Table 5. Nested Logistic Regression Models: Likelihood of Making a Visit for Birth Control or Contraception 
 Model 1 Model 2 Model 3 Model 4 
 Health Disparities 
Model 




Model 2 + Interpersonal Variables Model 3+Institutional 
Policy Factors 
 OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) 
Individual Attitudes, Knowledge, & 
Contraception Use 
    
Pregnancy avoidance attitude     
2  2.73* (1.13 - 6.63) 2.39 (.95 - 6.00) 2.46 (.97 - 6.24) 
3  3.45** (1.68 - 7.09) 3.05** (1.43 - 6.51) 3.04** (1.41 - 6.52) 
4  3.62*** (1.91 - 6.85) 2.67** (1.37 - 5.23) 2.59** (1.31 - 5.11) 
5  4.78*** (2.45 - 9.30) 3.32** (1.64 - 6.70) 3.27** (1.61 - 6.63) 
6 Very important to avoid pregnancy  6.22*** (3.60 - 10.75) 4.44*** (2.47 - 7.99) 4.39*** (2.43 - 7.94) 
Currently pregnant  .23** (.10 - .58) .26** (.11 - .67) .26** (.10 - .65) 
Knowledge of birth control methods  1.07 (.91 - 1.25) 1.06 (.90 - 1.25) 1.08 (.91 - 1.28) 
Past use of the pill  5.71*** (4.07 - 8.00) 5.56*** (3.90 - 7.92) 5.89*** (4.10 - 8.47) 
LARC at last wave  .71 (.43 - 1.19) .81 (.47 - 1.38) .82 (.48 - 1.41) 
Interpersonal Variables     
Visit: Doctor or nurse talked about future plans for 
children 
  .69 (.47 - 1.03) .71 (.47 - 1.06) 
Visit: Got info about birth control and pregnancy 
prevention 
  3.87*** (2.58 - 5.79) 3.79*** (2.52 - 5.71) 
Relationship status     
Broken up but back together   1.79 (.58 - 5.53) 1.59 (.52 - 4.85) 
Not together for six months or longer   .61 (.30 - 1.26) .54 (.26 - 1.15) 
Not dating anyone   .41** (.22 - .74) .38** (.21 - .69) 
Institutional Policy Factors     
Visit: Facility type     
Planned Parenthood or other family 
planning clinic 
   2.71* (1.16 - 6.30) 
Public health dept. or community health 
clinic 
   1.85 (.86 - 3.95) 
Student health clinic or some other type 
of healthcare facility 
   1.03 (.41 - 2.57) 
Visit: Payment     
Insurance paid    1.10 (.67 - 1.80) 
Reduced fee or free services    1.36 (.65 - 2.86) 
Has a regular place to go for medical care    .69 (.39 - 1.19) 
Lives in a state that expanded Medicaid under ACA  
 
 





Key Subgroups     
Race and ethnicity     
Black .85 (.51 - 1.40) 1.08 (.60 - 1.92) .97 (.53 - 1.77) .88 (.47 - 1.62) 
Other .93 (.45 - 1.92) 1.20 (.51 - 2.83) 1.01 (.41 - 2.48) 1.05 (.43 - 2.61) 
Hispanic 1.21 (.79 - 1.86) 1.52 (.91 - 2.52) 1.45 (.86 - 2.46) 1.41 (.83 - 2.41) 
Multiracial .63 (.31 - 1.27) .67 (.30 - 1.48) .55 (.24 - 1.26) .50 (.21 - 1.18) 
Socioeconomic status     
100-199% .75 (.46 - 1.22) .78 (.44 - 1.37) .89 (.49 - 1.62) .88 (.48 - 1.61) 
200%+ .74 (.46 - 1.20) .58 (.33 - 1.02) .64 (.35 - 1.16) .65 (.36 - 1.19) 
Insurance status     
Medicaid .55* (.35 - .87) .88 (.52 - 1.49) .73 (.41 - 1.28) .61 (.34 - 1.11) 
Uninsured .83 (.45 - 1.51) .69 (.34 - 1.39) .54 (.26 - 1.14) .32** (.14 - .75) 
Marketplace 1.03 (.57 - 1.88) 1.29 (.62 - 2.68) 1.09 (.50 - 2.35) .81 (.36 - 1.81) 
Control Variables     
Marital status     
Never married   1.89*** (1.34 - 2.66) .87 (.57 - 1.31) 1.28 (.79 - 2.07) 1.35 (.83 - 2.20) 
Living with partner 1.67* (1.11 - 2.53) 1.05 (.65 - 1.72) 1.26 (.76 - 2.10) 1.22 (.73 - 2.04) 
Divorced or separated 1.45 (.73 - 2.88) .77 (.34 - 1.70) .94 (.39 - 2.24) .97 (.40 - 2.34) 
Employment status     
Part-time 1.94** (1.22 - 3.07) 1.58 (.93 - 2.68) 1.71 (.98 - 2.98) 1.64 (.93 - 2.88) 
Full-time 1.40* (1.00 - 1.95) 1.34 (.90 - 1.98) 1.39 (.93 - 2.08) 1.35 (.90 - 2.04) 
Educational attainment     
High school .70 (.31 - 1.57) .72 (.29 - 1.80) .49 (.19 - 1.29) .60 (.23 - 1.60) 
Some college, no degree .89 (.42 - 1.90) 1.12 (.47 - 2.65) .72 (.29 - 1.80) .85 (.34 - 2.14) 
Associate’s degree .80 (.34 - 1.87) .82 (.31 - 2.15) .58 (.21 - 1.58) .65 (.24 - 1.81) 
Bachelor’s degree .71 (.33 - 1.55) .75 (.31 - 1.81) .49 (.19 - 1.26) .57 (.22 - 1.47) 
Master’s, professional, or doctorate 
degree 
.61 (.26 - 1.39) .72 (.28 - 1.86) .45 (.16 - 1.21) .51 (.18 - 1.39) 
Age      
18-26 4.02*** (2.29 - 7.04)   3.61*** (1.90 - 6.84) 3.13** (1.60 - 6.12) 3.01** (1.53 - 5.93) 
27-30 2.17** (1.24 - 3.83) 2.26* (1.18 - 4.31) 2.19* (1.11 - 4.29) 2.17* (1.10 - 4.30) 
31-36 1.87* (1.06 - 3.29) 1.81 (.96 - 3.44) 1.76 (.90 - 3.42) 1.79 (.91 - 3.52) 
Foreign-born .89 (.53 - 1.50) .66 (.36 - 1.20) .59 (.32 - 1.10) .57 (.31 - 1.07) 
     
Constant .46 (.18 - 1.20) .07*** (.02 - .27) .09** (.02 - .38) .10** (.02 - .53) 
Observations 982  982 982 982 
Log-likelihood -624.81 -493.29 -461.89 -455.02 
Log-likelihood ratio test p-value  .000 .000 .056 
Note. *** p<.001, ** p<.01, * p<.05. Reference categories are respectively: White; Less than 100% FPL; Private insurance; Married; Unemployed; Less than High School; Age 
37-39; Not foreign-born; Pregnancy avoidance attitude of 1; No past use of the pill; No LARC at last wave; Doctor didn’t talk about future plans for children; Didn’t get 
information about birth control; Together for six months or longer; Private doctor’s office; Respondent paid; No regular place for medical care; Lives in a state that did not expand 






Table 6. Nested Logistic Regression Models: Likelihood of Making an Annual Gynecological Visit 
 Model 1 Model 2 Model 3 Model 4 
 Health Disparities Model Model 1+ Individual 
Attitudes, 
Knowledge, & Contraception 
Use 




 OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) 
Individual Attitudes, Knowledge, & 
Contraception Use 
    
Pregnancy avoidance attitude     
2  .98 (.34 - 2.81) 1.04 (.36 - 3.00) 1.003 (.35 - 2.88) 
3  .97 (.41 - 2.27) 1.05 (.45 - 2.48) 1.06 (.44 - 2.53) 
4  .73 (.36 - 1.48) .80 (.39 - 1.65) .84 (.41 - 1.74) 
5  .54 (.27 - 1.10) .62 (.30 - 1.28) .64 (.31 - 1.33) 
6 Very important to avoid pregnancy  .46* (.26 - .83) .54* (.30 - .99) .56 (.31 - 1.04) 
Currently pregnant  .29*** (.15 - .57) .30** (.15 - .60) .31** (.16 - .61) 
Knowledge of birth control methods  1.01 (.87 - 1.19) 1.02 (.87 - 1.20) 1.01 (.86 - 1.19) 
Past use of the pill  1.25 (.89 - 1.75) 1.30 (.92 - 1.83) 1.25 (.88 - 1.78) 
LARC at last wave  1.86* (1.01 - 3.40) 1.80 (.98 - 3.32) 1.82 (.98 - 3.37) 
Interpersonal Variables     
Visit: Doctor or nurse talked about future plans 
for children 
  1.50* (1.04 - 2.16) 1.45 (1.00 - 2.10) 
Visit: Got info about birth control and 
pregnancy prevention 
  .76 (.52 - 1.11) .84 (.56 - 1.24) 
Relationship status     
Broken up but back together   1.18 (.40 - 3.51) 1.17 (.39 - 3.51) 
Not together for six months or longer   1.27 (.58 - 2.74) 1.39 (.63 - 3.07) 
Not dating anyone   .76 (.42 - 1.35) .78 (.43 - 1.41) 
Institutional Policy Factors     
Visit: Facility type     
Planned Parenthood or other family 
planning clinic 
   .29*** (.14 - .56) 
Public health dept. or community 
health clinic 
   .56 (.28 - 1.10) 
Student health clinic or some other 
type of healthcare facility 
   .44* (.20 - .98) 
Visit: Payment     
Insurance paid    1.01 (.62 - 1.63) 
Reduced fee or free services    .80 (.40 - 1.58) 
Has a regular place to go for medical care    1.00 (.62 - 1.64) 
Lives in a state that expanded Medicaid under 
ACA 
 





Key Subgroups     
Race and ethnicity     
Black 2.01* (1.02 - 3.95) 2.10* (1.05 - 4.18) 2.11* (1.05 - 4.23) 2.44* (1.18 - 5.04) 
Other 1.09 (.44 - 2.71) 1.24 (.49 - 3.14) 1.33 (.52 - 3.39) 1.46 (.55 - 3.87) 
Hispanic 1.02 (.63 - 1.66) 1.02 (.62 - 1.67) 1.00 (.61 - 1.64) 1.06 (.64 - 1.77) 
Multiracial .75 (.36 - 1.56) .74 (.35 - 1.58) .69 (.32 - 1.47) .81 (.37 - 1.76) 
Socioeconomic status     
100-199% .92 (.54 - 1.56) .97 (.57 - 1.66) .95 (.55 - 1.64) .92 (.52 - 1.60) 
200%+ .96 (.56 - 1.62) .99 (.58 - 1.70) .98 (.57 - 1.68) .88 (.50 - 1.53) 
Insurance status     
Medicaid 1.00 (.61 - 1.66) 1.05 (.63 - 1.77) 1.04 (.61 - 1.75) 1.23 (.70 - 2.14) 
Uninsured .57 (.30 - 1.06) .56 (.29 - 1.06) .57 (.30 - 1.09) .93 (.44 - 1.97) 
Marketplace 1.66 (.79 - 3.48) 1.77 (.83 - 3.74) 1.76 (.82 - 3.75) 2.43* (1.09 - 5.40) 
Control Variables     
Marital status     
Never married 1.29 (.87 - 1.91) 1.38 (.90 - 2.12) 1.55 (.96 - 2.50) 1.53 (.94 - 2.49) 
Living with partner 1.29 (.81 - 2.06) 1.35 (.83 - 2.19) 1.38 (.85 - 2.25) 1.46 (.89 - 2.41) 
Divorced or separated 1.68 (.66 - 4.29) 1.68 (.64 - 4.37) 1.72 (.64 - 4.63) 1.66 (.61 - 4.51) 
Employment status     
Part-time .71 (.44 - 1.15) .65 (.39 - 1.06) .64 (.39 - 1.06) .69 (.41 - 1.15) 
Full-time 1.36 (.94 - 1.99) 1.27 (.87 - 1.86) 1.26 (.86 - 1.85) 1.29 (.87 - 1.92) 
Educational attainment     
High school 2.25 (.94 - 5.39) 2.63* (1.08 - 6.40) 2.57* (1.04 - 6.33) 2.10 (.83 - 5.31) 
Some college, no degree 1.55 (.70 - 3.47) 1.60 (.70 - 3.63) 1.62 (.70 - 3.72) 1.37 (.58 - 3.25) 
Associate’s degree 1.43 (.58 - 3.51) 1.63 (.65 - 4.09) 1.54 (.61 - 3.91) 1.35 (.52 - 3.51) 
Bachelor’s degree 2.05 (.89 - 4.71) 2.22 (.95 - 5.18) 2.14 (.91 - 5.06) 1.87 (.77 - 4.54) 
Master’s, professional, or doctorate 
degree 
2.15 (.86 - 5.32) 2.21 (.88 - 5.59) 2.20 (.86 - 5.62) 1.94 (.74 - 5.09) 
Age      
18-26 .24** (.10 - .54) .24** (.10 - .57) .23** (.10 - .56) .23** (.10 - .56) 
27-30 .23** (.10 - .54) .25** (.11 - .59) .24** (.10 - .57) .23** (.10 - .55) 
31-36 .44 (.19 - 1.02) .46 (.19 - 1.09) .44 (.18 - 1.04) .40* (.17 - .97) 
Foreign-born         1.81 (.93 - 3.50) 1.80 (.92 - 3.53) 1.84 (.94 - 3.63) 1.98 (.98 - 3.99) 
     
Constant 4.43* (1.38 - 14.24) 5.62* (1.36 - 23.27) 4.69* (1.11 - 19.81) 6.50* (1.29 - 32.78) 
Observations 982 982 982 982 
Log-likelihood -508.80 -495.28 -491.88 -480.93 
Log-likelihood ratio test p-value  .001 .237 .003 
Note. *** p<.001, ** p<.01, * p<.05. Reference categories are respectively: White; Less than 100% FPL; Private insurance; Married; Unemployed; Less than High School; Age 
37-39; Not foreign-born; Pregnancy avoidance attitude of 1; No past use of the pill; No LARC at last wave; Doctor didn’t talk about future plans for children; Didn’t get 
information about birth control; Together for six months or longer; Private doctor’s office; Respondent paid; No regular place for medical care; Lives in a state that did not expand 





AIM #2: Controlling Birth Control? State-Level Conditions Influencing Availability of 
Telecontraception Platforms 
 
Telemedicine is a growing area of healthcare with the potential to cut costs and increase 
access, particularly for underserved and rural populations (Centers for Disease Control and 
Prevention 2020). The current COVID-19 crisis is raising many questions about health care 
delivery and the use of telemedicine. One emerging segment of telemedicine is the rise of 
telecontraception platforms, such as Nurx, Planned Parenthood Direct, and Pill Club, which 
deliver birth control directly to consumers through the mail or pharmacy pickup. These platforms 
represent a growing market and innovative approach that aims to address barriers in obtaining 
contraception in the United States. On-demand birth control services can help meet the needs of 
women who reside far from clinics or in contraceptive deserts, who lack the time or resources to 
go to a doctor to obtain or refill a birth control prescription, or who face long wait times for an 
appointment (Sundstrom et al. 2019; Grindlay and Grossman 2016; Chuck 2017). Research has 
demonstrated women’s positive attitudes toward telecontraception, such as the potential to 
reduce wait times and increase knowledge of birth control methods (Sundstrom et al. 2019). 
 However, currently it is not known whether telecontraception platforms increase 
accessibility to contraception for those who face barriers or whether they simply make it more 
convenient for those who already have access (Dorland, Fowler, and Morain 2019; Zuniga et al. 
2020). Recent studies have begun to look at issues of access by mapping out characteristics 
across telecontraception platforms, such as cost, age requirements, and state availability (Zuniga 
et al. 2020; Dorland, Fowler, and Morain 2019). As access to the internet and apps increase, 
online platforms increasingly employ a rhetoric of “choice” and “empowerment” (Lupton 2016; 




and prescribing of birth control. One study found that 39 percent of requests did not get filled 
from Nurx (Wollum et al. 2018). Barriers due to policy, legislation, cost, or insurance may all be 
possible explanations for why these requests were not filled. Policy and legislation can affect the 
reach of telecontraception platforms across states by dictating a platform’s ability to prescribe 
and/or dispense medications, limiting the ability of patients to access these services, yet less is 
known about what affects these factors. Technological innovations are subject to the social 
context from which they emerge (MacKenzie and Wajcman 1999). Political, social, economic, 
and legislative factors all combine to influence state climates. Therefore, theoretical and 
sociological issues are at stake in an investigation of what influences states to provide access and 
availability to telecontraception. 
This research addresses this knowledge gap by using fuzzy-set qualitative comparative 
analysis (fsQCA; Ragin 2000; Ragin 2008a; Ragin 2008b) to investigate state-level conditions 
found in states with high availability of telecontraception platforms. This method provides an 
opportunity for new insights on the social, economic, political, and legislative influences on 
technological innovations such as telecontraception because it focuses on the combinations of 
these multiple influences associated with telecontraception availability in a state. Reproductive 
rights activism often focuses on political factors, but other state-level conditions can also 
influence policy in combination with other conditions. Using fsQCA can provide a more realistic 
picture of the influences on telecontraception availability because it investigates how state-level 
conditions combine and operate with one another to pattern access. Telemedicine 
implementation is affected by various stakeholders with competing interests and visions 
(Greenhalgh et al. 2012). Despite their powerful influence on decision-making, research 




access to telemedicine are understudied (Wade, Gray, and Carati 2017). What combination of 
state-level conditions influence telecontraception platform availability? Investigating the state-
level conditions that pattern availability of telecontraception platform services is critical to 
illuminate the ability of these platforms to offer equitable access to telecontraception, or whether 
reproductive healthcare disparities remain despite these emerging technologies. Providing an 
analysis of state-level conditions affecting telecontraception platform access and availability can 
also help inform broader telehealth measures, interventions, and policy, areas of increasing 
importance during the current COVID-19 pandemic.  
LITERATURE REVIEW 
Overview of Telecontraception Platforms 
Nurx, Planned Parenthood Direct, and Pill Club are all examples of telecontraception 
platforms which provide birth control and other reproductive healthcare services via an app or 
website. Telecontraception platforms deliver birth control directly to customers or provide a 
prescription that a customer can pick up at a pharmacy. Customers download the app or go to the 
company website, create a profile with their contact information, and answer health history 
questions. Platforms differ on the degree of interaction between patients and providers, such as 
messaging versus video consultations (Dorland, Fowler, and Morain 2019). Users have the 
option to use an existing prescription or request a new prescription. They also have the option to 
use insurance or pay out of pocket. While billing through insurance for contraception costs 
nothing to the customer under the Affordable Care Act (with the exception of religious 
employers who may choose not to cover contraception (U.S. Centers for Medicare & Medicaid 
Services 2020)), the cost of paying for birth control without a prescription varies depending on 




the medical team in the user’s state (either a doctor, nurse practitioner, or physician assistant) 
then reviews, fills, and sends the prescription directly to the customer.  
Telecontraception platforms are growing in number and reach. Previous research has 
identified more than eight telecontraception platforms providing birth control prescriptions by 
mail or pharmacy pickup (Dorland, Fowler, and Morain 2019; Zuniga et al. 2020), with 
additional platforms available outside of the U.S. only (Ibis Reproductive Health 2020). Nurx, a 
startup telecontraception company, provides care to over 300,000 patients monthly (Shieber 
2020; Landi 2020). Less is known about who utilizes telecontraception platforms, although 
limited research has been conducted on Nurx users and attitudes toward telecontraception in 
general (Wollum et al. 2018; Sundstrom et al. 2019). One study found that contraception 
requests on the Nurx platform jumped from 3 per day in 2015 to 127 per day in 2017 (Wollum et 
al. 2018). According to Nurx’s founder, the largest amount of sign-ups comes from Texas, a state 
with the highest number of contraceptive deserts in the United States (Chuck 2017).  
The Social Shaping of Technology  
 The social shaping of technology (SST) is a theoretical framework arguing that 
technological design and advances are inseparable from the social context in which they emerge 
(MacKenzie and Wajcman 1999). Social, economic, and political factors influence technology at 
all stages, from design to implementation. Many different choices, decisions, and actors are 
involved with technology so that technology and society cannot be considered distinct entities; 
rather, they are intertwined and mutually shape one another (Kitchin 2014; Latour 1987; Winner 
1986; O’Neil 2016; Devlin 2018; Eubanks 2018; Cowen 1983). Despite these mutually 
reinforcing factors, rhetoric around technology still often portrays technological innovations and 




problems (Rogers 1995; Winner 1986; Wajcman 2004; Nakamura 2009; boyd & Crawford 2012; 
Mosco 2014; Devlin 2018; Zuboff 2019). This rhetoric ignores the power, control, and tools that 
certain groups hold over others at all stages of technological innovation.  
Prescription birth control is a prime example of SST. Many different political and social 
decisions, factors, and stakeholders shape and are shaped by this technology. Even as technology 
advances to produce online platforms that can aid in the delivery of healthcare through a tap on a 
smartphone, legislation affects access to prescriptions and birth control. Mort and Finch 
(2005:68) argue that the telemedicine literature paints telemedicine as a neutral, “value free” 
technology but that it cannot be separated from place-based political contexts. Stakeholders with 
competing interests and visions can affect the implementation of telemedicine initiatives 
(Greenhalgh et al. 2012), and legislation is one area in which this plays out. States dictate 
whether a telecontraception platform can prescribe and dispense prescription birth control. Thus, 
although these platforms aim to meet the reproductive healthcare needs of women across the 
United States through technological innovation, the ability of women everywhere to access these 
services is not patterned equally due to on-the-ground as well as policy factors. These competing 
forces illustrate that technological innovations are not a value-free, neutral occurrence but are 
heavily influenced by the social, economic, and political conditions present as they emerge.  
Political and Legislative Influences on Contraception  
By design, internet platforms of all kinds aim to disrupt the restrictions of place, allowing 
individuals around the globe access to information, goods, and services that may not be available 
where they live. However, platforms can be subject to place-based regulation, and regulation is 
influenced by regional stakeholders. Although platforms are portrayed as technology without 




local decision-makers (Zuboff 2019; Srnicek 2017). Regulations can affect the reach of 
telecontraception platforms across states by dictating a platform’s ability to prescribe and/or 
dispense medications. Thus, regulatory forces shaped by local political and social contexts can 
expand or limit the power of telecontraception platforms to reach the individuals that demand 
their services.  
For example, in the United States, access to telecontraception platform services differs by 
state: Nurx provides telecontraception services to 30 states and Pill Club prescribes to 42 states 
(Nurx Inc. 2020; Pill Club 2020). These lists frequently change as telecontraception platforms 
gain authority and access to more and more states. Furthermore, regulatory practices can produce 
discrepancies in what a platform can provide even within a single state. As one example, Pill 
Club can dispense to customers in North Dakota but cannot write prescriptions for these 
residents (Pill Club 2020). States differ on their telemedicine policies such as reimbursement, yet 
research has not examined the causes of these differences (Trout et al. 2017). Research 
investigating telemedicine implementation has found that policy and legislation is a determinant 
and prerequisite for successful telemedicine initiatives (Broens et al. 2007). 
Legal barriers are replacing technological barriers in telemedicine implementation (Daley 
2000). For example, Nurx has cited anti-abortion groups and conservative lawmakers as two 
sources of resistance to telecontraception platforms (Chuck 2017). Conflicting stakeholders and 
interests place different values on particular aspects of telemedicine, such as clinical quality 
versus return on investment, and these competing visions and priorities can affect telemedicine 
implementation (Greenhalgh et al. 2012). Debates and tensions among these stakeholders, such 
as physicians, pharmacists, pharmaceutical and insurance companies, may also play a role in 




play in telemedicine initiatives, limited research has been conducted on the political and cultural 
characteristics of telemedicine (Wade, Gray, and Carati 2017; Greenhalgh et al. 2012; Bareiss 
2001). 
States are a major player in this process because they determine where telecontraception 
platforms can prescribe and dispense contraception to customers. The ability of a platform to 
provide its services to customers is thus not solely up the platform and the technology but is 
dictated by regulations which act as a gatekeeper. Therefore, although platforms are in the 
process of adding more states to their lists, customers in different states may not have equal 
access to these services. Less is known about which specific state-level factors influence the 
availability and access of telecontraception platforms across states. For example, Nurx’s co-
founder cited wait times for doctor licensing approval as the main obstacle to gaining access in 
each state (Klabusich 2017). Other political, economic, and social factors beyond licensing may 
also influence state policy on telecontraception platform access and availability.  
The proportion of women to men in state legislative roles. One important factor which 
could influence state-level policy on telecontraception platform access and availability is the 
proportion of women to men in state-level policymaking roles. These positions of power create 
and influence policy, so it is possible that having greater proportions of women with interest in 
women’s issues, such as reproductive healthcare access, could result in increased availability of 
telecontraception platforms. Rising numbers of women in the legislature means that women’s 
representation in policymaking positions is increasing, along with the potential to push for 
legislation representing women’s issues. States with higher proportions of women 
representatives propose more bills pertaining to women, children, and families compared to men 




& Wittmer 2018; Thomas 1991; Saint-Germain 1989), regardless of political party (Volden, 
Wiseman and Wittmer 2018). International research has also found that women legislators were 
more likely to represent and advance women’s rights and interests compared to male legislators 
(Tam 2020; Tam 2017). The organizational environment, in terms of support through increased 
representation and proportions of women in these roles, is hypothesized to play a role in these 
findings (Thomas 1991; Saint-Germain 1989). However, one study found that while women 
legislators introduced more bills on women’s issues, they have lower success rates of becoming 
law (Volden, Wiseman and Wittmer 2018).  
State-level political party dominance. Another important factor to consider in 
telecontraception platform policy and legislation is the political control of a state. States can be 
categorized as Democrat, Republican, split, or nonpartisan depending on the partisan 
composition of the state legislature and governor (National Conference of State Legislatures 
2020). Divergent values and viewpoints of each political party are linked with reproductive 
healthcare issues such as women’s access to birth control and abortion, which are then translated 
into policy, restrictions, and legislation. These beliefs largely coincide with political party 
affiliation: a survey by Pew Research Center (2019) found that 82 percent of Democrats support 
legal abortion, compared to 36 percent of Republicans. At the state level, actions to overturn Roe 
vs. Wade largely consist of Republican lawmakers and anti-abortion groups (Sonmez 2020).  
Anti-abortion groups and social conservatives support Republican administrations and 
pressure these political administrations for restrictive policies on birth control and abortion 
(Bryson, Légier, and Ribieras 2018; Dreweke 2018). For example, legislation by the Trump 
administration allows employers to decline contraception coverage for their employees based on 




Adamczyk 2020). Nearly half of the states in the U.S. have some type of law dictating actions 
surrounding moral or religious objections to filling certain prescriptions, such as oral 
contraceptives or emergency contraception (Chiarello 2011). Some states have a “conscience 
clause” for medical providers that allows them to opt out of medical processes or procedures for 
moral or religious reasons, while other states have “duty-to-dispense” laws or “refuse-and-refer” 
laws which entail stricter enforcement of filling prescriptions (Chiarello 2011; Berlinger 2008; 
Harrington 2006).  
Given this link between state political party control and reproductive healthcare policy 
and legislation, it is logical that this connection would extend to telecontraception. Platforms 
which aim to increase the accessibility and availability of birth control may be at odds with the 
ideology and beliefs of certain political groups and parties who hold the power to write the rules 
and policies dictating their use. On the other hand, similar viewpoints which align with the 
philosophy of accessible, available birth control could accelerate policies and legislation granting 
the authority of telecontraception platforms to dispense and prescribe birth control in a state. 
Research is needed to illuminate whether the connection between state-level political party and 
access to contraception extends to telecontraception. 
Economic Factors Shaping Telecontraception Platform Availability 
 State conditions affecting the access and availability of telecontraception platforms may 
also be driven by economic considerations, such as the impact of federal policies that influence 
state funding for reproductive health, the proportion of uninsured women in a state, and the 
proportion of rural to urban residents, which can also shape state-level health care delivery costs. 
Telemedicine is often discussed in terms of cutting costs and increasing healthcare access, 




2020). States have their own economic and financial constraints which may shape the availability 
of telecontraception platforms. For example, some states have had to make financial decisions 
regarding their budgets for family planning clinics in response to the Trump administration’s 
“gag rule” barring clinics from providing abortion referrals if they receive federal funds under 
Title X (Modern Healthcare 2020). The gag rule has diminished the capacity of family planning 
clinics to provide services to their patients, with some states more impacted than others (Dawson 
2020). These political decisions and changes at the federal level have effects at the state level, 
typically by restricting access to federal funds, which can then affect state-level policy. States 
that face funding constraints on family planning services such as contraception may be more 
open to telecontraception platforms to mitigate the financial pressures as well as provide services 
to patients in need. 
 The proportion of uninsured women in a state. Related to this issue are the economic and 
financial pressures of states to meet the needs of their uninsured populations. Just over 11 
percent of women aged 19 to 64, or 11.1 million women, in the United States were uninsured in 
2019 (Kaiser Family Foundation 2021). Family planning clinics provide free or reduced fee 
services but given the increased economic and financial pressures faced by states regarding 
family planning clinic funding, patients may face increasing barriers to accessing the care they 
need. Although the Affordable Care Act (ACA) has increased insurance coverage rates, 
disparities persist by race and ethnicity (Shane and Ayyagari 2014; Breslau et al. 2018; Smith 
and Medalia 2014; O’Hara and Brault 2013). Rates of uninsurance are not patterned equally and 
can exacerbate existing economic disparities. States with higher numbers of uninsured women 




alleviate some of the financial and economic pressure to ensure reproductive healthcare access to 
their uninsured populations. 
 The proportion of a state population that is rural. Telecontraception platforms also have 
the potential to overcome geographic restrictions and barriers to accessing in-person 
reproductive healthcare, provided that women have access to the internet. States with larger rural 
populations may have limited resources for family planning clinics and services. Geographical 
barriers and smaller populations can pose issues of access and service availability for patients in 
need of reproductive healthcare services, such as long wait or travel times (Sundstrom et al. 
2019). There may be fewer clinics in rural areas which could place greater pressure on existing 
clinics. States with higher numbers of rural residents may thus turn to telehealth initiatives to 
better serve the needs of their populations. A qualitative interview study of women living in rural 
South Carolina found that women discussed the potential of telehealth contraception to fill an 
existing gap by reducing cost, wait, and travel times and also providing knowledge and 
information about different contraception options (Sundstrom et al. 2019).  
Rural areas may also have a smaller variety of contraception options. For example, a 
nationwide survey of community health centers showed that rural and suburban community 
health centers provide less options for contraception compared to urban health centers, such as 
long-acting reversible contraception options like IUDs and implants as well as emergency 
contraception such as Plan B (Packtor 2018). Less access to long-acting reversible contraception 
methods and emergency contraception can raise the risk of unintended pregnancy (Packtor 
2018). One study found higher adolescent birth rates for women living in rural areas with health 
professional shortages compared to women living in urban counties (Orimaye et al. 2020).  




telecontraception platforms since they can provide an array of contraception options and 
information, while also reducing access issues such as long wait or travel times.  
METHODS 
Data 
 This study draws from an original dataset constructed from a variety of public-use 
websites of state-level factors for all fifty states hypothesized to influence telecontraception 
platform access and availability. The method of fsQCA is well-suited for this research question 
because it allows for an investigation of multiple factors such as the social, economic, political, 
and legislative conditions across states and how they combine to pattern telecontraception 
availability. The total sample size of 50 fits the characteristics of fsQCA, which is suitable when 
analyzing small samples like this one (Fainshmidt et al. 2020). As an analytical tool, fsQCA is 
used to analyze samples that are larger than case studies but smaller than those needed to support 
multiple regression analyses (Fainshmidt et al. 2020). Missing data was minimal; one variable 
had three missing values and another variable had one missing value, so the final sample size 
was 46 states. This study was approved by the University of Wisconsin-Milwaukee Institutional 
Review Board (IRB #20.339).  
Measures 
Outcome variable. The outcome variable for this study is the availability of 
telecontraception platforms in each state as of 2019. This is operationalized as the number of 
companies providing telecontraception services that are available to residents in a state. 
Information about telecontraception platform availability across states comes from previous 
research that mapped out characteristics across telecontraception platforms, such as cost, age 




number of telecontraception platforms available in each state as of February 2019 was obtained 
from Dorland, Fowler, and Morain’s (2019) research and compiled into a dataset. This outcome 
variable serves as a proxy for policy regarding the dispensing and prescribing authority of a 
telecontraception company in a state, since it measures the number of companies available to 
provide telecontraception services to residents within a given state. The number of platforms 
ranged from two to five or more services. Telecontraception platform availability was coded as 
“high” if the number of services were three or more, and “low” if a state had two services. This 
was coded as a dichotomous variable (1 = high availability; 0 = low availability). Sensitivity 
analyses were conducted using alternative categorizations of all variables used in this study (see 
Appendix B).   
Condition variables. Four condition variables were hypothesized to pattern 
telecontraception platform availability: state political control, proportion of women legislators in 
each state, proportion of a state population that is rural, and proportion of uninsured women. 
Data for state political control and proportion of women legislators are from 2019 and were 
obtained from the National Conference of State Legislatures (NCSL) website (National 
Conference of State Legislatures 2019; National Conference of State Legislatures 2020). State 
political control examines the party control of each state legislature and governorship. Values 
consisted of 1 = Democrat control, 0 = Republican control, and 0.5 = divided state control. There 
was one missing value for this state control variable (Nebraska, which has a nonpartisan 
unicameral state legislature). This variable groups together state legislature control (Democrat, 
Republican, or divided) and governor (Democrat or Republican). Sensitivity analyses separated 
out this single variable into two separate variables. Since fsQCA software does not count cases 




coded as values of 0.4 or 0.6 (Charles Ragin, personal communication, March 4, 2021). This is 
because a value of 0.5 represents an exact middle ground and needs to be categorized “into” or 
“out of” a condition. States with divided state control were categorized as 0.4 (more Republican) 
or 0.6 (more Democrat) based on results of the last four presidential elections (“Red States and 
Blue States,” n.d.). 
Coding for proportion of women legislators took into consideration the degree of 
membership (Ragin 2008a). Degree of membership can be calibrated into various qualitative 
breakpoints to indicate membership in a set; this is referred to as “fuzzy set” data (Ragin 2008a). 
Qualitative comparative analysis uses either fuzzy set or crisp set data. With fuzzy set data like 
this, variables can be coded either as 0 (non-membership) to 1 (full membership), but thresholds 
and breakpoints can be set to delineate the level of membership in that condition (Devers et al. 
2013). Researchers must determine these various cut points (Devers et al. 2013), first by drawing 
on substantive and theoretical knowledge if possible, but in the absence of this guidance, 
technical criteria like distribution of cases can be used (Devers et al. 2013). Values for percent 
women legislators in each state ranged from 14% to 52%, and were coded into four categories 
reflecting the degree of membership in this variable: “fully in”, “more in than out”, “more out 
than in”, and “fully out” (Ragin 2008). Small percentages of women legislators in a state were 
coded as either “fully out” or “more out than in” of the category. For example, if a state had a 
small proportion of women legislators, such as 14 percent, it would be coded as “fully out”. 
Proportions of women legislators that were 33% and above were classified as 1 (fully in), less 
than 20% as 0 (fully out), 20-25% as 0.33 (more out than in), and anything from 26 to 32 was 




Proportion of a state population that is rural was obtained from the United States 
Department of Agriculture Economic Research Service (2020) website. Data from 2019 was 
collected and calculated by dividing the rural (nonmetro) population by the total population each 
state. Three states were missing this information (Delaware, New Jersey, and Rhode Island). 
Values for percent rural population ranged from 1% to 69% and were coded into three 
categories. Proportions of a state population that is rural that were less than 20% were classified 
as 0 (“fully out” using the language of fsQCA), 20-26% as 0.5 (“neither fully in nor fully out”), 
and anything above 26% as 1 (“fully in”). Since fsQCA software does not allow values of 0.5 as 
mentioned earlier (Charles Ragin, personal communication, March 4, 2021), states with values of 
0.5 were coded as 0.4 if they had values of 20-22% rural population (less rural) and coded as 0.6 
if they had values of 23-26% rural population (more rural). 
Proportion of uninsured women were obtained from the Guttmacher Institute Data Center 
website and represent the percentage of women aged 15 to 44 who were uninsured as of 2017 
(Guttmacher Institute 2020). Percent uninsured women ranged from 3% to 24%. Values that 
were 10% and above were coded as 1 (fully in), 8-9% were coded as 0.67 (more in than out), 7% 
as 0.33 (more out than in), and anything 6% or less as 0 (fully out).  
Analytic Plan  
Qualitative comparative analysis (Ragin 2000; Ragin 2008a; Ragin 2008b) is often used 
to analyze small samples like this one and can be particularly helpful for health services 
researchers because it can illuminate characteristics of interventions which produce a given 
outcome (Kane et al. 2014). This method also acts as a link between quantitative and qualitative 
analytical camps because it allows researchers to use both precision and substantive knowledge 
in their construction of membership scores (Ragin 2008a). Similar methods that examine 




sample sizes (Park and Yu 2018). Other similar methods such as discriminant class analysis 
requires a minimum sample size of 20 for four or five predictor variables, but researchers are 
strongly urged against using this method with low sample sizes (Poulsen and French 2008), and 
cluster analysis requires multiplying the number of variables by 70 to generate the appropriate 
sample size (Dolnicar et al. 2014). Given current knowledge about sample size and various 
analytical approaches, fsQCA is the best approach here (Ragin 2008b).  
Qualitative comparative analysis differs from standard methods such as multiple 
regression because it focuses on configurations of cases as packages, or sets, of relations (Ragin 
2000; Ragin 2008a). It preserves the complexity and variation across both conditions and cases, 
allowing for an analysis of multiple combinatory factors leading to an outcome. As a method, 
fsQCA is well-suited to the analyses conducted in this study because it examines specific 
combinations of state-level conditions associated with availability of telecontraception platforms. 
States are not a homogenous group; they have unique characteristics that can reflect competing 
interests. Therefore, fsQCA can capture this variation and examine patterns in telecontraception 
platform availability across states. There can be many different combinations of state-level 
conditions leading to an outcome, and fsQCA allows researchers to examine each of these 
possible combinations (Ragin 2008a). Once the variables are correctly constructed, different 
possible combinations of state-level conditions can be identified. Researchers can then conduct 
additional analyses to examine the coverage and consistency of various combinations leading to 
a particular outcome (Ragin 2008a). 
The analysis proceeds in three steps. First, state-level factors hypothesized to pattern 
telecontraception platform availability were collected and compiled into a raw data table and 




was used to identify all possible combinations of causal conditions patterning telecontraception 
platform availability (Ragin and Davey 2016; Ragin 2018). Third, the algorithm in fsQCA was 
used to evaluate solution consistency and coverage measures (Ragin and Davey 2016; Ragin 
2018). Sensitivity analyses were conducted and used different categorical constructions of key 
variables to examine how robust solutions, consistency, and coverage measures were to different 
operationalizations of key condition variables (see Appendix B). 
RESULTS 
 Table 7 documents the values for both the outcome and condition measures for all fifty 
states. This table shows descriptively the number of telecontraception platforms available in a 
state, the proportion of women legislators, state political party control, the proportion of 
uninsured women, and the proportion of a state population that is rural. Since fsQCA software 
eliminates cases with missing values, the four states with missing values (Delaware, Nebraska, 
New Jersey, and Rhode Island) were dropped from all subsequent analyses.      
Table 8 documents all possible combinations of condition variables generated from the 
dataset. The number of combinations is based on the number of condition variables, so in this 
analysis using four condition variables there are 16 possible combinations of state-level 
conditions (24 = 16) (Ragin 2008a; Ragin 2018). The number column represents the number of 
states that are sorted into a particular combination (Ragin 2008a, p. 131; Ragin 2018). The next 
set of columns in Table 8 document consistency scores generated from the fsQCA analysis 
(Ragin 2008a). These scores are used to help identify viable combinations linking specific 
conditions to the outcome from combinations that are less likely to result in the outcome, given 
these conditions (Ragin 2008a). Raw scores document the degree of membership in the outcome, 




document alternative ways of measuring consistency (Ragin 2018; Ragin 2015). All scores range 
from a low of 0 (indicating no consistency) to a high of 1 (indicating perfect consistency). Table 
8 shows that consistency scores across the different measures (raw, PRI, and SYM) were 
identical in all combinations. Values for consistency should be at least 0.80 or higher to be 
considered viable combinations of state-level conditions linking specific conditions to the 
outcome, although researchers can test different consistency cutoff values to see their effect on 
the results (Ragin 2018). Here, the general cutoff of 0.80 was used, resulting in eight out of the 
eleven configurations coded as substantially consistent. Robustness analyses were also 
conducted using an alternative cutoff value; see Appendix B. Each configuration was assigned a 
1 if it met or exceeded the cutoff value or “0” if it was less than the consistency cutoff value. The 
last column of Table 8 illustrates all combinations that were identified as exhibiting the outcome 
based on the consistency cutoff score of 0.80.  
Combinations of State-Level Conditions Linked to Telecontraception Platform Availability  
Table 9 documents the identification of three key combinations of state-level conditions 
associated with telecontraception platform availability. First, the conditions associated with each 
combination are delineated by either “Yes” or “No” to indicate high or low presence of a 
condition in a particular combination (“N/A” indicates that the condition was neither present nor 
absent). Thus, two combinations (#2, #3) identify the proportion of women legislators in a state 
as a key factor, in combination with other conditions, associated with telecontraception platform 
availability. Similarly, having Republican state political control is important in producing 
telecontraception platform availability in two combinations (#1, #3) in combination with other 




consistency and coverage scores for each combination. Maps illustrating the combinations of 
states found in each combination are shown in Figure 2.  
Solution consistency and coverage scores represent the scores for the entire solution; 
specifically, the entire body or combination of combinations taken together. Consistency 
indicates the percentage of cases with a combination of conditions which also exhibit the 
outcome; they range from a low of zero (no consistency) to a high of one (perfect consistency), 
with values of at least 0.75 interpreted as identifying meaningful combinations (Ragin 2008a; 
Legewie 2013). The individual consistency scores associated with each of the three identified 
combinations exhibit high consistency (0.85 – 1.0 > 0.75) with an overall solution consistency of 
0.91. Thus, the results in Table 9 demonstrate that all three combinations of state-level factors, 
both individually and taken together as a whole, represent meaningful conditions that are 
associated with telecontraception platform availability. 
Coverage indicates how well a combination of state-level conditions accounts for the 
outcome instance by measuring if the combination is empirically relevant or important to the 
outcome (Ragin 2008a; Legewie 2013). Coverage scores range from a low of zero (no coverage) 
to a high of one (high coverage). Raw coverage measures the percentage of cases exhibiting the 
outcome that are explained by the combinations of conditions in a combination, while unique 
coverage measures the percentage of cases in the outcome explained by each individual 
condition in a combination (Ragin 2018). Although there are no formal guidelines on cutoffs for 
coverage scores, its values have been compared to R2 ranging from zero to one (Legewie 2013; 
Thiem 2010). Table 9 documents both coverage scores for each combination (ranging from 0.24 
to 0.32) and the solution as a whole (0.62). Combinations can have high consistency but low 




theoretical standpoint (Ragin 2008a). Ragin (2008a) explains how consistency is similar to the 
idea of “significance” and coverage is similar to the idea of “strength” in correlation statistical 
analyses. These two measures of consistency and coverage analyze how well the combinations 
display the outcome and which conditions are most relevant or important for exhibiting the 
outcome.  
The results in Table 9 document that all four state-level conditions are relevant for 
evaluating the outcome of telecontraception platform availability. Put differently, there is not a 
single condition variable that was not utilized in these analyses, indicating that these state-level 
conditions are necessary if cultivating greater telecontraception access is a policy goal. Some 
combinations may not contain a condition, but others do, which indicates that there is more than 
one combination of conditions that coexist with telecontraception platform availability in a state. 
Ten states exhibit the first combination of state-level conditions, fifteen states display the second 
combination of conditions, and seven states show the third combination of conditions associated 
with telecontraception platform availability.  
Combination #1. The first combination documents cases in which telecontraception 
platform availability is present when there is Republican state political control, a presence of 
uninsured women, and the absence of a rural population (consistency = .85; coverage = .24). Ten 
states exhibited this combination (Arizona, Florida, Georgia, Indiana, Louisiana, North Carolina, 
South Carolina, Tennessee, Texas, and Utah). Figure 2 shows that these states are mostly 
clustered in the southwestern and southeastern regions of the United States. Two states 
(Louisiana and Utah) exhibit this combinations of conditions but lead to low telecontraception 
platform availability (2 services available in their states). The goal of fsQCA is to identify 




be few or no cases with an outcome value of zero (Charles Ragin, personal communication, 
March 5 and 10, 2021). Although this combination of conditions contains two cases which lead 
to low telecontraception platform availability, it yields a high consistency score of .85 which 
illustrates that this combination is a strong subset of the outcome. Percent women legislators was 
not a necessary condition to telecontraception platform availability for this combination.  
Combination #2. The second combination illustrates that telecontraception platform 
availability is present when there is a presence of women legislators, Democratic state political 
control, and an absence of a rural population (consistency = 1.0, coverage = .32). Fifteen states 
exhibited this combination (California, Colorado, Connecticut, Hawaii, Illinois, Massachusetts, 
Maryland, Michigan, Minnesota, Nevada, New York, Oregon, Pennsylvania, Virginia, and 
Washington). Looking at Figure 2, these states are grouped into regions within the northern half 
of the United States; there are no southern states in this combination of conditions. The 
consistency score of 1.0 represents perfect consistency, indicating strong identification of a 
combination of conditions to the outcome. Raw coverage is .32, illustrating that this combination 
of conditions is relevant or important to the outcome. The percentage of uninsured women in a 
state was not a necessary condition to telecontraception platform availability for this 
combination.   
Combination #3. The third combination consists of a presence of women legislators, 
Republican state political control, and a presence of uninsured women. Seven states exhibit this 
combination of conditions (Alaska, Arizona, Florida, Georgia, Idaho, Kansas, and Montana). As 
Figure 2 shows, these states are concentrated in the western and southeastern regions of the 
United States. Three states in this third combination (Arizona, Florida, and Georgia) also 




combinations illustrates how there are multiple pathways to telecontraception platform 
availability. Specifically, the focus of fsQCA is on the combinations of conditions across each 
grouping of states rather than the individual states themselves. States can be in more than one 
combination because each combination illustrates the shared pertinent combination of conditions 
linked to an outcome across these specific cases. This third combination exhibited high 
consistency (.91) and coverage (.25), indicating this is a meaningful and relevant combination of 
conditions to the outcome.  
Finally, the overall solution consistency and coverage scores for all three combinations 
are high (solution consistency = .91, solution coverage = .62), indicating that these three total 
combinations are meaningful and relevant combinations to the outcome of telecontraception 
platform availability. In total, the three combinations contain 29 states which indicates that most 
states in the U.S. are represented in this analysis. States that did not appear in any of the three 
combinations may have some other, unmeasured state-level conditions that are also important to 
telecontraception access but have yet to be investigated.   
DISCUSSION  
 This study utilized fsQCA to analyze combinations of state-level factors linked to 
telecontraception platform availability. Although telecontraception platforms are growing in 
number and scope, access to their services is not patterned equally across the United States. 
Thus, despite arguments about the “disruptive” nature of emerging platforms and technologies, 
where a woman lives can determine whether she can access telecontraception. Despite the 
growing number and scope of healthcare platforms, research has yet to examine the state-level 
conditions that have important effects on the on-the-ground experiences of women attempting to 




level features, alone or in combination with others, might be important for access to 
telecontraception. Although there are sixteen possible combinations that could occur, it is 
noteworthy that the analyses uncovered three combinations of state-level conditions linked to 
telecontraception platform availability with very high consistency.  
One major finding from this study is that having a large presence of women in state 
policymaking roles alongside other political and economic state-level conditions is an important 
ingredient for availability of telecontraception platforms, aligning with previous research that 
points to the importance of higher proportions of women legislators proposing bills related to 
women’s rights and issues (Tam 2020; Tam 2017; Volden, Wiseman & Wittmer 2018; Thomas 
1991; Saint-Germain 1989). Importantly, the presence of women legislators in combination with 
other state-level conditions was linked to telecontraception platform availability in both 
Republican and Democrat politically controlled states. This is interesting since many public and 
policy discussions surrounding birth control and reproductive rights often focus solely on 
political party. Robustness analyses examined whether this condition variable of women 
legislators is an indicator of larger Democratic political party control, since there are greater 
numbers of women legislators in the Democratic party compared to the Republican party 
(Blazina and Desilver 2021; National Conference of State Legislatures 2019). Results of this 
robustness analysis produced similar findings but lower coverage scores (see Appendix B), 
indicating that the partisan composition of women legislators in combination with other social, 
economic, and political conditions is less relevant in leading to telecontraception platform 
availability than the percentage of women legislators in combination with other factors.  
The gender makeup of legislative bodies may operate as a force in and of itself in 




higher proportions of women representatives propose more bills pertaining to women, children, 
and families compared to men and also compared to states with lower proportions of women 
representatives, regardless of political party (Volden, Wiseman & Wittmer 2018; Thomas 1991; 
Saint-Germain 1989). It may be that women legislators have firsthand, personal experience with 
hurdles or barriers to accessing birth control and reproductive healthcare services, which could 
drive their decisions and actions. Future research is needed on how women legislators prioritize 
and make decisions about telecontraception policy and legislation.   
The number of women in political positions of power is growing. In earlier research on 
the proportion of women in state legislatures, percentages ranged from 3 to 30% in 1988 
(Thomas 1991). Now, women in the legislature range from 14 to 52%, and 2019 yielded the 
largest number of women elected at a single time (National Conference of State Legislatures 
2019). As more women move into policymaking roles, their ability to push issues and influence 
decisions may increase. Many discussions surrounding birth control and reproductive rights often 
focus on political party. Findings from this study suggest that gender and having women in 
positions of power, in combination with other political and economic state-level factors, is 
another growing and important factor to consider in legislation and policy related to women’s 
issues such as reproductive health rights and policy. This also carries implications for broader 
policy issues related to women, suggesting another channel through which advocacy groups can 
push for change.  
Another important combination of state-level factors leading to high telecontraception 
platform availability was Republican state political control and the economic pressures of a state. 
Two out of the three combinations require Republican state political control but also have a high 




of their populations or respond to pressures regarding these populations, despite political party 
ideology towards contraception. Republican-controlled states may also endorse telecontraception 
platform services as a market-based solution to the needs of their population because they align 
with their ideology of business model market solutions to healthcare. It also may be that states 
are facing greater pressures on public family planning clinics due to the Trump administration’s 
gag rule, causing states to turn to market-based solutions such as telecontraception platforms that 
can grant these options to women living in these states. Looking at the set of these states, some 
have large populations and thus may have larger uninsured populations and metropolitan areas 
(such as Florida and Texas). This may also contribute to the finding of why the absence of a 
rural population was linked to telecontraception platform availability because states with non-
rural populations may have larger metropolitan areas with greater numbers of uninsured 
residents. On the other hand, it could also be that states with large rural populations may be less 
likely to deviate from socially conservative policies.  
 One last important pattern to note is the geographical clustering of states in the different 
combinations. Overall, the combinations illustrate distinct groupings of geographical regions. 
For example, the first combination is concentrated among states in the southwest and southeast 
regions of the United States. Neighboring states may share similarities not just in their 
geographical location but also in their attitudes, ideologies, and demographics. These regions can 
be viewed as “cultural groups” with their own set of political cultures and values (Elazar 1984). 
Even the names of these groupings are conceptualized as mini-regions: “New England” is one 
such example of a geographical region of a group of states “bound by the tightest of social and 
historical ties” despite differences among these states (Elazar 1984:138). Previous research has 




(Elazar 1984). Thus, states may share similar norms from which they operate to address new 
technological innovations such as telecontraception. States may also look to each nearby states 
for guidance when passing legislation, such as through the processes of diffusion, isomorphism, 
or legitimacy (Scott 2014; Rogers 1995). Communication and social networks across these 
clusters of states may be a key factor operating in the availability of telecontraception platforms. 
As these platforms are a new, innovative technology, states may look to nearby neighbors for 
guidance or tap into their communication networks in the face of uncertainty. These findings 
suggest that adoption of new technological innovations may first occur across geographical 
regions rather than nationwide.  
 Technologies shape and are shaped by their social context. This study illustrates how 
political, economic, and social factors pattern the accessibility and availability of 
telecontraception platforms across the United States. Technologies “are the products of social 
processes and social choices” (Saetnan 2000, p. 3), and telecontraception platforms are one 
example that illustrates how on-the-ground decisions affect technological designs and use, and 
vice versa. Findings from this study demonstrate how the path to telecontraception availability is 
not one-size-fits-all. Rather, there are many different decisions, choices, and possibilities to 
arrive at this outcome. Some states, such as Arizona, Florida, and Georgia, belonged to more 
than one combination linked with telecontraception platform availability. This illustrates the 
configurational nature of fsQCA which emphasizes the combinations of conditions linked to an 
outcome, rather than “independent variables” having separate effects on an outcome used in 
other forms of quantitative analyses (Ragin 2008a). Rather than viewing the states as separate 
entities operating independently, fsQCA considers the whole package of states that share a 




combination because they have multiple possible relevant configurational conditions linked with 
telecontraception platform availability. 
Limitations 
These results should be interpreted with a few limitations in mind. First, it is important to 
remember that telecontraception platform availability as the outcome variable in this study 
served as a proxy for policy regarding the dispensing and prescribing authority of a 
telecontraception company in a state. There may be other, missing factors not accounted for 
which influence the availability of telecontraception platforms in a state such as administrative 
policies or hurdles to telecontraception implementation. Another limitation to note is that this 
study uncovered four condition variables important to telecontraception policy, but there are 
undoubtedly many other important conditions that pattern telecontraception platform availability 
across states. One of the strengths of fsQCA is its ability to delineate the many different 
combinations that lead to an outcome. However, there are other possible conditions or factors 
that could pattern telecontraception access that have not been investigated yet, such as state laws 
allowing pharmacists to prescribe and provide contraceptives or states that expanded Medicaid 
under the Affordable Care Act. This may explain why 17 out of the 46 states in this sample did 
not fit the combinations of conditions linked to telecontraception platform availability in this 
study because they may have other unmeasured state-level conditions that are also important to 
telecontraception access. 
CONCLUSION 
The case of telecontraception platforms is a prime example of the social shaping of 
technology because it illustrates that social, economic, and political conditions influence the 




women have attempted to use the technology of their day to gain access to health information 
and products that were not available in their local area. In 1873, a federal law made it illegal to 
send contraception information and devices through the U.S. mail (May 2010). Today, many 
women are turning to telecontraception platforms to access birth control. Yet reproductive health 
products are still not available to all women because political climates regulate the ability of a 
platform to prescribe or dispense contraception, just as we regulated the mail—another “place-
disrupting” technology—in the nineteenth century. This study demonstrates that conditions at the 
state level are an essential and important area of study when looking at telecontraception access, 
as well as telemedicine and telehealth policy broadly. Technological innovations alone are not 
enough. They require the right social conditions to work as intended. Qualitative comparative 
analysis provides an innovative and informative approach for policymakers, stakeholders, and 
researchers to examine the state-level factors that pattern access to telecontraception, 
illuminating opportunities for intervention and improvement of reproductive healthcare across 
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Table 7. Descriptive Table of Outcome and Condition Variables 
 
  














Alabama 3 16 Republican 14 23 
Alaska 4 38 Republican 15 33 
Arizona 5 39 Republican 13 5 
Arkansas 3 24 Republican 11 37 
California 5 31 Democrat 9 2 
Colorado 5 47 Democrat 10 12 
Connecticut 5 33 Democrat 7 5 
Delaware 2 24 Democrat 7 --- 
Florida 5 30 Republican 18 3 
Georgia 5 31 Republican 19 17 
Hawaii 3 32 Democrat 5 19 
Idaho 3 31 Republican 16 32 
Illinois 5 36 Democrat 9 11 
Indiana 5 24 Republican 11 22 
Iowa 5 29 Republican 5 40 
Kansas 3 28 Split 11 31 
Kentucky 4 23 Republican 7 41 
Louisiana 2 16 Split 10 16 
Maine 3 39 Democrat 11 41 
Maryland 3 39 Split 8 3 
Massachusetts 5 29 Split 3 1 
Michigan 5 36 Split 6 18 
Minnesota 5 32 Split 6 22 
Mississippi 2 14 Republican 17 53 
Missouri 5 25 Republican 13 25 
Montana 5 30 Split 11 65 
Nebraska 5 29 --- 12 34 
Nevada 3 52 Democrat 15 9 
New Hampshire 2 34 Split 7 37 
New Jersey 5 31 Democrat 11 --- 
New Mexico 2 36 Democrat 12 33 
New York 5 32 Democrat 7 7 
North Carolina 4 25 Split 15 21 
North Dakota 4 21 Republican 10 50 
Ohio 5 27 Republican 7 20 
Oklahoma 2 22 Republican 20 34 
Oregon 4 40 Democrat 9 16 
Pennsylvania 5 27 Split 7 11 
Rhode Island 5 38 Democrat 6 --- 
South Carolina 4 16 Republican 16 14 
South Dakota 4 24 Republican 12 51 
Tennessee 5 16 Republican 11 22 
Texas 5 24 Republican 24 11 
Utah 2 24 Republican 11 10 
Vermont 3 40 Split 5 65 
Virginia 5 26 Split 12 12 
Washington 5 42 Democrat 8 10 
West Virginia 2 14 Republican 8 38 
Wisconsin 5 27 Split 7 26 




Table 8. All Combinations of State-Level Conditions Linked to Telecontraception Platform 
Availability 
























.76 .76 .76 0 








1.0 1.0 1.0 1 







1.0 1.0 1.0 1 







.83 .83 .83 1 




.90 .90 .90 1 
6 1 0 1 0 3 AZ, 
FL, 
GA 
.94 .94 .94 1 
7 1 1 0 1 3 NH, 
VT, 
WI 
.73 .73 .73 0 
8 1 1 1 1 2 ME, 
NM 
.65 .65 .65 0 
9 1 0 0 0 1 OH 1.0 1.0 1.0 1 
10 0 0 0 1 1 KY .86 .86 .86 1 
11 1 0 0 1 1 IA .87 .87 .87 1 
12 0 0 0 0 0      
13 0 1 0 0 0      
14 0 1 1 0 0      
15 0 1 0 1 0      





Table 9. Key Combinations of State-Level Conditions Linked to Telecontraception Platform 
Availability 
 Combination #1 Combination #2 Combination #3 
Conditions    
Women Legislators N/A Yes Yes 
State Political Control (Dem) No Yes No 
Uninsured Women Yes N/A Yes 
Rural Population No No N/A 
    
States with this combination of 
conditions 
AZ, FL, GA, IN, LA, NC, SC, 
TN, TX, UT 
 
CA, CO, CT, HI, IL, 
MA, MD, MI, MN, NV, 
NY, OR, PA, VA, WA 
 
AK, AZ, FL, GA, ID, 
KS, MT 
 
Consistency .85 1.0 .91 
Raw coverage .24 .32 .25 
Unique coverage .10 .27 .11 
    
Solution consistency .91   
Solution coverage .62   





























Figure 2. Maps Showing States Associated with Each Combination of State-Level Conditions 
Linked to Telecontraception Platform Availability  
(Source: Mapchart.net 2020). 
 





AIM #3: An Analysis of User Reviews from Nurx and Planned Parenthood Direct: What 
User Experiences Reveal About Mobile Apps for Reproductive Health 
 
Health apps and telemedicine are growing in numbers and demand, particularly with the 
current COVID-19 crisis (Lupton 2018; Carroll et al. 2017; Payne et al. 2015). One growing 
segment is the rise of telecontraception platforms that aim to provide accessible birth control and 
reproductive healthcare services via an app or website. Telemedicine can save time and money 
and is linked with high patient and provider satisfaction (Hanson et al. 2019), yet it is not known 
whether these same findings carry over to telecontraception. Given that nearly one-third of 
women reported difficulties obtaining prescription birth control or refills (Grindlay and 
Grossman 2016), telecontraception serves as a potential solution to address important existing 
access barriers such as geography (Chuck 2017; Sundstrom et al. 2019), time (Rodler et al. 2020; 
Jain and Mehrotra 2020), and cost (Weigel et al. 2019; Grindlay and Grossman 2016).  
Despite recent media coverage of telecontraception platforms (Stengel 2020; Basu 2019; 
Chuck 2017), research examining women’s experiences and evaluations of telecontraception 
platforms is lacking. Nurx, a startup telecontraception company, provides care to over 300,000 
patients monthly (Shieber 2020; Landi 2020). While there has been research on health app users, 
such as their demographic characteristics and health behaviors (Carroll et al. 2017), little 
research exists on telecontraception platform users and their experiences using these platforms. 
Existing research has looked at telecontraception requests (Wollum et al. 2018; Martinez et al. 
2020), experiences of those who requested PrEP (pre-exposure prophylaxis) (Hughes and 
Koester 2019), and rural women’s perceptions of the idea of telecontraception (Sundstrom et al. 
2019). There are also studies on the users of online informational reproductive health apps 




Research has shown that women value accessible contraception. One study found that 
over two-thirds of women in the United States would use contraception available directly from 
pharmacists, with higher interest among low-income and uninsured women (Landau, Tapias, and 
McGhee 2006). Another study found that 39 percent of U.S. women would be likely to use a 
progestin-only birth control pill if it was available over the counter, particularly if they are 
insured or tried to get a birth control prescription in the last year (Grindlay and Grossman 2018). 
However, it is unknown whether these same patterns and attitudes carry over to telecontraception 
platforms, nor the main reasons why women seek contraception outside of an in-person doctor 
visit. Highlighting user evaluations of telecontraception platforms can uncover motivations for 
using the platform, delineate the pros and cons of using the platforms, and illuminate needs gaps 
in the traditional in-person healthcare system, an area of growing importance during the current 
COVID-19 pandemic. Doing so can help inform reproductive health policy and services both in 
telemedicine and traditional in-person healthcare systems.  
To address this gap in knowledge, this study analyzed user reviews for two major 
telecontraception platforms: Nurx and Planned Parenthood Direct. These platforms represent two 
contrasting entities in terms of their size, stage of development, and user orientation. While Nurx 
is an online startup company operating completely in the virtual sphere, Planned Parenthood has 
been around for over 100 years and has local, physical locations where users can go for in-person 
appointments (Planned Parenthood Federation of America Inc. 2021). Therefore, these two 
telecontraception platforms offer varying degrees of telehealth services, name recognition, and 
user orientations to their platform. Findings from this study illustrate that while there are 
similarities in user evaluations of telecontraception services, there are important differences by 




accessing telecontraception, their experiences can differ across telecontraception platforms. Most 
importantly, user reviews of both platforms illuminate areas in which telecontraception is 
addressing existing barriers to contraception as well as identify areas for improvement.    
LITERATURE REVIEW 
User Reviews and Health Care Experiences 
Mobile apps have been used in many different types of health interventions, ranging from 
diet and physical activity to mental health, and there are now over 31,000 health-related apps 
(Payne et al. 2015). Analysis of user reviews is a growing way of studying apps because they can 
yield valuable insights about user experiences. “User experience” is a term originally used in the 
human-computer interaction field but is now a growing term applied to various other contexts 
and settings (Araz 2018). Studies of user experience examine the interaction between a user and 
an artifact in a certain context (Araz 2018). App designers have a goal in mind about what they 
would like users to experience when they create an app (Araz 2018). Thus, analyzing user 
experiences can uncover whether these apps are producing the desired experience for users. 
User experience is also important from a sociological standpoint since it incorporates and 
relies upon context. When looking at user experience, there is more than just the “user” and the 
“app”: the user and app interact in a certain context or situation (Araz 2018). All three factors are 
necessary when studying user experience. Studying user reviews of health apps can yield 
valuable insights about these three factors: the user, the object, and the context. User reviews can 
illuminate what users find valuable about an app, how and why they use an app, and requests for 
desired features (Stawarz et al. 2018; Genc-Nayebi and Abran 2017; Caldeira et al. 2017). This 
information can provide a greater understanding of social life and the broader social context, 




that purport to make life easier and solve existing problems. Apps are an example of this, in that 
users may turn to an app for a problem or a need (Light, Burgess, and Duguay 2018). 
 Technological innovations such as apps arise from a particular social context (MacKenzie 
and Wajcman 1999). Studying apps can thus reveal information about societal dynamics and 
areas of sociocultural and economic transformation (Light, Burgess, and Duguay 2018). From a 
sociological standpoint, analysis of apps can move beyond simply the functionality of apps to 
reveal deeper insights about its users, its intentions, and its cultural meanings – what researchers 
have termed “the walkthrough method” (Light, Burgess, and Duguay 2018). This method fuses 
science, technology, and cultural studies into one to provide a framework for critically analyzing 
an app (Light, Burgess, and Duguay 2018). At its core, this method recognizes that culture and 
technology shape one another and users experience a technology in a particular social context or 
culture (Light, Burgess, and Duguay 2018). In practice, it highlights the cultural discourses 
embedded in an app’s interface and how this might influence user interactions with an app 
(Light, Burgess, and Duguay 2018). The walkthrough method examines an app’s vision, 
operating model, and governance, then moves to features and functions such as registration and 
entry, everyday use/activities, and app suspension or closure (Light, Burgess, and Duguay 2018). 
Using this method can yield insights about the vision and the larger context in which these apps 
are developed and can be combined with interviews or content analysis of user reviews or 
discussions to provide a fuller picture of how users adapt and apply the app in their life. 
Overview of Telecontraception Platforms 
Nurx, LemonAid, Pill Club, and Planned Parenthood Direct are all examples of online 
platforms which provide birth control via an app or website. Known colloquially as “the Uber for 




reproductive healthcare services such as birth control, sexually transmitted infection (STI) testing 
and treatment, urinary tract infection (UTI) treatment, and emergency contraception by providing 
access to on-demand providers for consultations and shipping prescriptions directly to customers 
or to their pharmacy. Users download the app or go to the company website, create a profile with 
their contact information, and answer health history questions. Costs for birth control vary 
depending on the platform, insurance status or type, and whether a drug is a brand name or a 
generic equivalent. Some platforms charge a consultation fee.  
During consultations, patients are provided access to on-demand providers who can 
discuss needs, concerns, and provide information and education about different options. Patients 
can interact directly with a provider and ask questions on their schedule when it is convenient for 
them. The degree of interaction can vary depending on the platform, such as messaging versus a 
video consultation. Once a patient has selected an option, a licensed member of the medical team 
in the user’s state (either a doctor, nurse practitioner, or physician assistant) reviews, fills, and 
sends the prescription directly to the customer. However, policy and legislation affect the reach 
of a platform by dictating its ability to prescribe and/or dispense medication. Therefore, 
customers may not have equal access to these services simply due to the state they live in. 
In-Person Reproductive Health Care Interactions vs. Telecontraception 
In-person visits. Obtaining prescription contraception or reproductive health care 
typically requires an in-person visit to a healthcare provider in a medical setting such as a 
doctor’s office or clinic (Hariton and Tracy 2019). Visits for contraception are considered 
preventive care and are covered under the Affordable Care Act (ACA) by most insurance plans, 
although religious employers may choose not to cover contraception (U.S. Centers for Medicare 




pay out-of-pocket for a visit, although some clinics offer discounted rates or free services under 
certain programs which can vary by state. This preventive care is called a “well-woman visit” 
and consists of obtaining health history, screenings, and counseling depending on the patient’s 
age and family history (The American College of Obstetricians and Gynecologists 2020). The 
well-woman visit provides an opportunity for a provider to assess a woman’s overall health, 
although taking a blood pressure reading is the only test that is medically necessary for starting 
hormonal contraceptive use (Centers for Disease Control and Prevention 2017). 
Ideally, an in-person visit for contraception consists of a dialogue between the patient and 
provider regarding information and options. There are mixed findings regarding how these 
interactions play out and these can vary depending on different factors. Research has found that 
black women were more likely than white women to report pressure to use contraceptives by a 
provider (Becker and Tsui 2008), pressure that can be implicit such as through provider tone of 
voice or imbalanced information favoring certain methods (Gomez and Wapman 2017). Other 
research did not find differences in contraceptive counseling by race or ethnicity or 
socioeconomic status of the patient but found that providers largely did not assess patient 
pregnancy intention, birth control preferences, or allow patients an opportunity to ask questions 
(Dehlendorf et al. 2017). Educational, interactive decision tools for patients to choose birth 
control and a printout given to the provider about their preferences prior to a healthcare visit 
have been effective in patient-provider communication by allowing patient concerns and 
preferences to enter the discussion rather than being dictated by the provider’s presumptive 
expertise (Holt et al. 2020).  
There are both benefits and drawbacks to requiring an in-person visit to obtain 




information and ask questions about different birth control options, assessing overall health and 
vital signs, and zero cost under ACA (if a patient has insurance). There are also certain birth 
control methods that must be physically carried out in person, such as insertion of an implant or 
intrauterine device (IUD). Drawbacks include time, transportation, cost (if uninsured), and a non-
indicated invasive pelvic exam, which research has shown is not necessary for prescribing birth 
control (Ellison et al. 2021; Stormo et al. 2011). Other drawbacks can influence the quality of 
care such as limited time to cover all the information, answer patient questions, or complete 
additional tasks such as screenings, as well as other provider interaction issues such as pressure, 
imbalanced information, or lack of patient input (Becker and Tsui 2008; Gomez and Wapman 
2017; Dehlendorf et al. 2017).  
Telecontraception “visits”. Research on telemedicine illustrates that it reduces or 
eliminates many barriers associated with in-person visits. Convenience is a major factor in 
telemedicine studies because patients can access healthcare providers and services outside of 
normal business hours (Jain and Mehrotra 2020; Rodler et al. 2020). Patients also receive access 
to on-demand providers who can provide information and education about different options, 
discuss concerns, and answer questions, in comparison to an in-person visit where a provider 
may be pressed for time due to juggling multiple tasks such as assessing a woman’s whole health 
history or conducting other screenings. The ability to discuss options with a provider was 
mentioned as a benefit of telecontraception, as rural women indicated that this could provide 
knowledge and information about different contraception options (Sundstrom et al. 2019). In 
contrast, research on in-person visits found that providers largely did not assess a patient’s 
pregnancy intention, birth control preferences, or allow patients an opportunity to ask questions 




work to go to an appointment, transportation issues, and an invasive, non-indicated pelvic exam 
are all eliminated through telecontraception. 
Research has demonstrated both family planning provider and patient support for 
telecontraception services (Stifani, Avila, and Levi 2021; Sundstrom et al. 2019). Despite this 
support, uptake of its services varies. A recent report found that contraceptive management 
represented 65 percent of all reproductive health telemedicine claims for those with employer-
sponsored health insurance plans (Weigel et al. 2019). Rates of telemedicine use are higher for 
those with private insurance, higher income, and living in suburban and urban areas (Weigel et 
al. 2019; Jain and Mehrotra 2020). One explanation for this finding is that most telecontraception 
platforms do not accept Medicaid, and there can be cost issues if a platform provider is not 
considered in-network (Weigel et al. 2019). In contrast, users visiting an in-network provider for 
birth control in a traditional healthcare setting can have those reproductive healthcare services 
covered at no cost under ACA. Depending on insurance, patients may end up paying more using 
these platforms than visiting a healthcare provider in person (Weigel et al. 2019). Cost and 
coverage are two important potential explanations for low uptake rates of telecontraception 
services, despite patient and provider support for these platforms (Stifani, Avila, and Levi 2021; 
Sundstrom et al. 2019). 
Barriers to Accessing Contraception 
Nearly one-third of women reported difficulties obtaining prescription birth control or 
refills (Grindlay and Grossman 2016). The most common barriers related to the in-person visit 
include long appointment wait times, requirements of in-person exam or pap smears, 
transportation issues, not having a regular place to go for health care, and cost or insurance 




accessing contraception (Grindlay and Grossman 2016). Barriers are such a large factor in 
obtaining contraception that The American College of Obstetricians and Gynecologists (2019) 
published a committee opinion expressing their support and recommendation of over-the-counter 
hormonal contraception.  
Geography. By removing the in-person visit requirement, telecontraception can help meet 
the needs of women in contraceptive deserts or rural areas who reside far from clinics (Chuck 
2017; Sundstrom et al. 2019). Elimination of geographical barriers is a frequently cited benefit of 
telemedicine, but the research is mixed. One study found that rural women discussed the 
potential of telecontraception to fill an existing gap by reducing cost, wait, and travel times 
(Sundstrom et al. 2019). However, another study found that patients using telemedicine lived in 
urban areas with higher income and most did not live in a primary care health professional 
shortage area (Jain and Mehrotra 2020). This suggests that the idea of telemedicine might 
operate differently than its implementation, since in practice it may not address geographical 
barriers due to lack of awareness of telemedicine services, internet access, or cost (Jain and 
Mehrotra 2020). State-level legislation and policy can also affect the reach of telemedicine 
across states by dictating a platform’s ability to prescribe and/or dispense medications. Thus, 
although telecontraception platforms are designed to increase access to contraception, access can 
still be limited depending on place-based regulation.  
Medical gatekeeping. Another important barrier to obtain contraception is medical 
gatekeeping. Although not medically necessary, many women report that their doctor requires 
pelvic exams prior to prescribing hormonal contraception (Mencimer 2012; Ellison et al. 2021). 
For example, one study found that 71.6 percent of obstetrician-gynecologists and 67.7 percent of 




hormonal contraception (Stormo et al. 2011). However, blood pressure is the only test that is 
medically necessary for starting hormonal contraceptive use (Centers for Disease Control and 
Prevention 2017). Pelvic exams are “not necessary before initiation of combined hormonal 
contraceptives because it does not facilitate detection of conditions for which hormonal 
contraceptives would be unsafe” (CDC 2017; Westhoff, Jones, and Guiaha 2011; Stewart et al. 
2001; The American College of Obstetricians and Gynecologists 2015). These exams carry the 
risk of over-testing and false positives, anxiety, pain, and distress due to their invasiveness, and 
women may avoid the doctor altogether due to pelvic exams (Rabin 2014; Stormo et al. 2011). In 
contrast, telecontraception platforms only require blood pressure or a brief health overview, 
complying more with scientific findings regarding birth control prescriptions than in-person 
providers. Consequently, telecontraception platforms provide a direct challenge to the traditional 
healthcare system linking birth control prescriptions with exams by eliminating the need to see a 
provider in person and undergo an invasive, non-indicated exam to receive birth control.  
Policy and legislation. Access to birth control is heavily influenced by policy and 
legislation. Nearly half of the states in the U.S. have some type of law dictating actions 
surrounding moral or religious objections to filling certain prescriptions, such as oral 
contraceptives or emergency contraception (Chiarello 2011). Some states have a “conscience 
clause” for medical providers, which allows them to opt out of medical processes or procedures 
due to moral or religious reasons (Chiarello 2011; Berlinger 2008; Harrington 2006). Other states 
have “duty-to-dispense” laws or “refuse-and-refer” laws which entail stricter enforcement of 
filling prescriptions (Chiarello 2011). Legislation by the Trump administration allows employers 
to decline contraception coverage for their employees based on personal religious or moral 




Telecontraception platforms aim to reduce these barriers by facilitating women’s access to 
doctors and pharmacists who believe in accessible birth control.  
Overall, existing research highlights how barriers to obtaining contraception are linked 
with the requirement of an in-person visit. Telecontraception aims to alleviate many of these 
barriers through its technology, but no studies to date have examined these claims through an 
analysis of users’ experiences, as revealed by reviews. Research is needed to illuminate whether 
telecontraception platforms provide a viable alternative to in-person birth control visits by 
addressing barriers related to obtaining contraception, such as those related to geography and 
medical gatekeeping, as well as how and why users use these apps. Qualitative research using 
analysis of user reviews allows for an in-depth study of the meanings and experiences of 
telecontraception platform users, an advantage that cannot be captured through experimental 
design or survey questionnaires (Atieno 2009). Furthermore, user reviews represent a source of 
information and insights from many people (Frie et al. 2017) and thus can illuminate why 
women are using telecontraception platforms and their evaluations of these services on a larger 
scale. Illuminating motivations, reasons, and experiences using telecontraception can shed light 
on the potential of telecontraception to address existing barriers as well as identify unmet needs 
and areas for improvement related to obtaining contraception in the traditional healthcare system. 
METHODS 
Sample 
There are currently 17 telecontraception platforms that provide reproductive health 
services in the United States (Ibis Reproductive Health 2021). Telecontraception platforms that 
did not write birth control prescriptions, did not contain any user reviews, or only offered 




reviews only on their company website or a specialty review website were also excluded due to 
concerns about company control of this content. Telehealth platforms which offered birth control 
as one of a myriad of health services were also excluded because user reviews contained 
information on unrelated issues (e.g., ordering contacts). After these exclusions, two strictly 
telecontraception platforms (Nurx and Planned Parenthood Direct) remained which cover the 
largest number of states, contain the largest number of user reviews, and represent two 
contrasting stages of development in the emerging field of telecontraception platforms.  
While Nurx is an online startup company founded in 2015 and currently has over 16,000 
user reviews (Crunchbase Inc. 2021; Nurx Inc. 2021), Planned Parenthood Direct began as a 
pilot program in six states and has over 200 user reviews (Lovett 2019; Google Play 2021). Nurx 
and Planned Parenthood Direct are opposites of the telecontraception platform spectrum, 
representing contrasts in size, development stage, and user orientation. While Nurx operates 
completely in the virtual sphere, Planned Parenthood Direct also lets users request in-person 
appointments at their local Planned Parenthood location (Lovett 2019). Planned Parenthood has 
also been around for over 100 years and so may have greater name recognition and familiarity, 
which could make the transition to telemedicine easier for some patients who have visited its in-
person locations (Planned Parenthood Federation of America Inc. 2021). 
Data 
User reviews were collected using AppFollow, an open-source tool specializing in app 
analytics, to compile all user reviews for Nurx and Planned Parenthood Direct. AppFollow 
contained reviews for these two platforms beginning in 2017, so data for this study contains user 
reviews posted on either platform between 2017 through January 2021. The data for user reviews 




available data of user reviews in app stores represents an opportunity to naturally investigate 
consumer perspectives (Nicholas et al. 2017). Thus, a qualitative analysis of a convenience 
sample of user reviews is the best method for this exploratory research question because it serves 
as a way to unobtrusively garner user evaluations and experiences with using this emerging 
service of telecontraception platforms. This study was approved by the University of Wisconsin-
Milwaukee Institutional Review Board (IRB #20.339). 
Due to concerns about companies controlling the content of reviews, reviews were 
collected from the Google Play Store and Apple App Store rather than the company websites. 
Nurx had 269 reviews on the Google Play Store and 1,055 reviews on the Apple App Store. 
Nurx was initially only available through the Apple App Store, which could explain why the 
number of reviews are so much higher for that platform. In addition, although the majority of 
smartphone users around the world use the Android system, iOS is the most popular mobile 
operating system in North America (Afilias Technologies Limited 2019; Chadha 2018). The 
length of user reviews varied from a few sentences to a couple paragraphs. Since a user could 
theoretically post a review on both platforms, duplicate usernames were checked using SPSS 
27.0 (IBM Corp. 2020). Nurx had one duplicate user review and username, which brought that 
sample size down to 1,323 reviews. Planned Parenthood Direct had 283 reviews on the Google 
Play Store and 239 reviews on the Apple App Store, resulting in a total of 522 reviews. There 
were no duplicate reviews or usernames for Planned Parenthood Direct.  
Analytic Plan 
Qualitative data analysis was used to conduct a thematic analysis of user reviews from 
these two telecontraception platforms. Thematic analysis is conducted in several steps, starting 




(Braun and Clarke 2006). In this study, several codes were expected to capture themes 
hypothesized to emerge from the data based on the previous literature review illustrating 
research on barriers to obtaining contraception, such as medical gatekeeping and issues 
pertaining to policy and legislation. Additional themes, such as those capturing interactions with 
online clinicians or the ease of use of the app itself emerged from the data during the coding 
process. Codes were combined, refined, or added in an iterative process, going back and forth 
between the user reviews and the codes. This approach followed previous research conducting a 
qualitative analysis of user reviews which utilized thematic analysis (Stawarz et al. 2018). All 
user reviews were coded and analyzed using Dedoose software (Dedoose 2020). Appendix C 
provides further detail on the codes developed for this study and their frequency in both the Nurx 
and Planned Parenthood Direct User reviews. User reviews were analyzed separately for each 
platform, then compared to analyze similarities and differences.  
RESULTS 
A Brief Walkthrough of Telecontraception App Visions 
 I first draw on the walkthrough method to provide a brief overview of the vision and 
claims made by the two telecontraception apps as a way to examine cultural and social meanings 
embedded within these apps (Light, Burgess, and Duguay 2018). This can yield insights about 
the purpose, vision, and larger context in which these apps are created and used. Combined with 
user reviews, this provides a fuller picture of user experience of telecontraception apps. Nurx and 
Planned Parenthood Direct both have different philosophies and motives regarding their rationale 
for providing telecontraception. While Nurx aims to transform and disrupt the existing healthcare 
system, Planned Parenthood Direct focuses more on providing access, autonomy, and education. 




example, the mission statement of Nurx is “Our mission is putting you in control of your own 
health!” (Comparably 2021). The Nurx homepage uses large, attention-grabbing headlines in all 
capital letters such as “Expert care from your home” and “We’re on a mission to transform 
healthcare” (Nurx Inc. 2021). Overall, the Nurx homepage conveys the message that they value 
the patient and have a vision of transforming healthcare yet still draws on traditional language of 
medicine and healthcare to emphasize the legitimacy of their services through references to 
“expert care” and “your medical team” (Nurx Inc. 2021).  
In contrast, the Planned Parenthood Direct homepage does not make claims about 
changing healthcare but instead provides brief, clear information on obtaining reproductive 
healthcare services virtually. Their focus is not on “transforming” healthcare because they have 
been providing in-person reproductive healthcare services within the healthcare sphere for over 
100 years (Planned Parenthood Federation of America Inc. 2021) but rather on providing and 
fighting for affordable reproductive healthcare. Their mission statement focuses on access, 
affordability, autonomy, advocacy, and education (Planned Parenthood Federation of America 
Inc. 2021). This is reflected on their homepage through its straightforward approach to providing 
clear, concise information and education about reproductive healthcare access and cost. For 
example, the homepage contains practical aspects such as a step-by-step explanation of how their 
services work and a map of the U.S. where users can select their state and are given a short, 
bulleted list of the costs and services available to them (Planned Parenthood Direct 2020). Both 
telecontraception homepages also have a woman of color prominently featured at the top of the 
homepage, possibly to convey inclusiveness. This is especially important in the reproductive 
healthcare sphere, where historical abuses and systemic control, surveillance, and sterilization of 




reproductive healthcare interactions, and also during a time period in the United States where 
racial injustice and discrimination is at the forefront of national and global attention. 
Overview of Themes 
User reviews for both Nurx and Planned Parenthood Direct largely yielded the same 
major themes. Codes for each platform were analyzed, grouped, and categorized into five 
themes: 1) access and timeliness of apps, 2) clinician interaction, 3) cost and affordability, 4) 
support for the idea of telecontraception, and 5) platform development. Although the user 
reviews for both platforms yielded similar themes, the codes within each theme could have 
different meanings depending on the platform. This is discussed in the cost and affordability and 
platform development subsections.  
Access and Timeliness of Apps 
 Approximately one in five user reviews across both platforms (N=243 Nurx reviews; 
N=101 Planned Parenthood Direct reviews) cited problems with in-person healthcare visits to 
obtain birth control which were alleviated by using telecontraception. Not having to take time off 
work, having a busy schedule, and waiting months to wait for an appointment with a booked in-
person provider were the most common codes under this theme. This is particularly important in 
the case of birth control, where time is of the essence: 
I couldn’t find an appointment for birth control before when I’m supposed to put a new ring, 
when I downloaded the app I got my prescription in less than 5 hours! (PP Direct user) 
 
This app is amazing and saved my skin when I needed birth control asap. My employer provided 
health insurance was cancelled, my prescription then void, and I wasn’t able to have access to 
BC through my hospital. I logged on to the app, in literally less than an hour I talked to a Dr, 
verified my identity, and had BC pills sent directly to my home. I received them in 2 days! This 
app and Planned Parenthood are life savers and I wish I could give them 10 stars! (PP Direct 
user) 
 
I found myself unemployed and without health insurance, and my healthcare provider cut off my 
birth control prescription. With only a week to try and find a new prescription, I was freaking out 





My obgyn was refusing to fill my birth control prescription unless I went in to see them, but 
wouldn’t give me an appointment for a couple months, so I decided to try out the app to see if I 
could my prescription before then. I use birth control for menstrual/hormonal regulation so for 
me it’s very stressful not having it. I signed up for the app on a Sunday and the Monday 
immediately afterwards they had given me a prescription… (Nurx user). 
 
This theme of access and timeliness of apps illustrates the drawbacks of certain 
characteristics of the in-person healthcare system and how telecontraception alleviates many of 
these barriers. In the current in-person system, obtaining contraception is tied to an in-person 
visit with a provider. This presents barriers, such as not being able to get a timely appointment 
or insurance tied to employment. The above quotes illustrate how timeliness is an integral 
component of birth control which can present a major barrier if women cannot get a timely 
appointment with a provider or lost insurance tied to their job. Obtaining a refill of an existing 
prescription in a traditional healthcare setting still requires an in-person visit from a provider, so 
telecontraception platforms represent a way for women to access birth control on their schedule 
when they need it. The words “lifesaver” and “game changer” were commonly used to describe 
these platforms: references to these terms were mentioned in 112 of 1,845 total reviews (6% of 
all reviews).  
Another code connected to this theme was the medical need for birth control, which was 
mentioned by approximately ten percent of users across both platforms (N=143 Nurx reviews; 
N=50 Planned Parenthood Direct reviews). For these users, being on birth control was 
medically necessary to alleviate medical conditions like endometriosis, painful periods, or 
hormonal regulation. Not having timely access to an in-person provider combined with medical 
needs results in a major barrier to obtaining the reproductive healthcare a user needs. 
Eliminating wait times for visits and facilitating on-demand contact with a clinician is one way 
in which telecontraception platforms purport to break down this barrier. Additional codes under 




convenience, and shipping. Only four reviews across both platforms explicitly mentioned living 
in a rural area. 
Clinician Interaction 
Interactions with telecontraception clinicians was another major theme mentioned by 
approximately one in four user reviews across both platforms (N=331 Nurx reviews; N=141 
Planned Parenthood Direct reviews). Users indicated that providers answered their questions and 
concerns and were supportive and knowledgeable: 
I’ve had nothing but fantastic experiences using Nurx. It’s such a contrast to the care I’ve 
received at a doctors office or clinic (judgmental, flippant, and I’ve had doctors flat out tell me 
my birth control side effects were “impossible” and all in my head... What could I possibly gain 
from making it up?). Nurx is completely different. Their staff and doctors treat me with respect, 
and they treat me like an intelligent person…When I told them I was having side effects, they took 
my concerns seriously and made recommendations for a different pill. (Nurx user) 
I’ve used this app several times and always feel listened to and helped. The doctors are extremely 
nice and it’s easy to get help. (PP Direct user). 
 
 Friendly, informative, and helpful clinicians were largely mentioned in the Planned 
Parenthood Direct reviews. Users often described their clinicians as “sweet” or “nice”. User 
reviews of Nurx expressed more negative experiences regarding their requests than users of 
Planned Parenthood Direct, although the line between provider and customer service is blurred in 
these reviews. For example, it is impossible to discern who the user is referring to when they 
discuss sending a request since this could be a question to a clinician or a question to the 
customer service department (for example, about a billing issue). In addition, Planned 
Parenthood Direct conducts video visits with patients while Nurx reviews requests and fills a 
prescription so contact is made through messages rather than face-to-face virtual visits. The 
mode of interaction then may influence user experiences with a clinician, such as if they are 
viewing and interacting with them in real time versus messaging through an online portal. 




design choices of the platform itself. For example, Nurx does not require a video visit and 
presents this is a positive aspect of their service by stating that users can access services on their 
schedule (Nurx Inc. 2021). On the other hand, Planned Parenthood Direct mentions that video 
chats may be necessary (Planned Parenthood Direct 2020), and most Planned Parenthood Direct 
users who mentioned clinician interactions referred to a video visit. Telecontraception platforms 
may operate from different standpoints and perspectives regarding what is required to provide 
quality reproductive healthcare, and their design choices reflect these philosophies.  
 Related to this theme are the additional codes of birth control options, information and 
education, and discreet/privacy characteristics of telecontraception. Birth control options was a 
code that was specific to Nurx. One in five user reviews (N=260) mentioned different birth 
control options offered by Nurx, which was often related to clinician interaction and 
information/education about the various options. Some users expressed their need for a specific 
brand of birth control, which was often associated with a higher cost versus a generic version. 
Users were often upset about this, citing a medical need to be on a name-brand contraception. 
Other users expressed gratitude for “finally” finding a birth control that was right for them, and 
how it was the first time experiencing this despite visiting providers in-person for birth control. 
Information and education was related to this theme, as users expressed how they learned about 
birth control options through informational resources or through their provider: 
I’ve had so many struggles finding the right pill for me and this app got it right on the first try. 
The papers with all the informations they send is so helpful and makes me feel so comfortable. 
(Nurx user). 
 
I ended up trying a few birth controls through this app. I once used the doctor’s recommendation 
function, but I also found their listing of all the birth controls available to be one of the most 
comprehensive and easy-to-read guides on the internet. At the OBGYN, I never felt empowered to 
do my own research and make my own choices. In years of using birth control, I never felt like I 





I got a notification from a doctor hours after submitting my request with lots of very useful 
information. (Planned Parenthood Direct user). 
 
I was sent a ton of helpful information. (Planned Parenthood Direct user). 
 
The above quotes illustrate the increased information and educational resources available 
to patients through telecontraception platforms. Patients can review these informational materials 
and ask questions. This stands in contrast to in-person visits, where a provider often selects a 
brand of birth control. Here, in telecontraception apps, patients can choose based on many 
different options. The second quote references the doctor recommendation function available in 
the Nurx app, which selects an option for the patient based on what the provider would 
recommend if the patient is unsure about making a decision. This is similar to in-person visits. 
However, these quotes also illustrate the potential of telecontraception to address existing 
barriers in the in-person healthcare system such as not having enough time to discuss options or 
providing a comprehensive guide to choosing contraception which would be the best fit. Finally, 
the last code categorized under this theme relates to the discreet and private nature of 
telecontraception. Some patients mentioned not wanting others to find out about their use of 
contraception, such as a religious parent, and appreciated the discreet packaging.  
Cost and Affordability 
 User reviews discussing the cost or affordability of telecontraception was mentioned by 
approximately one in five users across both platforms (N=292 Nurx reviews; N=104 Planned 
Parenthood Direct reviews). Users were divided on this issue, illustrating how telecontraception 
has yet to alleviate barriers of cost and affordability. Just like the current in-person healthcare 
system, accessing and paying for care is dictated by insurance and socioeconomic status. Thus 
overall, the platforms largely mirror existing dynamics in in-person healthcare. On one hand, 




too high. Prices seemed to vary widely. Some users mentioned paying $20, while others 
complained of inflated prices such as $150. Another major difference was that Nurx charged a 
$15 nonrefundable consultation fee, even if the user later found out that the platform did not 
accept their insurance. They were drawn in by the idea of the platform but were charged before 
finding out they could not use it. Users felt that this was a deceptive practice, since this felt to 
them like a “bait and switch.” Lack of transparency about pricing was a common complaint 
among Nurx users. However, Planned Parenthood Direct provides a clear guide to how much 
users will pay for using its services. This reflected in its user reviews: while billing complaints 
were mentioned in 14% of Nurx user reviews, this issue only represented 2% of Planned 
Parenthood Direct reviews. Issues of cost represent the operating model and design choices of 
each company on its website or app, and also whether it is a for-profit or non-profit company. 
Providing direct, explicit information about reproductive healthcare costs was a clear focus on 
the Planned Parenthood Direct homepage, while this information was harder to find on the Nurx 
website. This might reflect the different philosophies of the two companies regarding how they 
view the purposes of their services, whether that is rooted in affordability and access (Planned 
Parenthood Direct) or financial interests and running a business to compete with in-person 
healthcare (Nurx).  
 On the other hand, users praised the platforms for being an “affordable” option. Some 
users even mentioned that there was no cost. Cost was also often mentioned alongside 
convenience: 
I feel that they are reasonably priced for how convenient it was. (PP Direct user). 
So convenient and cheaper than seeing my own doctor! (PP Direct user). 






Absolute easiest and most cost effective way to be in control of your reproductive health (Nurx 
user). 
 
I’ve never had to pay anything out of pocket since my insurance covers my BC, until this year. 
This year, Nurx decided to charge people $15 (which I believe is for the year). Though it’s 
annoying, it’s less than the copay I would need to pay to see my doctor AND they don’t charge 
for shipping (Nurx user).  
 
 Users mentioned convenience alongside cost to justify or rationalize paying for 
contraception. Getting birth control shipped directly to them or not having to go to a doctor’s 
office or pharmacy were mentioned by many users in terms of cost and convenience. Many 
women who indicated that they did not have health insurance said that the services were a 
“lifesaver” for them. Affordable birth control may mean different things to different users. 
Others complained that their insurance was not accepted by the platform, despite paying nothing 
for birth control with their insurance if they went through their in-person provider. Having 
insurance did not necessarily guarantee a cost-effective, affordable experience since the 
platforms did not work with all types of insurance. For example, users with Medicaid insurance 
lamented the fact that Nurx did not accept their insurance. Planned Parenthood Direct users 
mentioned that even though they had insurance, the platform would not accept it but that they did 
not mind paying the cost because it was supporting an organization they believed in. Overall, the 
platforms contained mixed reviews of cost and affordability, suggesting that telecontraception 
platforms have not yet fully addressed barriers to affordable contraception.  
Support for the Idea of Telecontraception 
 Another major theme across both platforms was support for the idea of telecontraception 
(N=263 Nurx reviews; N=73 Planned Parenthood Direct reviews). Many user reviews expressed 
gratitude directly to the platform for providing its services, indicating a long-time need for their 




experiences, indicating that these platforms are tapping into an unmet need. Reviews frequently 
used the words “game changer” to describe telecontraception platforms. 
Thank you!!! This app is easy to use, well-designed, and you really can have birth control 
ordered in mere hours. That’s absolutely incredible. (PP Direct user). 
 
Honestly, I love everything about Nurx. This system is a complete game changer. (Nurx user). 
 
I’ve never written an App Store review before, but this was worth the effort. This is truly a game 
changer for how we treat birth control. (Nurx user). 
 
I’m telling every girl I know about this. (Nurx user). 
 
I was getting increasingly frustrated with how much effort it took to obtain birth control, 
something that is over the counter in other countries, when I found Nurx and it changed my life. I 
recommend it to everyone searching for a simple solution! (Nurx user). 
 
I cannot stress enough how great this service is….It’s just been such a huge relief and I cannot 
imagine going back to life without it. (Nurx user). 
 
I am so glad this app exists. (PP Direct user). 
 
This was the best invention! Love this app and the services provided to me. (Nurx user). 
 
PPDirect is revolutionary! (PP Direct user). 
 
What women and menstruating persons have needed forever. (PP Direct user). 
 
Love the idea of this and it should be more of a thing!!!! Thank you guys for creating something 
like this. (PP Direct user). 
 
Thank you Planned Parenthood for creating this app. It is wonderful! (PP Direct user). 
 
 Related to this theme was that many users of Planned Parenthood Direct had a history 
with the organization. Ten percent of reviews for PP Direct (N=50) mentioned being a patient or 
supporter of Planned Parenthood. Name recognition and having a prior history with the 
organization seemed to influence users, as they were grateful for its services both in-person and 
through the platform:  
I’m a huge supporter of Planned Parenthood and have been for 25 years. This is the first time in 
20 years I have not had health insurance so I was DELIGHTED to find this app and I’m literally 





Thank you Planned Parenthood for all that you do. Have been going there for years ever since I 
started my birth control and will always go there. (PP Direct user). 
 
This is where I first started getting birth control because I could get it without insurance and 
without my dad finding out (religious) I was 19. (PP Direct user). 
 
I was interested when I saw an ad for another company that offered the same service but I didn’t 
really feel comfortable with it until I saw that Planned Parenthood also offered the service. I 
decided to go with Planned Parenthood. (PP Direct user). 
 
Having an established orientation to the company or platform made users feel more 
comfortable using telecontraception services, since they could trust it as a legitimate service 
based on the recognition of the company name. In contrast, many user reviews of the Nurx 
platform mentioned being “skeptical” ordering birth control through an app. They were not sure 
if it was legitimate or not. Having the history and name recognition of an established 
organization like Planned Parenthood seemed to eliminate any concerns about legitimacy, as no 
user reviews mentioned being skeptical of their telecontraception services.  
Another code related to this theme of support for the telecontraception idea is state 
(un)availability. While the number of user reviews mentioning this was small (3 percent of 
reviews for Nurx and 8 percent of reviews for Planned Parenthood Direct), it is an important to 
mention because it illustrates the policy and legislative influences on telecontraception platform 
availability. These users mentioned how the platform was not available to them because they 
lived in a certain state, often linking their statement about the lack of access to needing access: 
I downloaded this app getting very excited to find something like this. I cannot express how much 
these service(s) are needed. Then I notice that pretty much every state is on the app except 
Nevada. What a huge deflate I had immediately…(Nurx user). 
 
Need this in GA and every other state they don’t offer it in!!! Thanks!!! (Nurx user). 
 
I’m assuming it’s great so I’ll give you a high rating for just existing as an option for women! But 
please expand to Maryland!!! It seems as though you’re everywhere else but where I am…and 
quite honestly, it would be an INBELIEVABLE help to the community if you guys ever were to 
expand to Maryland. When young girls living in the socioeconomic nightmare that is the inner 
city-a pregnancy can ruin not only the life of the mother, but that of the child as well! Smart girls 





Thus, users would express a need for obtaining contraception in this virtual sphere while 
simultaneously expressing their support for the idea of telecontraception. This illustrates the need 
for women in all states to be provided with the opportunity to access the services. Lack of access 
does not mean lack of interest for these users. Quite the contrary, they expressed a desire for the 
platform to expand services to include their state. 
Platform Development 
 The final theme was platform development, which drew on statements coded to reflect 
comments about app rollout, technological complaints about the app, and customer service. This 
largely represented “growing pains” of a new business, such as how Nurx began as a startup 
company and Planned Parenthood Direct began with a select number of pilot states to test its 
app. It also reflected the different backgrounds and experiences the two companies have in the 
reproductive healthcare sphere. Planned Parenthood’s wealth of historical, institutional 
knowledge and experience may have helped with rolling out their virtual services compared to 
Nurx which is a startup company and new to the healthcare services arena. 
Technological complaints about the app were mentioned in over one-third of reviews for 
Planned Parenthood Direct and 13% of reviews for Nurx. However, Nurx had a large amount of 
reviews (33%) mentioning customer service, which overlapped with these codes. For example, 
as Nurx grew and rolled out their app to the Google Play Store, their customer service was 
seemingly bombarded by requests. Users mentioned how the Nurx app contained a banner 
expressing the long hold or wait times to speak with a representative. Users complained about 
slow response times, citing how they often waited on hold for over an hour on the phone to reach 
customer service. Some reviews also mentioned that as Nurx grew over time, this became more 




However, it is worth mentioning that some users praised the customer service department. The 
trajectory to establish a telecontraception app seems to be a bit rocky regardless of the company 
model. Both platforms experienced “bugs”, crashes, slow loading times, and problems with app 
functionality. However, Nurx contained many more reviews related to slow service than Planned 
Parenthood Direct. 
DISCUSSION 
This qualitative analysis of user experience of telecontraception platforms allows for an 
on-the-ground perspective of what users experience both in the virtual and non-virtual spheres. 
Findings illustrate how areas where telecontraception both alleviates and falls short of addressing 
barriers to obtaining contraception in the current in-person healthcare system. Specifically, the 
user reviews demonstrate that telecontraception platforms address important accessibility issues 
inherent in the current traditional healthcare system but findings are more mixed regarding 
affordability and equitability. This demonstrates how technological innovations often make 
broad claims to “solve” existing issues, yet they must still grapple with real-world, on-the-
ground forces such as insurance systems. Telecontraception is no exception, though it does 
address many problems women face in obtaining contraception in the current in-person 
healthcare system. 
 Overall, users express how telecontraception platforms do alleviate some barriers 
associated with an in-person provider visit. Not having to take time off work, having a busy 
schedule, and waiting months to wait for an appointment with a booked in-person provider 
reflect the advantages of these platforms and how they can reduce geographical and time barriers 
associated with in-person healthcare. These findings reflect earlier research on telemedicine and 




normal business hours (Jain and Mehrotra 2020; Rodler et al. 2020). This allows patients to 
request what they need when they need it, rather than having to conform to a 9-to-5 clinic 
schedule. Users express these new telecontraception systems as “game changers” or “life 
savers”, illustrating how these platforms are literally changing the “game” of in-person 
healthcare visits. Related to this is user support for the idea of telecontraception. Many users 
expressed effusive gratitude for this service, which suggests unmet reproductive health needs in 
the current in-person healthcare system.  
Clinician and patient interactions in telecontraception platforms were brought up by 
approximately one in four women across both platforms. Users mentioned the friendliness and 
knowledge of their clinician and expressing how they valued that they could ask questions and 
were not judged. This stands in contrast to previous research illustrating how providers largely 
did not assess patient pregnancy intention, birth control preferences, or allow patients an 
opportunity to ask questions during an in-person visit for birth control (Dehlendorf et al. 2017). 
This study’s finding illustrates that these platforms are meeting the visions of women about 
telecontraception, such as the ability to discuss options with a provider and provided with 
knowledge and information about different contraception options (Sundstrom et al. 2019). 
Although clinician and patient interaction is characteristic of both in-person and virtual 
reproductive healthcare services, the positive experiences of patients with their telecontraception 
providers illustrates that there may be other factors influencing the quality of care of these visits.  
It may be that telecontraception interactions are less subject to time restrictions since 
patients can access providers on their schedule rather than vice versa and in a relaxed setting 
such as their home. Online visits also place patient concerns and needs at the forefront (Basu 




rapport since the sole focus of the interaction is reproductive healthcare, as opposed to a well-
woman visit where there are many different competing tasks to accomplish. In-person visits may 
have more restrictions such as short appointment time slots or competing tasks to complete 
during the visit which could affect the quality of the patient-provider interaction or amount of 
information and discussion conducted during the visit. This may explain previous research 
findings about in-person providers failing to assess patient pregnancy intention, birth control 
preferences, or allow patients an opportunity to ask questions (Dehlendorf et al. 2017). 
Telecontraception platforms may also provide greater information, education, and resources 
about different options which patients can read about and discuss with a provider in their own 
time. Providing educational decision tools about birth control choices and preferences are 
effective in patient-provider communication by allowing patient concerns and preferences to 
enter the discussion rather than provider choice (Holt et al. 2020).  
One important finding to note was that the mode of interaction seemed to make a 
difference in a user’s experience of telecontraception. Nurx and Planned Parenthood Direct 
contained differing perspectives of the clinician interaction. This could be due to the way 
patients and providers interact on these platforms. While Planned Parenthood Direct providers 
conduct video visits with patients, Nurx providers review requests made through the app and 
interact with patients through messages rather than face-to-face virtual visits. Planned 
Parenthood Direct users praised their clinicians, while Nurx users had more mixed reviews. The 
mode of interaction may influence user experiences with a provider because they are viewing 
and interacting with them in real time, versus back-and-forth messages. It could also be the 
growing pains associated with Nurx, if clinicians are bombarded with messages and not able to 




operating model behind the telecontraception platforms. Planned Parenthood has advocated and 
provided reproductive healthcare for over 100 years, so they may value transferring aspects of 
their quality of care such as face-to-face interactions to the virtual sphere. On the other hand, 
Nurx is a startup company aiming to gain more users for its business so they may value 
messaging as a way to handle a larger volume of users. Overall, users expressed clinician 
interactions in a largely positive way, especially when tying it to finding the right birth control 
for them, obtaining information, and the discreet, private, non-judgmental manner of getting 
contraception.  
However, this analysis also showed that telecontraception platforms fall short in 
addressing some barriers in obtaining contraception. The theme of cost and affordability largely 
reflects the current dynamics of in-person healthcare, where the ability to access affordable care 
is tied to existing insurance and employment patterns and state-level policy (U.S. Centers for 
Medicare & Medicaid Services 2020; Adamczyk 2020; Jones and Sonfield 2016), factors that 
limit the scope of “disruption” that platform designers can realize. Technological design and 
advances are inseparable from the social context in which they emerge (MacKenzie and 
Wajcman 1999). Telecontraception platforms must still operate within existing economic and 
political environments, such as insurance systems or legislative policy. This limits the ability of 
technological innovations to “solve” existing problems because they are still subject to and must 
grapple with prevailing institutional forces. Rhetoric around technology often portrays 
technological innovations as a “techno-utopia” where technology is portrayed as a cure-all for 
the current problems of the day, yet this mythology ignores the power, control, and tools that 
certain groups hold over others at all stages of technological innovation (Rogers 1995; Winner 




provide an example of this through their limits of addressing barriers tied to insurance systems 
and state-level policy on prescribing and dispensing authority because they still exist within 
these institutional contexts and constraints.  
Limitations 
There are limitations to using data such as user reviews from publicly available websites. 
It raises questions about the validity and reliability of the data, as well as who it represents (boyd 
& Crawford 2012). User reviews can represent sample selection bias since users are not required 
to write reviews (Caldeira et al. 2017) so the reviews may represent atypical experiences. They 
may not be representative of all telecontraception users. Another problem in mining user reviews 
is that is difficult to detect spam or fake reviews (Genc-Bayebi and Abran 2017). This sample is 
also restricted to users who have internet access. Research has demonstrated a digital divide in 
internet access, skills, and information, and these are patterned by existing social inequalities 
such as income (DiMaggio et al. 2004; Hargittai 2002). A recent study found that racial and 
ethnic minorities had higher odds of telehealth use during the COVID-19 pandemic and 
illustrates the need for continued expanded access and coverage of telehealth services (Campos-
Castillo and Anthony 2021). In addition, research has documented disparities among health 
platform users and non-users (Carroll et al. 2017; Mesch 2016; Bidmon and Terlutter 2015; 
Anthony, Campos-Castillo, and Lim 2018), although studies have not yet looked at 
telecontraception platform users. Telecontraception platform users may differ in ways from other 
non-users, such as having internet access, use, skills, and knowledge to navigate the internet. 
However, given the dearth of data on telecontraception platforms, analyzing user reviews on a 
large scale serves as an exploratory first step toward uncovering more about these platforms and 




using these platforms as well as their experiences and evaluations of the platform services. This 
research also identifies areas for further research that can examine representative samples of 
women across the United States, such as the potential of telecontraception to empower women 
by providing more information and education about different options. 
CONCLUSION 
Telecontraception platforms represent a novel way to approach contraception access and 
availability. These apps are growing and expanding, and are particularly helpful during the 
current COVID-19 pandemic as many users mentioned how they do not want to visit an in-
person provider to obtain birth control due to concerns about contracting the virus or they have 
lost insurance through losing a job. Nurx and Planned Parenthood Direct are two platforms 
which represent opposites in terms of size, development stage, and user orientation. Yet user 
reviews of the two platforms yielded similar themes, suggesting that widely experienced 
motivations and intentions drive use of telecontraception. However, the way telecontraception 
platforms deliver these services can vary depending on their characteristics, underlying 
philosophies, and business operating models, which can serve to either alleviate or reinforce 
current in-person healthcare system dynamics associated with obtaining contraception. Severing 
the tie between in-person visits and contraception can improve women’s experiences obtaining 
birth control in that they are not limited to geographical and time barriers present in the in-person 
system (Grindlay and Grossman 2016; Jain and Mehrotra 2020; Rodler et al. 2020), and they 
also enjoy patient-centered interactions with their provider and increased information and 
education about their options and preferences, which are all important factors in improving 
patient-provider communication in reproductive healthcare services (Holt et al. 2020; Dehlendorf 




platforms are “game changers” and “life savers” in many ways, this study indicates that 
overcoming the barriers faced by women who need reproductive healthcare is less about 
technological innovation, and more about disrupting entrenched social forces that shape 
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 This research set out to investigate the current landscape of reproductive healthcare and 
telecontraception with an eye toward accessibility, affordability, and equitability. In the 
introduction, three aims were discussed. Aim #1 sought to better understand sources of 
reproductive healthcare access, affordability, and equity issues by providing a current picture of 
the in-person, traditional reproductive healthcare system. The goal of aim #2 was to investigate 
the state-level conditions that pattern accessibility and availability of telecontraception platforms 
to uncover the combinatory political, economic, or social conditions linked to availability of 
these platforms across the United States. Aim #3 analyzed user reviews of two telecontraception 
platforms to gain insight into user experiences and evaluations of these emerging platforms. 
These three aims used mixed methods that informed one another to examine the relationships 
between gender, health, and technology. Using a national survey of women, state-level data 
about social, economic, and political climates of states, and user reviews of telecontraception 
platforms all provide different lenses for looking at the accessibility, affordability, and 
equitability of telecontraception platforms. These different data sources and findings inform one 
another to provide a fuller picture of this fast-growing phenomenon. Taken together, findings 
illustrate both the promises and pitfalls of how technological innovations currently address 
reproductive health needs and disparities. The remainder of this dissertation will discuss the 
major themes and implications of these findings. 
PROMISES OF TELECONTRACEPTION 
 This research uncovered many areas in which telecontraception is disrupting entrenched 
institutional forces and conditions. Telecontraception addresses issues of accessibility and 




traditional healthcare environments. User reviews in Aim #3 revealed that these platforms do 
alleviate many of the existing in-person barriers to obtain contraception, such as waiting months 
for a booked provider and having to take time off work for a visit in order to fit into the nine to 
five healthcare office hours. As many user reviews mentioned, birth control is a time-sensitive 
medical need. Telecontraception addresses the issue of time because it provides on-demand 
access to providers and birth control quickly. Many users expressed support and gratitude for 
telecontraception, illustrating that these services are tapping into unaddressed issues and needs in 
obtaining contraception. Furthermore, states with high proportions of women legislators in 
combination with other state-level conditions were linked to telecontraception platform 
availability. This was true regardless of the political party of the women legislators in each state. 
Having women in positions of power alongside other state conditions may be an important factor 
moving forward for advocates of reproductive rights and policy, regardless of whether a state is 
controlled by Democrats or Republicans. 
 Another area where telecontraception has the potential to improve reproductive health 
care for women is through how they may affect the quality of reproductive healthcare visits. 
Using a mixed methods approach illustrated the different aspects of this theme and how each aim 
informs one another. As revealed in Aim #3, telecontraception platforms provide on-demand 
access to knowledgeable, supportive clinicians as well as information and education about 
different birth control options. This aligns with previous qualitative research on rural women’s 
perceptions of telecontraception, such as the ability to discuss options with a provider and obtain 
information and knowledge about different contraception options (Sundstrom et al. 2019). Aim 
#1 revealed that individual attitudes and interpersonal interactions were important factors in 




especially salient in efforts to access birth control. It also illustrated that only half of women 
reported that they got information about birth control at their last visit or that their doctor spent 
time talking to them about future plans for having or not having children. Telecontraception may 
therefore be addressing an unmet need in the current traditional healthcare system which may be 
pressed for time and competing priorities by giving patients more time to discuss options and 
obtain information about birth control from on-demand providers. Since telecontraception visits 
are initiated by the patient, their concerns are the main focus of the visit instead of a well-woman 
visit where competing priorities take time and attention away from more substantial discussions 
about options. Online visits place patient concerns and agenda at the forefront of the visit (Basu 
2019), so telecontraception visits may represent a potential channel for achieving improved 
quality of visits and patient-provider interactions about birth control.  
This carries important implications for racial and ethnic minority women who are more 
likely to experience racism through healthcare provider interactions, such as through pressure, 
imbalanced information, lack of patient input, and exclusion (Becker and Tsui 2008; Gomez and 
Wapman 2017; Dehlendorf et al. 2017; Gary et al. 2015). Having more time during a visit may 
help alleviate some of these barriers related to racism and time pressures because patients are 
provided with access to supportive, knowledge providers and information about all the birth 
control options. The focus of the visit is also solely on contraception, so not having other 
competing priorities such as exams and questionnaires taking up precious time during a visit can 
also allow for improved discussions and interactions between patients and providers. Previous 
research has shown that providing educational decision tools about birth control choices and 
preferences are effective in patient-provider communication by allowing patient concerns and 




potential to improve dialogue and interactions between patients and providers because their focus 
is concentrated solely on birth control and patient concerns. 
Telecontraception is a rapidly growing segment of telemedicine. As the number of users 
and services continue to expand, it is important to identify how platforms focused on 
reproductive health fit within the larger landscape of telemedicine. Findings from this research 
illustrate that the promises of telecontraception have the potential to extend to other telehealth 
initiatives and health apps more broadly. Specifically, telecontraception platforms disrupt the 
accessibility barriers of the traditional healthcare system by providing on-demand contact with 
providers and information. Patients do not have to mold their lives around a schedule of nine to 
five appointments, booked medical providers, and rushed visits where they might not have time 
to discuss all their questions, concerns, and options. The online visit is driven by the concerns 
and agenda of the patient which has the potential to improve the quality of visits and interactions 
between patients and providers. This is of the utmost importance in reproductive healthcare 
visits, where information and choice are essential for women to make choices about their bodies 
and lives.  
PITFALLS OF TELECONTRACEPTION 
All three aims illustrate that emerging innovations shape and are shaped by existing 
social conditions and arrangements. Technological innovations such as telecontraception 
platforms do not exist outside of their social, political, and economic contexts. Although in 
theory this technology allows for greater access to more people, the ability of consumers to 
utilize the services provided by these platforms is still limited by long-standing inequalities in 
institutional systems. Institutional factors permeate every finding from each aim of this 




platforms in a certain state, and the experiences of telecontraception platform users are all shaped 
by institutional influences. The pitfalls of telecontraception are related to issues of affordability 
and equitability and largely mirror existing, on-the-ground systemic inequalities such as 
insurance and socioeconomic status. 
The Mythology of Technological Determinism 
 Technological determinism and the mythology of a techno-utopia permeate the language 
and rhetoric surrounding technological innovation (Rogers 1995; Winner 1986; Wajcman 2004; 
Nakamura 2009; boyd & Crawford 2012; Mosco 2014; Devlin 2018; Zuboff 2019). This 
discourse focuses on the idea that any kind of technological advancement or innovation is 
beneficial for humanity, along with a noticeable absence of questioning its meaning or costs and 
ignorance of physical, social realities (Winner 1986; Nakamura 2009). In contrast, the social 
shaping of technology theoretical framework recognizes that technological design and innovation 
are inseparable from the contexts in which they emerge (MacKenzie and Wajcman 1999). There 
is nothing inherent or deterministic about technology itself, and technology can operate 
differently depending on time and place (Wajcman 2004). The social contexts, relationships, and 
hierarchies which shape and are shaped by technology are important to study because they are 
inextricably bound up in the concept of technological innovation; technology and society are not 
separate factors (Latour 1987).  
 All three aims illustrate the social shaping of technology, whether that is accessing the 
technology of contraception itself or using online platforms to access contraception. Individual, 
interpersonal, and institutional factors all play a role in the decision to make a visit (virtual or 
non-virtual) for contraception and the experience of doing so. State-level conditions influence 




status impact the experience of telecontraception users. In the case of telecontraception, this 
technological innovation in theory grants access to anyone with a smartphone, but in reality 
access is often limited along the lines of existing social, political, and economic inequalities. 
Previous research questioned whether telecontraception platforms increase accessibility to 
contraception for those who face barriers or whether they simply make it more convenient for 
those who already have access (Dorland, Fowler, and Morain 2019; Zuniga et al. 2020). This 
research demonstrates that these platforms do represent a novel way of addressing barriers but 
are still limited by entrenched institutions and forces. They must still grapple with insurance 
coverage and networks, as well as policy and legislation dictating their ability to prescribe and 
dispense medication. Uninsured women still face barriers with these new innovations, despite the 
finding in Aim #1 that this group shows the strongest pregnancy avoidance attitudes. 
As access to the internet and apps increase, online platforms increasingly employ a 
rhetoric of “choice” and “empowerment” (Lupton 2016; Lupton 2018). However, the ability of 
users to access these services is patterned by existing inequalities such as insurance and 
socioeconomic status. It is critical that health app designers, stakeholders, and policymakers 
consider how their decisions and choices fit into existing contexts, otherwise they will fail to 
address barriers that they are aiming to tear down. These choices affect who these apps reach and 
as a result may fail to reach everyone who needs their services. Not doing so also risks 
perpetuating existing inequalities (O’Neil 2016). The digital and material are linked (Mosco 
2014). Many times with technology, social factors only appear when something goes wrong 
(Latour 1987). With the rapid pace and adoption of technology and “big data”, health app 
designers need to consider how their decisions and choices may affect and be affected by 




One last important point to note about technological innovation and apps is the role of 
privacy in the use of personal data. Many telecontraception platform users lamented that there 
was no way to “delete” their profiles if they no longer wanted to use the app. Apps are an 
emerging area of society in which legislation is slow to catch up in the United States (Zuboff 
2019; Martínez-Pérez, De La Torre-Díez, & López-Coronado 2015). The General Data 
Protection Regulation (GDPR) was implemented by the European Union (EU) as recently as 
2018 and outlines privacy and security standards for organizations using personal data (Wolford 
2021). As much as health apps such as telecontraception aim to provide access to needed 
services, it is also important to consider what they are taking away from users in terms of 
personal information and “digital breadcrumbs” which can be sold, combined, and used by other 
organizations (Zuboff 2019:90).  
Overall, the pitfalls of telecontraception illustrate many of the same drawbacks of 
telemedicine and health apps more broadly. Findings from this research indicate that issues of 
affordability and equitability do not have the same disruptive effect on the healthcare system as 
the accessibility of telecontraception. User reviews revealed that cost and insurance were major 
influences on the experiences of telecontraception platform users and largely mirrored the 
frustrations of navigating insurance coverage and high prescription costs in the traditional in-
person healthcare system. Furthermore, telecontraception experiences differed depending on the 
platform itself. While Nurx is a for-profit company, Planned Parenthood Direct is a non-profit 
organization. This carries implications for users because it affects their experiences of the 
platform and whether they can afford to use it. Platform medicine designers make decisions 
about who they want to reach through their business and operating models. Choices and 




in turn the equitability of these platforms. Although findings from this research illustrate that 
telecontraception does alleviate many of the existing access barriers, findings also show that 
users may still encounter roadblocks through affordability barriers. Breaking down the barriers 
related to affordability and equitability requires innovation not only through the decisions and 
choices of the platforms themselves, but also knowledge of how to achieve these goals within an 
entrenched system of insurance and payment networks.  
REPRODUCTIVE HEALTHCARE COMMONALITIES AND DISPARITIES 
Commonalities 
While findings from this research illustrate disparities in reproductive healthcare access 
and affordability, it is also important to make note of the commonalities and similarities 
uncovered among women in terms of their shared attitudes and experiences. The majority of 
women in Aim #1 indicated a strong pregnancy avoidance attitude, with no statistically 
significant differences by race or ethnicity, socioeconomic status, or insurance status. With most 
women in each subgroup of this national survey expressing this shared attitude, this finding 
illustrates that pregnancy avoidance is largely a shared attitude among women even by subgroup. 
Similarly, user reviews in Aim #3 indicated support and gratitude for the idea of 
telecontraception. This suggests a long-standing need for these services and their goal of 
addressing existing barriers to obtaining contraception. While women may of course differ on 
their individual views or modes of contraception, both findings illustrate that pregnancy 
avoidance and accessible birth control are important to women. This is an important finding to 
note because it demonstrates the importance of creating accessible reproductive healthcare 




support accessible contraception, such as pharmacist-provided birth control or over-the-counter 
birth control (Landau, Tapias, and McGhee 2006; Grindlay and Grossman 2018). 
 Another commonality among women are the many shared barriers they face in obtaining 
contraception. Many user reviews of the telecontraception platforms mentioned barriers 
associated with obtaining birth control in the in-person healthcare system. This mirrors findings 
that nearly one-third of women report difficulties obtaining prescription birth control or refills 
(Grindlay and Grossman 2016). Users expressed their gratitude for having a service that allowed 
them to access contraception without having to take time off work, waiting months for an in-
person appointment with a booked provider, or losing employer-sponsored health insurance with 
the loss of a job. These are all features of the in-person, traditional healthcare system which 
creates barriers to obtaining contraception. Telecontraception platforms have the potential to 
address these barriers by providing convenient access to contraception and providers.  
Clinician and patient interactions are also an important commonality shared by women in 
accessing reproductive healthcare. Many users of telecontraception platforms mentioned 
friendly, knowledgeable, nonjudgmental providers with whom they could ask questions. While 
this is a factor that could arguably be present in the in-person healthcare system too, it is possible 
that telecontraception platforms provide something that is missing in the in-person context such 
as more time to discuss options, answer questions, and build rapport. Similarly, Aim #1 found 
that women who went to Planned Parenthood or another family planning clinic for their last 
women’s healthcare visit had nearly three times higher odds of making a birth control visit 
compared to women who went to a private doctor’s office, while the opposite was true for 
preventative annual gynecological healthcare visits. The context of the environments that provide 




Previous research has found that teens and other groups of women may prefer to utilize Planned 
Parenthood for not only cost and confidentiality, but also for additional dimensions of care such 
as ease of getting care and medical staff treatment (Sugerman et al. 2000; Oglesby 2014). There 
may be other factors associated with family planning providers or telecontraception platforms 
that influence women’s experiences of accessing contraception. Perhaps having the focus of the 
visit being on contraception, rather than a “well-woman visit” that aims to cover many facets of 
health, plays an important role in these dynamics. Previous research has found that in-person 
providers largely fail to assess patient birth control preferences or allow patients an opportunity 
to ask questions (Dehlendorf et al. 2017). Whether that it is due to time or other factors is 
unknown, but a virtual or non-virtual visit for birth control arguably places the focus squarely on 
birth control rather than other competing demands.  
Women have firsthand experience with shared barriers to obtaining contraception, and 
having women in positions of political power could be an important factor in translating these 
barriers to solutions. Aim #2 demonstrated that the percentage of women legislatures in 
combination with other political, social, and economic state-level factors was linked to 
availability of telecontraception platforms across the United States. These findings did not 
change even when considering the political orientation of these women legislatures, indicating 
that gender may play a potentially important role in shaping access to these platforms. While I 
cannot make claims that women legislators passed these policies, their higher percentages are 
associated with the availability of these platforms in combination with other state-level factors 
and this finding occurred in both environments of Democrat and Republican state political 
control. This is consistent with previous research which found that states with higher proportions 




compared to men and also compared to states with lower proportions of women representatives, 
regardless of political party (Volden, Wiseman & Wittmer 2018; Thomas 1991; Saint-Germain 
1989). Overall, this indicates a potentially optimistic avenue for women, as having women in 
positions of power can help introduce issues important to women regardless of the political 
environment in which they operate. 
Disparities 
Findings from this research also illustrate reproductive healthcare disparities among 
women that largely reflect long-standing inequalities in institutional systems. Insurance is a main 
driver behind access and affordability of reproductive healthcare both in in-person and virtual 
environments, as demonstrated by both Aim #1 and Aim #3. Uninsured women had lower odds 
of making a birth control visit compared to privately-insured women, despite having the highest 
pregnancy avoidance attitudes compared to women with other types of insurance. Institutional 
variables such as insurance status and facility type were associated with making a birth control 
visit and making an annual gynecological preventive visit.  
User evaluations of telecontraception platforms uncovered major cost differences 
depending on insurance status and coverage. This illustrates that regardless of the mode of 
delivery, existing social institutions such as insurance still play a major role in influencing access 
to healthcare. Over ten percent of women in the U.S. are uninsured, and there are still significant 
racial and ethnic disparities in insurance coverage despite passage of the Affordable Care Act 
(Kaiser Family Foundation 2021; Shane and Ayyagari 2014; Breslau et al. 2018; Smith and 
Medalia 2014; O’Hara and Brault 2013). This was reflected in the Aim #1 findings that black 




Taken together, these findings illustrate that factors such as insurance intersect with race and 
ethnicity to produce disparities rooted in access and affordability.   
Where a woman lives dictates her access to telecontraception platforms. The mixed 
methods approach used in this research yields findings that inform one another, especially 
regarding this issue. Findings from Aim #2 showed that political, social, and economic state-
level factors all combine to pattern availability of these platforms across the United States. But as 
Aim #3 shows, the availability of these platforms is not based upon demand or desire for the 
platforms within these states. Many user reviews mentioning that the telecontraception platform 
was unavailable in their state also pleaded to expand the services to their state. However, it is 
important to note that the number of states serviced by a platform rapidly changed even during 
the course of conducting this research. Since user reviews dated back to 2017, many of these 
pleas have been answered as telecontraception platforms expand access to a greater number of 
states. This illustrates the importance of making sure technological innovations such as 
telecontraception are accessible, affordable, and equitable. Telecontraception platforms arose out 
of a specific social, political, and economic context. They are clearly meeting an unaddressed 
need for women across the United States. However, without considering how they affect and are 
affected by existing institutions they will fail to address all of the barriers women currently face 
in the traditional in-person healthcare system.  
Conclusion 
 As platform medicine continues to emerge and innovate, what are telecontraception 
platforms adding to the landscape of reproductive healthcare services? What problems are they 
solving and where do they fall short? This research identified key research questions which 




contraception. Overall, the findings illuminated areas for improvement in both the virtual and 
traditional healthcare spaces. Results show that telecontraception addresses many of the 
accessibility barriers associated with obtaining contraception in the United States. User reviews 
expressed support and gratitude for telecontraception, indicating a need for these services that is 
not being adequately addressed by the traditional healthcare system. However, existing social 
forces such as insurance and legislation limit the affordability and equitability of 
telecontraception. This carries important implications because this research also found that most 
women across the United States expressed strong pregnancy avoidance attitudes, regardless of 
subgroup. While telecontraception platforms disrupt issues of accessibility in the traditional 
healthcare system, affordability and equitability still have room for improvement which carries 
implications for who can use these platforms and their experiences of doing so. Harnessing the 
potential of these apps, as well as health apps and telemedicine in general, requires knowledge 
about the material, on-the-ground conditions and circumstances women operate in as they access 
these platforms. Knowing more about these factors in both the traditional and virtual 
environments can help tailor better approaches to ensure that all women across the United States 
have equitable, affordable access to the care they request and deserve to make decisions about 
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Appendix A: Supplementary Analyses for Aim #1 
 
Table 1a. Logistic Regression Comparing Estimation Sample, Sample without Pregnant Women, and Imputed Data 




























       
 OR OR OR OR OR OR 
Individual Attitudes, Knowledge, & Contraception Use       
Pregnancy avoidance attitude       
2 2.46 2.52 2.25 1.00 .94 .97 
3 3.04** 3.10** 2.88** 1.06 1.04 1.05 
4 2.59** 2.65** 2.39* .84 .83 .82 
5 3.27** 3.38** 2.87** .64 .64 .66 
6 Very important to avoid pregnancy 4.39*** 4.49*** 3.98*** .56 .57 .56 
Currently pregnant .26**      .26** .31**  .29*** 
Knowledge of birth control methods 1.08 1.09 1.08 1.01 1.05 .99 
Past use of the pill 5.89*** 5.75*** 5.65*** 1.25 1.20 1.26 
LARC at last wave .82 .75 .88 1.82 1.73 1.69 
Interpersonal Variables       
Visit: Doctor or nurse talked about future plans for children .71 .68 .70 1.45 1.29 1.46* 
Visit: Got info about birth control and pregnancy prevention 3.79** 3.61*** 3.90*** .84 .81 .83 
Relationship status       
Broken up but back together 1.59 1.55 1.48 1.17 1.20 1.20 
Not together for six months or longer .54 .53 .56 1.39 1.35 1.38 
Not dating anyone .38** .37** .40** .78 .75 .81 
Institutional Policy Factors       
Visit: Facility type       
Planned Parenthood or other family planning clinic 2.71* 2.92* 2.67* .29*** .25*** .30*** 
Public health dept. or community health clinic 1.85 1.88 1.77 .56 .51 .56 
Student health clinic or some other type of h.c. facility 1.03 .94 1.03 .44* .38* .43* 
Visit: Payment       
Insurance paid 1.10 1.24 1.10 1.01 1.07 .97 
Reduced fee or free services 1.36 1.39 1.36 .80 .82 .79 
Has a regular place to go for medical care .69 .72 .65 1.00 1.01 1.06 
Lives in a state that expanded Medicaid under ACA .89 .88 .88 .98 1.01 .998 
Key Subgroups       
Race and ethnicity       







Other 1.05 1.14 .98 1.46 1.90 1.56 
Hispanic 1.41 1.39 1.35 1.06 .98 1.07 
Multiracial .50 .52 .50 .81 .91 .81 
Socioeconomic status       
100-199% .88 .96 .87 .92 1.05 .96 
200%+ .65 .70 .65 .88 .91 .95 
Insurance status       
Medicaid .61 .67 .62 1.23 .98 1.23 
Uninsured .32** .36* .31** .93 1.01 .93 
Marketplace .81 .91 .82 2.43* 2.84* 2.31* 
Control Variables       
Marital status       
Never married 1.35 1.34 1.29 1.53 1.48 1.46 
Living with partner 1.22 1.22 1.20 1.46 1.57 1.41 
Divorced or separated .97 1.01 .95 1.66 1.56 1.63 
Employment status       
Part-time 1.64 1.53 1.70 .69 .73 .70 
Full-time 1.35 1.35 1.35 1.29 1.35 1.28 
Educational attainment       
High school .60 .60 .58 2.10 2.10 1.97 
Some college, no degree .85 .85 .86 1.37 1.30 1.34 
Associate’s degree .65 .65 .66 1.35 1.26 1.25 
Bachelor’s degree .57 .54 .58 1.87 1.76 1.73 
Master’s, professional, or doctorate degree .51 .50 .52 1.94 2.05 1.84 
Age        
18-26 3.01** 3.05** 2.95** .23** .24** .29** 
27-30 2.17* 2.04* 2.12* .23** .25** .28** 
31-36 1.79 1.83 1.79 .40* .46 .48 
Foreign-born .57 .55 .61 1.97 1.92 1.96 
       
Constant .10** .09** .12* 6.50* 5.40 5.93* 
Observations 982 889 1,008 982 889 1,008 
Note. *** p<.001, ** p<.01, * p<.05. Reference categories are respectively: White; Less than 100% FPL; Private insurance; Married; Unemployed; Less than High School; Age 
37-39; Not foreign-born; Pregnancy avoidance attitude of 1; No past use of the pill; No LARC at last wave; Doctor didn’t talk about future plans for children; Didn’t get 
information about birth control; Together for six months or longer; Private doctor’s office; Respondent paid; No regular place for medical care; Lives in a state that did not expand 









Appendix B: Supplementary Analyses for Aim #2 
 
Table 1b. Sensitivity Analyses Conducted with Alternate Coding Schemes for Outcome and Condition Variables 
 Coding Used in Original 
Analysis 
Coding Used in Sensitivity 
Analyses 
Result of Sensitivity 
Analysis 
Final Decision 
Outcome Variable     
Number of telecontraception 
platform services  
 
Range: 2, 3, 4, or 5 or more 
services 
High availability = 3 or 
more services 
 
Low availability = 2 
services 
High availability = 4 or 
more services 
 
Low availability = 2 or 3 
services 
Lower consistency scores 
Lower coverage scores 
Solution coverage dropped in 
half (.33); solution 
consistency was similar  
Retained the original coding 
scheme for greater 
information about patterns to 
the outcome, and greater 
consistency and coverage. 
Condition Variables     
State political control  
 
Democrat, Republican, or split 
Groups together state 
legislature (D, R, or split) 
& state governor (D or R) 
Separated out state 
legislature and state 
governor into two separate 
variables 
Similar consistency and 
coverage scores 
Similar combinations of 
conditions 
Retained the original 
combined variable of 
legislature plus governor for 
easier interpretation. 
Proportion of women legislators 
 
Range: 14% – 52% 
Four-value fuzzy set: 
 
33% or higher = 1 (fully 
in) 
 
26% to 32% = 0.67 (more 
in than out) 
 
20-25% = 0.33 (more out 
than in) 
 




30% or higher = 1 (fully in) 
 
Less than 30% = 0 (fully 
out) 
Lower coverage scores 
 
Retained the original coding 
scheme because it provided 
greater coverage and thus 




Range: 3% - 24% 
Four-value fuzzy set: 
 
10% or higher  = 1 (fully 
in) 
 





10% or higher = 1 (fully in) 
 
Less than 10% = 0 (fully 
out) 
Similar findings 
Slightly lower coverage 
scores 
Retained the original coding 








7% = 0.33 (more out than 
in) 
 
6% or less = 0 (fully out) 
Rural population 
 
Range: 1% to 69% 
Three-value fuzzy set: 
 
27% or higher = 1 (fully 
in) 
 
20% - 26% = 0.5 (neither 
fully in nor fully out) 
 




40% or higher = 1 (fully in) 
 
Less than 40% = 0 (fully 
out) 
Lower solution coverage 
Fewer pathways (2 pathways) 
with large groupings of states 
in each pathway 
 
Retained the original coding 
scheme because it provided 
greater solution coverage and 
diverse information about the 
pathways. 
Final robustness check using all 
recalibrated variables from each 
sensitivity analysis listed above 
--- --- Very low coverage scores 
Lower solution coverage and 
consistency scores 
Retained original coding 
decisions because this 
provided greater coverage 
and preserved the rich 
variation and information 
about the different pathways. 
Robustness check using 
consistency cutoff value of 0.75 
--- --- Lower consistency scores 
Fewer pathways with large 
groupings of states in each 
pathway 
Retained original cutoff 
value of 0.80 to preserve the 
diversity of information 
present in these pathways. 
Robustness check using a 
variable representing the 
percentage of women legislators 
who are Democrat 
 
Range: 24% to 93% 
--- Crisp set: 
 
51% or higher = 1 (fully in) 
 
Less than 51% = 0 (fully 
out) 
Similar findings 
One of the pathways had low 
raw and unique coverage 
scores (.16 and .05, 
respectively). 
Retained original women 
legislators variable due to 










Appendix C: Supplementary Coding Information for Aim #3 
 
Table 1c. Descriptions of Codes and their Frequency in Nurx User Reviews 
Note: Percentage of total reviews do not add up to 100% since user reviews can contain multiple, overlapping codes. 
Themes and Codes Number of 
Reviews 
Percentage of Total 
Reviews (N=1,323) 
Code Description 
Access and Timeliness of Apps    
Speed/quick service 207 16% Fast process to order birth control 
Easy to use 235 18% App itself is easy to use (functionality), ordering process is easy 
Convenience 108 8% Mentions that the service is convenient, doesn’t have to leave home or go to 
doctor or pharmacy 
Medical need  143 11% Requires contraception to deal with medical side effects and symptoms, need for 
specific brands, existing medical conditions  
Shipping 143 11% Shipping orders out – fast or slow, never received or shipped 
In-person visit problems or barriers 243 18% References to any barriers associated with in-person visits: long appointment wait 
times, scheduling, time, cost, exams 
Clinician Interaction    
Provider 331 25% Answering questions, medical consultation, team, messaging 
Birth control options 260 20% Requests for a specific brands, different options offered for birth control  
Information/education 45 3% Provided information and education about birth control options, educational 
resources, choice tailored to individual and their preferences 
Discreet/privacy 24 2% Mentions how the service is discreet, private, confidential; not wanting others to 
find out, discreet packaging 
Cost and Affordability    
Cost/affordability 292 22% Explicit dollar amounts patients pay, thoughts about the cost-effectiveness and 
price of these services 
Insurance 339 26% Having or not having insurance and whether it is accepted by the app, whether 
certain insurance plans cover costs 
Billing complaints 183 14% Problems with incorrect amounts or charges, need a reversal 
Support for the Idea of Telecontraception    
Supports telecontraception idea  263 20% References to support or love the idea of this service, company, believes in 
expanding women’s health access 
State (un)availability 46 3% Mentions services not available in a certain state; need the services there 
Platform Development    
Technology complaints about app 167 13% Technological issues with app functionality, bugs, loading times, notifications, 
crashes, cannot add insurance, signs out 
App rollout  12 1% Conversion from the website to an app; experiences using the newly added app to 
the Google Play Store 
Customer service 437 33% Mentions customer service department, contact with them, resolving issues 







Table 2c. Descriptions of Codes and their Frequency in Planned Parenthood Direct User Reviews  
Note: Percentage of total reviews do not add up to 100% since user reviews can contain multiple, overlapping codes. 
 






Access and Timeliness of Apps    
Speed/quick service 158 30% Fast process to order birth control 
Easy to use 129 25% App itself is easy to use (functionality), ordering process is easy 
Convenience 80 15% 
Mentions that the service is convenient, doesn’t have to leave home or go to doctor 
or pharmacy 
Medical need 50 10% 
Requires contraception to deal with medical side effects and symptoms, need for 
specific brands, existing medical conditions 
In-person visit problems or barriers 101 19% 
References to any barriers associated with in-person visits: long appointment wait 
times, scheduling, time, cost, exams 
Clinician Interaction    
Provider 141 27% 
Answering questions, medical consultation, video consultation, video chat, demeanor 
of physician, speak to a physician 
Information/education 15 3% 
Provided information and education about different birth control options, educational 
resources, choice is tailored to the individual and their preferences 
Discreet/privacy 14 3% 
Mentions how the service is discreet, private, confidential; not wanting others to find 
out, discreet packaging 
Cost and Affordability    
Cost/affordability 104 20% 
Explicit dollar amounts patients pay, thoughts about the cost-effectiveness and price 
of these services 
Insurance 56 11% 
Having or not having insurance and whether it is accepted by the app, whether 
certain insurance plans cover costs 
Billing complaints 10 2% Problems with incorrect amounts or charges, need a reversal 
Support for the Idea of Telecontraception    
Supports telecontraception idea 73 14% 
References to support or love the idea of this service, company, believes in 
expanding women’s health access 
State (un)availability 44 8% Mentions services not available in a certain state; need the services there 
Planned Parenthood patient/history 50 10% Planned Parenthood supporter, in-person patient, grateful for the organization 
Platform Development    
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